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Abstract 
Development of a Three-dimensional Cell Culture Model for Epidermal Barrier 
Permeability Testing.  
 
By David Lundy 
 
In this thesis, a novel 3D polystyrene scaffold was investigated for use as a 3D cell 
culture material to support keratinocyte culture. Methods of collagen-coating the 
scaffold were investigated and a keratinocyte model was developed at the air-liquid 
interface to form an in vitro epidermal equivalent. The procedures for culturing 
keratinocytes were analysed experimentally to promote optimal proliferation and 
differentiation of the cells.  
Keratinocytes cultured in the scaffold showed signs of differentiation, visualised by 
immunofluorescence staining and ultrastructural analysis by scanning and 
transmission electron microscopy. The 3D model established is different to other 
epidermal models as keratinocytes differentiate inside the 3D substrate, rather than 
forming multiple layers on the air-exposed surface. 
Mature cornified envelopes with covalently attached lipids were isolated from the 
cultures after fourteen days at the air-liquid interface, showing that keratinocytes 
reached terminal differentiation in the 3D scaffold. Lipid extractions, identification 
and quantitation showed that the cultures produced a lipid profile similar to native 
human epidermis, and optimisations to the culture media further improved this 
similarity. 
In the final chapter, the barrier permeability of the 3D model to corticosterone was 
measured and the model was used to investigate the effect of inhibiting the JNK 
stress signalling pathway on keratinocyte differentiation and barrier function. This 
has previously not been investigated using a 3D model, and findings indicated that 
targeting this pathway may be useful for the treatment of psoriasis, a common skin 
disorder.  
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1.1 Prologue 
The skin is an essential protective organ of the human body. Of particular interest is 
the epidermis - the upper-most layer of the skin which forms a largely impermeable 
barrier between the body and the outside world. Disruption to the epidermis by 
disease, genetic defects or physical damage is implicated in many pathogenic 
conditions (Uitto et al, 2007, Sandilands et al, 2009). These conditions often reduce 
the ability of the epidermis to retain water and prevent the entry of foreign 
substances, resulting in dehydration or infection. The epidermis also represents a 
barrier to topical delivery of therapeutic agents and so understanding this barrier is 
essential for successful delivery of transepidermal medications and restoring barrier 
defects caused by disease (Godin et al, 2007). 
In order to study the epidermis, animal and human tissue samples have often been 
used. However there are clear practical, legal and ethical concerns with using excised 
samples, cadaver skin or live test subjects. Therefore keratinocytes, the main 
component of the epidermis, have been cultured in vitro in order to study their 
behaviour. Since the 1980's, keratinocytes have been used to generate tissue 
equivalents that replicate native epidermis (Prunieras et al, 1983). These equivalents 
have been primarily used for transplantation (i.e. for burn victims) and for in vitro 
experimentation to increase our understanding of the skin (Pappinen et al, 2007, 
Sobral et al, 2007). In vitro epidermal equivalents can also be used as a tool to 
further understand keratinocyte behaviour, in particular the complex and highly 
ordered process of differentiation that results in the formation of the epidermal 
barrier. 
Recently, European Union legislation and changing public perception is reducing the 
permissibility of testing chemical additives and pharmaceuticals on animals 
(Hartung, 2010, Wagner et al, 2012). As such, in vitro epidermal equivalents are 
gradually gaining acceptance as alternative methods for testing of pharmaceutical 
and cosmetic additives and there is a clear and growing demand for models which 
can accurately predict the permeability of a particular compound through human 
epidermis (Netzaff et al, 2005).  
In this thesis, a novel polystyrene-based 3D scaffold was investigated for its 
suitability in cell culture as the base for an in vitro epidermal model. Once this model 
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was established, it was characterised in terms of keratinocyte differentiation, then 
assessed for suitability in epidermal permeability testing. 
1.2 The Function of Skin 
The skin is mainly a protective organ - protecting the body against physical damage, 
chemical exposure, infectious pathogen entry, radiation and dehydration. The body is 
protected from impacts and shearing forces by the robust, flexible and self-renewing 
nature of the skin and a largely impermeable lipid and protein barrier prevents 
evaporation or absorption of water. Close cell-cell contacts, antibacterial agents and 
the presence of immune cells prevent pathogen entry through the skin. This thesis 
will primarily focus on the skin as a barrier to entry of external substances. 
The skin is a multi-layered organ composed of two main layers; the dermis and the 
epidermis which are separated by a basement membrane. The dermis is a supportive, 
connective tissue formed from collagen, elastic fibres, and extracellular matrix with 
vasculature that provides nutrition to the epidermis through the basement membrane. 
The epidermis and dermis interact across this basement membrane through growth 
factor and cytokine signalling which can regulate keratinocyte behaviour (Werner 
and Smola, 2001). 
The epidermis is a continually renewing tissue, primarily formed by keratinocytes 
which represent 95% of all epidermal cells. Keratinocytes form this skin barrier 
through the process of keratinocyte differentiation. Differentiation can be briefly 
summarised as follows. Basal keratinocytes proliferate while attached to the 
basement membrane, then detach from the membrane while remaining attached to 
other keratinocytes. A number of factors then contribute to a co-ordinated process of 
differentiation during which keratinocytes express insoluble proteins, produce 
hydrophobic lipids and flatten into insoluble, anucleate corneocytes embedded in a 
hydrophobic lipid matrix. These corneocytes eventually desquamate from the upper 
surface of the epidermis, allowing for the constant turnover of the epidermis and 
maintenance of the renewing epidermal barrier. This process takes approximately 28 
days in human skin and disruptions caused by imbalances in proliferation, 
differentiation or desquamation are implicated in many skin disorders (Baroni et al, 
2012, Elias et al, 2012, Sandilands et al, 2009, Uitto et al, 2007). 
A diagram showing the structure of the epidermis is shown in Figure 1.1.  
18 
 
 
Figure 1.1. Schematic Overview of Epidermal Differentiation 
Schematic diagram showing keratinocyte transition from the basal layer, through to 
the stratum corneum and subsequent desquamation. Major features of keratinocyte 
differentiation such as organelles and changes in keratin expression are noted. 
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1.3 Differentiation of Epidermal Keratinocytes 
Epidermal differentiation is a highly organised, multi-stage process during which 
basal keratinocytes detach from the basement membrane and undergo changes which 
adapt them for epidermal barrier function. This process is highly complex, involving 
profound changes in keratinocyte structure, protein expression, enzyme activity, lipid 
metabolism and multiple signalling pathways. Therefore, a brief overview will be 
presented containing information necessary for the understanding of material 
presented in this thesis, although not a complete review of all aspects of epidermal 
differentiation. 
1.3.1 The Basal Epidermal Layer 
Basal keratinocytes are roughly cuboidal cells attached to the basement membrane 
which are responsible for the renewal of the epidermis (Wickett and Visscher, 2006). 
Around 15% of these basal cells are proliferative at any given time under normal 
conditions, but when the skin is wounded more basal cells are able to enter cell cycle 
and begin to proliferate (Blanpain and Fuchs, 2006). During routine in vitro cell 
culture, cultured keratinocytes are normally in a state of proliferation which 
corresponds to approximately this basal state (Micallef et al, 2008). 
1.3.1.1 Basal Keratinocyte Integrins 
In the skin, basal epidermal keratinocytes are attached to a basement membrane 
which separates the dermis and epidermis. This basement membrane plays a 
structural role in the skin and also acts as a semi-permeable barrier to mediate the 
interaction of the dermis and epidermis through growth factors and cytokines. 
Keratinocyte keratin filaments attach to hemidesmosomes in the cell membrane 
which mediate contact with the basement membrane (Breitkreutz et al, 2009). 
Integrins are heretodimeric proteins on basal keratinocyte cell surfaces, formed from 
an alpha and beta subunit which transduce signals between the cell and the 
extracellular matrix (Watt, 2002). Together, integrins can regulate keratinocyte 
differentiation, proliferation and adhesion, and are also implicated in aging, wound 
healing and tumour formation (Watt and Fujiwara, 2011). The first evidence of this 
was presented by Green, 1977, who showed that keratinocytes held in a liquid 
suspension begin to terminally differentiate. This is now known to be caused by 
integrin binding suppressing keratinocyte differentiation. Integrins on basal 
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keratinocytes bind basement membrane components, the most abundant being 
integrin α2β1 (binds collagen), α3β1 (laminin 5) and α6β4 (laminin) (Watt, 2002, 
Cabrijan et al, 2011), suppressing keratinocyte differentiation. Basically, unoccupied 
integrins send signals to differentiate, while occupied integrins send signals to 
suppress differentiation (Levy et al, 2000). Intergrin-linked kinase (ILK) is one of the 
several  protein kinases that mediate cellular responses to integrin stimulation and 
ILK(-/-) mice show reduced transcription of several proteins and enzymes associated 
with differentiation and barrier function, including transglutaminase 3, small proline 
rich protein 9 and cornulin (involved in cornified envelope formation) as well as 
enzymes essential for formation of hydrophobic barrier lipids (Judah et al, 2012). 
The basement membrane is connected to the dermis by anchoring fibrils (Breitkreutz 
et al, 2009) and on the dermal side of the basement membrane, spindle-shaped 
fibroblasts exist in an extracellular matrix of collagen and elastic fibrils embedded in 
proteoglycans.  
1.3.1.2 Basal Keratins 
Epidermal keratins are synthesised by keratinocytes in pairs which are classified as 
either type I (acidic, low molecular weight) or type II (basic/neutral and high 
molecular weight) (Schweizer et al, 2006). Type I keratins are clustered on 
chromosome 17 and type II clustered on chromosome 17 (Hesse et al, 2001). As 
shown in Figure 1.1, basal keratinocytes express the intermediate filaments Keratin 
14 (K14) and Keratin 5 (K5) with K14 being type I and K5 being type II. Type I 
keratins contain a greater proportion of negatively charges amino acid side chains 
(aspartic or glutamic acid) and type II keratins contain more positively charged side 
chains (lysine, arginine, histidine), allowing the two keratins to pair together and 
form insoluble but highly dynamic coiled filaments essential for cell structure and 
function (Vaidya and Kanojia, 2007). These keratin filaments are organised in an 
ordered manner inside keratinocytes, appearing to emanate from a nuclear "cage" and 
extending through the cytoplasm, finally anchoring to junctional desmosomes and 
hemidesmosomes on the cell membrane (Uitto et al, 2007). Although robust and 
highly resilient, keratin subunits are not static scaffold. Rather, they participate in a 
cycle of constant turnover of assembly and disassembly. This begins with formation 
(nucleation) of keratin subunits at the cell edges, followed by elongation of the 
filaments and bundling around the cell nucleus. Some filaments form part of a 
permanent network surrounding the nucleus, while others become soluble and diffuse 
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through the cytoplasm, ready for integration into new filaments (reviewed by 
Windoffer et al, 2011).  
K5 and K14 are essential for the mechanical and structural integrity of the epidermis, 
and mutations in either are associated with epidermolysis bullosa simplex (EBS), a 
condition resulting in severe blister formation (Coulombe et al, 1991 and 2012). This 
fragility arises partially from weakened individual keratinocytes as well as poor 
transmittance of force between multiple cells. Lulevich et al, 2010 showed that KEB-
7 keratinocytes derived from a Dowling-Meara EBS patient with mutant K14 were 
1.6-2.2 times weaker and collapsed more easily when compressed compared to 
keratinocytes expressing normal K14. 
1.3.1.3 Epidermal Desmosomes 
Basal keratinocytes are connected to adjacent cells by desmosomes. Desmosomes are 
intercellular junction structures containing cytoplasmic proteins (plakoglobins, 
plakophilins and desmoplakin) and transmembrane cadherin proteins (desmocollins 
and desmogleins).  The transmembrane cadherins interact with the cadherins of 
neighbouring cells in the intercellular space and the cytoplasmic proteins link the 
cytoplasmic domain of the cadherins to the intracellular keratin networks Cabral et 
al, 2012). The overall effect of this linkage is to integrate neighbouring cell 
cytoskeletons, providing tissue cohesion and contributing to the epidermal barrier 
function (Wickett and Visscher 2006). A schematic diagram of two cells linked by a 
desmosome is shown in Figure 1.2. 
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Figure 1.2. Schematic Structure of Desmosomal Junctions 
A) TEM image of desmosome between two keratinocytes. The inner dense plaque 
(IDP), outer dense plaque (ODP) and intercellular space (ICS) are clearly visible. 
Scale bar 250µm. B) Schematic diagram showing keratin intermediate filaments bind 
C-terminal of desmoplakin in the IDP. The N-terminal of desmoplakin binds 
plakoglobin (PG) which then binds transmembrane desmoglein (DG) or desmocollin 
(DC). PG and DG interact in the intercellular space to join neighbouring cells. This 
shows how desmosomes effectively join adjacent cell keratin cytoskeletons, 
providing strength to the skin.   
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Desmoplakin is a rod-shaped protein, constituting the most abundant component of 
desmosomes. There are two isoforms (DSPI and DSPII) generated by alternate 
splicing and varying by the length of the central rod domain. Both have an N-
terminal domain which binds plakoglobin, which then interacts with the cytoplasmic 
tail of desmosomal cadherins, and a C-terminal domain which targets to intermediate 
filaments directly (Sumigray et al, 2011). Both splice variants DSPI and DSPII (and 
a recently discovered DSPIa variant (Cabral et al, 2010) are expressed in almost 
identical levels in the epidermis (although DSPI is expressed preferentially in the 
heart), but the precise function and interplay of each isoform is still not fully 
understood. It does not appear that the two proteins are redundant to one another in 
the skin, as siRNA knockout of DSPI or DSPII in cultured keratinocytes shows 
altered cellular responses to stress induced by stretching (Cabral et al, 2012). It 
appears that DPSII is more important in intermediate filament stability, but DSPI 
plays some role in the expression and activity of other plakin proteins (Cabral et al, 
2012).  
Desmoplakin mutations are associated with a variety of clinical phenotypes including 
skin fragility, blistering and increased transepidermal water loss, but also 
cardiomyopathy owing to desmosome importance in contractile heart muscle 
(Brooke et al, 2012). Desmoplakin also seems important in morphogenesis, as 
desmoplakin-null embryos die at E6.5 after failing to form blood vessels or heart 
tissue (Vasioukhin et al, 2001) and skin-targeted ablation of desmoplakin in mice 
results in post-natal lethality after a few days due to massive water loss caused by 
blistering (Lai Cheong et al, 2005).  
In the intercellular space, desmocollins (Dsc 1-3) and desmogleins (Dsg 1-4) bind to 
attach neighbouring cells (Naoe et al, 2009). Both desmocollin and desmoglein 
proteins have an intracellular anchor domain which binds plakoglobin, a 
transmembrane domain, and varying numbers of extracellular 110 amino acid 
repeats, each separated by calcium binding motifs. Desmogleins contain an extra 
intracellular linker protein and terminal domain (Delva et al, 2009). It is not known 
whether Dsc and Dsg binding is homophilic, heterophilic or a combination of both, 
but it is known that both proteins are required for optimal cell-cell adhesion (Getsios 
et al, 2004). 
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In the epidermis, desmosomes are important for tissue integrity and barrier function 
as described earlier, and all seven desmocollin and desmoglein cadherins are 
expressed. Desmoplakin is expressed in all layers of the epidermis but the expression 
pattern of the desmosomal cadherins changes throughout the process of keratinocyte 
differentiation, with Dsg2, Dsg3, Dsc2 and Dsc3 preferential in the basal and spinous 
layers, and upregulation of Dsg1, Dsg4 and Dsc1 in the granular layers (Delva et al, 
2009). Peter Elias and colleagues, 2001, expressed basal Dsg3 under an involucrin 
promoter (i.e. forcing expression in suprabasal differentiating epidermial layers) in 
mice and showed that the epidermis developed a morphology more closely 
resembling oral mucosa than stratified epidermis. These mice died within 10 days 
from severe dehydration even though they showed normal differentiation markers. 
Whereas Dsg1 and Dsg3 are restricted to stratified epithelia, Dsg2 and Dsg4 are 
located in most simple epithelia as well (Brennan et al, 2007). In a similar 
experiment, Brennan et al, 2007 expressed basal Dsg2 under the mouse involucrin 
promoter and showed a hyperproliferative, hyperplasic morphology with normally 
basal K14 expression extending into the differentiating granular layer. These 
experiments show that desmosomes are not only important for tissue integrity, but 
also play a role in guiding differentiation. These changes will be discussed 
throughout the relevant stages in this introduction. Merkel cells of the epidermis are 
also adhered to keratinocytes through desmosomes, although they express 
plakophilin Pkp2, which is not found in keratinocytes (Rickelt et al, 2012). The 
importance of this asymmetric connection is not yet understood. 
Basal keratinocytes also have an apical centrosome acting as an organiser of 
microtubules, which is lost as cells detach from the basement membrane and undergo 
differentiation. Centrosomal proteins Lis1 and Ndel1 are involved in the attachment 
of microtubules to desmoplakin during differentiation, and loss of either desmoplakin 
or Lis1 is lethal due to barrier permeability induced dehydration (Sumigray et al, 
2011).  
1.3.1.4 Keratinocyte Adherens Junctions 
Adherens junctions are essential for the structural integrity of the epidermis. The 
main constituent of epidermal adherens junctions are E-cadherin, a transmembrane 
protein which links cells by forming homophilic interactions based on calcium ions 
(Kim et al, 2011). The inner portion of transmembrane E-cadherin couples to actin 
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via α-catenins and β-catenins and vinculin, thus linking the cytoskeletons of adjacent 
cells (Young et al, 2003). E-cadherin ablated mice display epidermis with reduced 
numbers of adherens junctions, and widening of intercellular spaces, leading to 
stiffness and greater susceptibility to physical damage (Young et al, 2003). These 
results also showed that E-cadherin plays a role in guiding differentiation, with 
keratinocytes showing upregulation of K6, a marker of hyperproliferation, and 
reduced loricrin expression. 
Increasing calcium concentration during differentiation induces E-cadherin binding 
on neighbouring cells and formation of adherens junctions. The E-cadherin-catenin 
complex at the cell membrane then recruits PLP3-kinase which activates 
phospholipase C increasing intracellular calcium (Tu et al, 2011). E-cadherin 
mediated adhesion is regulated by tyrosine kinases such as Fyn, also activated by 
rising extracellular calcium. 
It is becoming clear that cell surface cadherins influence cell signalling, proliferation 
and differentiation. E-cadherin derived signalling in keratinocytes has been 
implicating in reducing cellular response to epidermal growth factor (EGF) and 
inducing growth arrest (Muller et al, 2007). Further evidence for this is provided by 
Ctnna1 α-catenin embryonic knockout mice that demonstrated enhanced 
proliferation of basal epidermal cells, but apoptosis in suprabasal differentiating 
keratinocytes (possibly due to lack of attachments) and reduced growth factor 
receptor localisation to the cell membranes. The protection of basal cells against 
apoptosis was ablated by inhibiting focal adhesion kinase, further supporting the role 
of adherens junctions in preventing apoptosis and showing the importance of 
signalling by adherens junctions and focal adhesions (Livshits et al, 2012). 
1.3.1.5 Epidermal Stem Cells 
The epidermis is an organ which relies on constant renewal, making it the most 
abundant source of stem cells in the human body (Fuchs, 2012). Cells desquamating 
from the surface of the stratum corneum are replaced from underneath by cells 
originating from the proliferating basal layer and these basal proliferative cells also 
need to be replaced in order to maintain a steady state during turnover of the 
epidermis. This balance between self-renewal and differentiation is finely regulated, 
in a complex field of science with implications in cancer, wound healing and skin 
therapies which is still being revealed (Beck and Blanpain, 2012).  
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The epidermis can be divided into anatomical structures such as the hair follicle, 
sebaceous glands, sweat glands and the interfollicular epidermis (IFE). Specific 
compartments of the epidermis appear to be maintained by stem cells from specific 
epidermal niches, even though epidermal stem cells are able to differentiate into any 
epidermal lineage (Blanpain et al, 2007, Ambler and Määttä, 2009). Stem cells, 
identified as slow-cycling, "label retaining" cells (referring to BrdU DNA labeling, 
(Bichenbach, 1981)) have been found in several compartments of the epidermis, 
primarily (~90-95%) in the bulge region of hair follicles, underneath the sebbaceous 
glands. When transplanted into immunodeficient mice these cells only participate in 
maintaining the hair follicle itself, and not the sebacceous glands or interfollicular 
epidermis. However, if these mice are wounded by punch biopsy, the same cells then 
participate in restoration of the interfollicular epidermis (Nowak et al, 2008). The 
hair follicle goes through cyclical phases of destruction, rest and renewal during 
which hair follicle stem cells and melanocyte stem cells go through tightly controlled 
periods of rest and activation, allowing the co-ordinated production of pigmented 
hair (Fuchs, 2012). Precise mechanisms are still being revealed.  
However, since some areas of the body such as the palms and soles of feet are 
hairless, hair follicles are unlikely to be the only source of epidermal stem cells. 
Biedermann et al, 2010 showed that isolated human eccrine sweat gland cells are 
able to reconstitute an in vitro epidermis on collagen gels or wounded athymic rats. 
Stem cells have also been isolated from the upper hair follicle, hair bulb, upper 
isthmus and sebacceous glands, as well as the interfollicular epidermis and bulge 
mentioned previously (Ambler and Määttä, 2009). 
Under normal conditions, the continuous replacement of cells in the interfollicular 
epidermis has been attributed to "epidermal proliferation units" (EPUs) throughout 
the epidermis which contain at least one stem cell per unit. Stems cells attached to 
the basement membrane then undergo either symmetric or asymmetric division, 
producing either two more stem cells or one stem cell and one committed cell 
respectively. This process is still debated, with opposing models stating that 
epidermal stem cells provide committed daughter cells through transit amplifying 
cells (Fuchs and Horsley, 2008) or directly from asymmetrical division (Clayton et 
al, 2007, Doupe et al, 2010). It has been proposed that the outcome of progenitor 
division is random, but with equal probability of generating differentiated or 
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progenitor cells, thus maintaining homeostasis (Doupe et al, 2012). Upon 
differentiation, these cells detach from the basement membrane into the suprabasal 
layers and begin to differentiate (Trappmann et al, 2012).  
Many different molecular regulators are involved in the maintenance, commitment 
and differentiation of these epidermal stem cells. Wnt/β-catenin appears to be highly 
significant, with upregulation of this pathway pushing cells towards a hair follicle 
lineage and downregulation directing cells to a basal interfollicular epidermis 
keratinocyte lineage (Lowry et al, 2005). Proteins downstream of β-catenin also 
appear independently involved, such as c-myc which causes epidermal hyperplasia 
and hair loss in mice with atopically activated c-myc (Watt et al, 2008). P63 is found 
in all stratified epithelia in the body, and in the absence of p63, the epidermis fails to 
form, although the precise nature of this role is not yet understood (Beck and 
Blanpain et al, 2012). Notch is a cell membrane receptor important in cell-cell 
communication found in all cellular epidermis layers (Lowell et al, 2000). It is 
activated by delta 1 and jagged 1 on neighbouring cells or when cleaved jagged 1 is 
secreted by more distant cells (Urs et al, 2008). Notch signalling appears to induce 
differentiation of epidermal cells (Estrach et al, 2007) and in a mouse model using 
inducible Notch intercellular domain, Notch activation by jagged 1 caused epidermal 
thickening, hair clumping and lymphocyte accumulation in the dermis, indicating 
several different roles in the skin (Ambler and Watt, 2010). 
1.3.1.6 Epidermal Aquaporins 
Aquaporins are water-transporting proteins present in epithelial tissues, including the 
skin, which assist the transporting of water or glycerol into cells. Aquaporin 3 
(AQP3) is abundantly expressed in the basal and spinous layers of the epidermis and 
is involved in skin hydration (Hara-Chikuma and Verkman, 2005) but also plays a 
role in epidermal proliferation during wound healing. AQP3-null mice display dry 
skin, increased transepithalial water loss, reduced elasticity and delayed recovery of 
epidermal barrier function after wounding by removal of the stratum corneum (Hara-
Chikuma and Verkman, 2008). Interestingly, although AQP3 is found only in basal 
and spinous layers, AQP3 expression is important for the concentration of glycerol in 
the stratum corneum, where it functions as a natural moisturising factor (Hara-
Chikuma and Verkman, 2005). Psoriatic epidermis also shows reduced expression of 
AQP3 compared to healthy controls (Lee et al, 2012). 
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1.3.2 The Spinous Epidermal Layer 
Once basal cells detach from the basement membrane, they begin to differentiate, 
undergoing changes in morphology, keratin expression, organelle formation and lipid 
synthesis until they are flat, anucleate remnants of cells forming the stratum 
corneum. Spinous cells form 4-8 layers of the human epidermis and although post-
mitotic, these cells are highly metabolically active, synthesising large amounts of 
proteins involved in epidermal barrier function (Fuchs, 1990).  
As shown in Figure 1.1, these spinous keratinocytes begin to synthesise Keratin 1 
(type II keratin) and Keratin 10 (type I keratin), which are considered the earliest 
markers of terminal keratinocyte differentiation (Micallef et al, 2008). Owing to the 
long half-life of the proteins, keratin 14 and 5 can still be detected in the spinous 
layers, although they are no longer actively synthesised (Fuchs and Green, 1980, 
Rugg et al, 1994). Cell transfection experiments have shown that existing K14/5 
networks are required for K1/10 networks to form properly as K1 associates to 
existing K14/5 networks before K10 is then integrated (Kartasova et al, 1993).  
Similar to K14 and K5, K1 and K10 are also anchored to desmosomes which attach 
spinous keratinocytes together, making them essential for skin structure and barrier 
function. As well as being structural proteins, keratins may play a role in cell 
proliferation. Santos et al, 2002 expressed K10 under the K5 promoter and 
demonstrated that the presence of K10 within basal keratinocytes inhibits their 
proliferation. This is further hinted at during epidermal wounding, where K10 
expression is downregulated, possibly to allow more proliferation to occur and repair 
the wound (Koch and Roop, 2004). 
Mutations in Keratin 10 are associated with epidermal ichythoses presenting as skin 
erosions, scaliness, frequent and fragile blistering and dehydration (Cheng et al, 
1992). These mutations can be lethal, causing death by dehydration and infection 
(Covaciu et al, 2010). Recent evidence (Wallace et al, 2011) demonstrated that 
double deletion of K1 and K10 in mice does not inhibit stratification or formation of 
a competent permeability barrier. This is surprisingly, due to the role of keratin 
attachment to involucrin in the formation of the cornified cell envelope (Candi et al, 
2005). Nevertheless, postnatal lethality still occurred in double knockout K1/K10 
mice due to increased epidermal fragility leading to lesions. Desmosomal proteins 
were reduced and denucleation of keratinocytes occurred earlier than normal within 
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the epidermis of these mice as a side-effect of K1 and K10 deletion and interestingly, 
the double knockout was not compensated by upregulation of other keratins. K10 
knockout alone has been shown (Reichelt et al, 2001) to be compensated by 
upregulated basal K5 and K14. 
Keratinocytes in the upper spinous layer also begin to produce involucrin, first 
described by Rice and Green, 1979. Involucrin is a 68Kda, rod-shaped protein with 
an internal region containing 39 repeats of 10 amino acids which provide the 
substrate for extensive crosslinking (Eckert et al, 1993). Involucrin is important 
during cornified envelope formation, but only represents 2-5% of the protein in 
mature human cornified envelopes. During terminal differentiation, involucrin is 
deposited to the inner surface of the keratinocyte membrane and will eventually form 
the backbone of the cornified cell envelope after cross-linking by transglutaminase 
enzymes, also produced by spinous stage keratinocytes (Eckert et al, 1993). This will 
be discussed in greater detail under the "Cornified Envelope" portion of this 
Introduction. In this thesis, Keratin 1 and Involucrin will be used as markers of 
keratinocyte differentiation. 
1.3.3 The Granular Epidermal Layer 
Although only a few cell layers in thickness, the granular zone of the epidermis is 
where the major transitions between viable, living keratinocytes and flattened 
remnant skeletons of the stratum corneum occur. This includes the collapse of the 
keratinocyte cytoskeleton, release of lipids into intercellular spaces and the 
replacement of the plasma membrane with the cornified envelope (Wickett and 
Visscher, 2006).  
1.3.3.1 Filaggrin 
The granular layer is so-called because of deeply-stained keratohyalin granules 
observed in H&E staining, characterised by Brody, 1957. Keratohyalin granules are 
synthesised in the granular layer and are composed primarily of pro-filaggrin 
(400KDa) which is a histidine and arginine-rich, heavily phosphorylated and highly 
insoluble protein (Rawlings and Harding, 2004). Human pro-filaggrin contains 10-12 
filaggrin repeats, joined by hydrophobic linker peptides (Kezic et al, 2011). Upon 
high extracellular calcium concentration keratinocytes degranulate and pro-filaggrin 
is processed to release multiple filaggrin monomers (37KDa) (Fleckman and 
Brumbaugh, 2002). This process requires dephosphorylation of pro-filaggrin, 
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followed by separation of the N-terminus from the filaggrin repeat domain. Many 
protease enzymes participate in this process, such as profilaggrin endopeptidase 1 
(PEP1), matriptase 1 (MT-SP1) and CAP1 (Sandilands et al, 2009). The cleaved N 
terminus then translocates to the nucleus during the terminal differentiation of the 
keratinocyte preceding the loss of the nucleus, possibly suggesting a role in the 
denucleation of the cell (Ishida-Yamamoto, 2005).  
The end-product, filaggrin (filament aggregating protein) is a protein essential for 
aggregation of keratin filaments into higher molecular weight parallel structures 
during the final stages of differentiation where keratinocyte flatten and become 
anucleate. These tightly-aggregated keratin filaments aid in the collapsing of the 
keratinocyte into the flattened corneocyte and also form the cytoskeletal base for the 
attachment of loricrin, involucrin, envoplakin and periplakin to form a scaffold on 
the inner keratinocyte plasma membrane (Sandilands et al, 2009).  
Loss or mutation of filaggrin, profilaggrin or their processing enzymes is relatively 
common within European populations and is correlated with numerous skin disorders 
including ichthyosis vulgaris (Morar et al, 2007) but also immune-related disorders 
such as eczema (Bohme et al, 2012) and atopic asthma (Sandilands et al, 2009). This 
may be due to increased percutaneous sensitisation to allergen antigens, altered 
immune reactions to skin surface bacteria or reduced natural moisturising factors 
(O'regan et al, 2009, Kezic et al, 2011). The precise mechanism between filaggrin 
mutations and atopic diseases is still not understood, but filaggrin mutations and 
eczema are one of the mostly strongly correlated gene-to-disease associations 
currently known (O'regan et al, 2009). Filaggrin may also play a role in maintaining 
the acidic pH of the stratum corneum, as filaggrin deficient "flaky tail" mice show 
poor pH buffering when exposed to neutralising agents (Roelandt et al, 2011) which 
may also contribute towards increased atopic disease through weakening of the skin 
barrier. Filaggrin mutation  may also be linked to inflammatory responses. Kezic and 
colleagues, 2012, examined 129 patients with atopic dermatitis and found strong 
correlations between filaggrin mutation severity and increased pH and reduced NMF 
content. They also detected upregulated IL-1 in the stratum corneum, with possible 
implications in the inflammatory effects associated with filaggrin mutations. 
Patients with ichthyosis vulgaris (IV) have shown abnormalities in the granular layer 
and lack or keratohyalin granules (Fleckman and Brumbaugh, 2002). In a 
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comprehensive study of patients with heterozygous and homozygous filaggrin 
deficient IV, filaggrin genotype was associated with the degree of abnormalities 
(Gruber et al, 2011). Epidermal skin abnormalities were observed in almost every 
area of barrier function including increased cornified envelope fragility, intermediate 
filament retraction, reduction in the number and size of keratohyalin granules, 
increased skin surface pH, reduced stratum corneum hydration with hyperkeratosis 
and associated increases in stratum corneum cohesion. These factors combine to 
increase transepithelial water loss and paracellular penetration, as observed by a 
tracer dye which passed more readily between flattened corneocytes. These results 
were confirmed using in vitro models formed with filaggrin knockout keratinocytes, 
demonstrating that filaggrin is a highly important protein in the function of the 
epidermis. Filaggrin is used throughout this thesis as a marker of late stage 
keratinocyte differentiation. 
1.3.3.2 Lamellar Bodies 
Lamellar bodies are an excretory organelle found in keratinocytes of the granular 
layer, originating from the Golgi. Lamellar bodies are round/oblong packaging 
organelles which play a key role in terminal differentiation (Bergman et al, 2008). 
During the process of differentiation, keratinocytes synthesise a number of precursor 
lipids such as glucosylceramides (GluCer), cholesterol sulphates (CSO4), 
sphingomyelin (SM) and long chain free fatty acids.  
In response to high intracellular calcium concentration in the granular layer of the 
epidermis, lamellar bodies fuse with the keratinocyte plasma membrane and 
exocytose their contents into the extracellular spaces (Baroni et al, 2012). This 
releases lipid precursors into the extracellular spaces between flattening cells. These 
precursor lipids such as glycosphingolipids, sphingomyelin and glucosylceramides 
are converted to hydrophobic ceramides by lysosomal enzymes, and most 
phospholipids are converted into free fatty acids (Proksh et al, 2008, Duan et al, 
2012). Transglutaminase enzymes covalently attachment ceramides and fatty acids to 
proteins such as involucrin to increase hydrophobicity of the epidermal barrier. The 
result is that terminally differentiated corneocytes are embedded in a matrix of 
extracellular lipid lamellae of ceramides, free fatty acids (FFA) and cholesterol, 
forming a highly impermeable barrier (Proksh et al, 2008). This shows that lamellar 
32 
 
bodies are highly important for forming a large component of the epidermal 
hydrophobic barrier. 
These precursor lipids are primarily packaged into lamellar bodies with the aid of 
ATP-binding cassette transporters, namely at least 11 members of the ABCA12 
transporter family (Zuo et al, 2008, Mizutani et al, 2009). The latest evidence 
suggests that golgi pH receptor (GPHR) also plays some role in either the packaging 
or excretion of lipids by lamellar bodies, as GPHR knockout mice display abnormal 
lamellar bodies and reduced ceramide content of the stratum corneum (Tarutani et al, 
2012). Mice lacking ABCA12 transporters are unable to transport precursor lipids 
into lamellar bodies (Zuo et al, 2008). These mice displayed hyperkeratosis of the 
stratum corneum but lacked mature Ceramide 1/Cer(EOS), possibly because lamellar 
bodies were not able to transport immature glucosylceramides to a location where 
they could be converted into mature, hydrophobic ceramides. These ABCA12-null 
mice die at birth due to rapid dehydration caused by accelerated transepidermal water 
loss. In humans, ABCA12 mutations cause the devastating disease Harlequin 
Ichythosis, characterised by hard, plate-like scales over all epidermal surfaces, poor 
appendage formation and often infant mortality due to lack of temperature 
regulation, enhanced water loss and bacterial infection (Zuo et al, 2008). 
As well as Harlequin Ichythosis, two further disorders are associated with abnormal 
lamellar body transportation. CEDNIK (cerebral dysgenesis, neuropathy, ichythosis, 
and palmoplantar keratoderma) syndrome is caused by loss of function mutation in a 
SNARE protein, responsible for mediating membrane fusion which is utilised 
heavily in the golgi. This has implications for the entire body, but patient skin shows 
empty, abnormal granules throughout the epidermis and unsecreted lamellar body 
contents in cornified cells (Hershkovitz et al, 2008). The second known disorder is 
ARC syndrome, caused by mutation in VPS33B, a protein which regulates SNARE 
membrane fusion. In this disorder, intact lamellar granules were found inside the 
cornified layers, indicating dysfunction in proper secretion (Ishida-Yamamoto and 
Kishibe, 2011). 
As well as precursor lipids, lamellar bodies also contain antimicrobial defensins 
(Ishida-Yamamoto, 2005), which are released into the extracellular areas of the 
stratum corneum to aid in the skin's protective role. Lamellar bodies may also play a 
role in both the formation and degradation of corneodesmosomes in the stratum 
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corneum, as they have been found to contain corneodesmosin, desquamation 
enzymes (kallikreins) and inhibitors of those enzymes (Ishida-Yamamoto et al, 
2011). 
1.3.3.3 Loricrin 
Loricrin is a globular 26kDa protein which is expressed late in the granular layer. 
Loricrin is the main component of the cornified cell envelope where calcium-
dependent transglutaminase (TGase) enzymes crosslink loricrin and involucrin 
(linking glutamine to lysine side chains by isopeptide bonds), followed by other 
proteins to form an insoluble protein backbone (Steinert et al, 1997). This process is 
described in more detail in relation to cornified envelope formation.  
1.3.3.4 Epidermal Tight Junctions 
While epidermal barrier function is largely derived from the flattened cells of the 
stratum corneum, nucleated cells of the stratum granulosum and lower layers also 
play an important role. Tight junctions regulate the paracellular diffusion barrier of 
the epidermis by closely connecting neighbouring nucleated cells in the granular 
layers. Tight junctions, containing occludin, zonula occludens proteins (ZO-1 and 
ZO-2), JAM-A, cingulin and claudin-1, claudin-4 and claudin-5, are found in the 
lower granular layer of the epidermis (Peltonen et al, 2006) and are lost towards the 
most superficial granular layer (Ishida-Yamamoto et al, 2012). Tight junction 
proteins are found expressed throughout different layers of the epidermis, but only 
seem to form mature junctions, capable of trapping hydrophilic tracers, in the lower 
granular layer (Kirschner et al, 2012). The question of whether differentiation 
induces tight junction formation, or whether tight junction formation influences 
differentiation, is yet to be understood and has been posed as a "chicken and egg" 
situation (Kirschner et al, 2012). 
Tight junctions are clearly important in epidermal barrier function, as claudin-1 
deficient mice die shortly after birth due to water loss caused by tight junction 
deficiencies. However, if the epidermis is transplanted onto nude mice, it grows in a 
hyperproliferative manner (Furuse et al, 2002). Tight junctions may also be able to 
compensate in epidermis which is affected by other disorders. For instance, in 
psoriatic lesions, tight junctions are present deeper in the epidermis (into the spinous 
layers), which was not observed in either normal skin or healed lesions from the 
same patient (Peltonen et al, 2006).  
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There is evidence (Kuroda et al, 2010) showing that functional tight junctions play a 
role in lamellar body secretion, and that disrupting tight junction formation inhibits 
properly polarised (i.e. towards the stratum corneum) lamellar body release. This 
suggests a role of tight junctions as guiding lamellar bodies, perhaps acting as a 
"fence" to prohibit secretion along some axis of the keratinocyte. Calcium is one 
regulators of lamellar body secretion and disturbances in tight junctions by sodium 
caprate have been shown to upset the normal epidermal calcium gradient and 
disregulate the balance between proliferation and differentiation (Kurasawa et al, 
2011). This may implicate tight junctions formation in guiding differentiation. 
However, a recent study (Ishida-Yamamoto et al, 2012) showed that in the sequence 
of keratinocyte differentiation, lamellar granule secretion occurs before epidermal 
tight junctions are fully formed which adds further confusion to this interaction. 
Tight junctions may play role in the immunological function of the skin. It has been 
suggested (Kubo et al, 2009) that the tight junctions in the stratum granulosum allow 
Langerhans cells to present antigens from the stratum corneum while still 
maintaining epidermal barrier function. Evidence suggests that tight junctions are 
formed between keratinocytes and Langerhans cells, which themselves express 
claudin 1. Toll-like receptor 2 (TLR2) activation was also found to increase tight 
junction formation in the epidermis, further indicating an immune system linkage 
(Yuki et al, 2011). 
Other new evidence (Haftek et al, 2011) shows that tight junctions may 
compartmentalise the stratum corneum by providing lateral but not horizontal 
connections between cornified envelopes. As such, the precise roles of tight junctions 
in the epidermis are not yet fully understood, although they are recognised as 
important for many aspects of barrier function. 
In this thesis, ZO-1 staining will be used to identify tight junctions in cultured 
keratinocytes. 
1.3.3.5 Granular to Stratum Corneum Transition 
In the upper granular layer, keratinocytes collapse, become anucleate and expel their 
contents into the extracellular spaces. This process has been likened to a form of 
apoptosis, but several differences are noted - apoptosis occurs in individual cells, 
whereas terminal differentiation is synchronous across multiple cells. Differentiation 
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also takes many days, whereas apoptosis occurs within minutes. Cells undergoing 
apoptosis also fragment and display membrane blebbing, but flattening keratinocytes 
do not (Candi et al, 2005). 
During the transition between viable to non-viable keratinocytes, the phospholipid 
cell membrane of viable keratinocytes is replaced by the cornified envelope and the 
membrane phospholipids are broken down into free fatty acids by phospholipases. 
These free fatty acids are then metabolised into other hydrophobic barrier lipids 
(Fluhr et al, 1992). Cellular proteins such as keratins and filaggrin are deiminated 
and further degraded into natural moisturising factors which will be discussed later. 
1.3.4 The Cornified Layer 
The stratum corneum has been termed "bricks and mortar" (Elias, 1983) where 
heavily-crosslinked, insoluble cornified envelopes of protein and lipid form the 
bricks, embedded in mortar of intercellular lipid lamellae formed primarily by 
ceramides (Nemes and Steinert, 1999). This mixture provides a structurally robust 
but flexible , hydrophobic barrier. A schematic diagram of this structure is shown in 
Figure 1.1. The stratum corneum is approximately 12-16 layers thick on most body 
sites, although as few as 9 layers on the eyelids and over 50 layers on the palms or 
soles of the feet (Wickett and Visscher, 2006).  This corresponds to approximately 
10-100µm thickness depending on body site. In order to pass through the stratum 
corneum, molecules must weave their way through the extracellular lipids around the 
insoluble cornified envelopes, or pass directly through the flattened corneocytes 
(Elias et al, 1981).  
Cornified envelope formation is a carefully ordered process which is essential for the 
proper development of the epidermal barrier. For instance, lamellar bodies locate to 
the cell membrane to excrete lipids precursors used in cornified envelope formation, 
but they need to do this before access to the membrane is blocked by the formation 
of the cross-linked protein barrier (Määttä, 2004).  
Cornified envelopes are insoluble structures, 5-20nm in thickness, which have 
replaced the viable keratinocyte plasma membrane during the process of 
differentiation. They contain an insoluble inner layer of heavily crosslinked 
involucrin, loricrin and small proline rich proteins with an outer layer of covalently 
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attached lipids and represent the end-point of a keratinocyte life cycle in the 
epidermis - so-called "terminal differentiation" (Proksh et al, 2008). 
Involucrin and loricrin have already been discussed, but they are not the only protein 
constituents of the cornified envelope. There are several small proline rich proteins 
(SPRPs) ranging from 6-25kDa in the epidermis. Of particular importance are 
SPRR2G and SPRR4 which function as bridge-forming amino acid donors and 
receivers during TGase assembly of cornified envelopes (Magdalini et al, 2012). 
SPRP4 may also play a role in quenching reactive oxygen species in the skin 
(Vermeij et al, 2010). Other proteins such as trichohyalin, which bears structural 
similarities to involucrin (Kypriotou et al, 2012) and Kazrin, first described by Groot 
et al, 2000, also form part of the scaffold on which the cornified envelope is formed. 
Kazrin binds to periplakin and plays a role in regulating differentiation. 
Overexpression of kazrinA in human keratinocytes promotes differentiation and 
knockout of kazrinA impairs differentiation (Chhatriwala et al, 2012). S100 proteins 
are calcium binding proteins located within the nucleus and/or cytoplasm of 
keratinocytes. Under the influence of increased intracellular calcium concentration 
S100 proteins undergo conformational change and bind to target proteins to modify 
their function.  S100 proteins can also act as transglutaminase substrates and 
cornified envelope precursors (Broome and Eckert, 2004).  
Desmosomes appear to be the initiation sites of cornified envelope formation (Di 
Colandrea et al, 2000). Two of the earliest cornified envelope precursors are 
envoplakin and periplakin, which begin the process by forming heterodimers and 
locating to the desmosome where the C-terminus binds intermediate filaments 
(Sevilla et al, 2007). Periplakin binds kazrin, a protein which localises to the cell 
membrane, desmosomes or adherens junctions (Groot et al, 2004), and also appears 
to play a role in initiating differentiation (Sevilla et al, 2008). Transglutaminase 
enzymes link envoplakin, periplakin and involucrin by iso-peptide bonds, forming a 
scaffold which bridges the gaps between desmosomes just inside the cell plasma 
membrane. Late envelope proteins such as loricrin, SPRPs and bundled keratin 
filaments are then attached to the scaffold (Kypriotou et al 2012). 
Interestingly, many of the proteins  essential for epidermal differentiation in humans 
are encoded by genes clustered on chromosome 1q21 in the so-called "epidermal 
differentiation complex (EDC). These proteins include involucrin, loricrin, small 
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proline-rich proteins, transglutaminases, S100 family proteins and profilaggrin which 
constitute the cornified envelope (Kypriotou et al, 2012). 
Hydrophobic lipids such as ω-hydroxyceramides are covalently attached onto this 
protein backbone, thus forming a highly insoluble, hydrophobic matrix which 
replaces the normal cell membrane (de Koning et al, 2012). There are four TGase 
enzymes expressed in keratinocytes, each with slightly different functions. Of 
particular importance is TGase1 which cross-links cornified envelope precursor 
proteins, and mutations of this enzyme cause lamellar ichthyosis and proliferative 
hyperkeratosis, leading to increased transepidermal water loss (Kypriotou et al, 
2012). 
Interestingly, despite the ubiquitous presence of involucrin, envoplakin and 
periplakin in cornified envelopes, loss of either one does not confer significantly 
abnormal barrier function (Määttä et al, 2001, Aho et al, 2004). Even knockout of 
loricrin, which is the most abundant cornified envelope protein, does not cause a 
serious phenotype (Koch et al, 2000), suggesting compensation mechanisms are able 
to recover barrier function. Triple knock-out mice with ablated envoplakin, 
periplakin and involucrin (Sevilla et al, 2007) showed dry, scaly skin, fragile 
cornified envelopes and reduced ω-hydroxyceramide content, but no fatal barrier 
dysfunction. Compensation was achieved by downregulation of cathepsin and 
proteinase enzymes, resulting in reduced desquamation of flattened corneocytes and 
accumulation of a thicker stratum corneum. 
1.3.4.1 Natural Moisturising Factors 
The term natural moisturising factors (NMFs) describes a number of hydrophilic 
amino acids, metabolites and ions which maintain the hydration and acidic pH of the 
stratum corneum. As well as the protein and lipid barrier of the epidermis, a water 
gradient is also present across the stratum corneum under normal conditions (Caspers 
et al, 2001), allowing it to function as a barrier in dry environments. The cellular 
layers of the epidermis contain approximately 70% water, which drops rapidly to 40-
45% in the stratum corneum over a distance of only 15-20µm, with the total stratum 
corneum being approximately 150µm thick (Caspers et al, 2003). NMF distribution 
is inversely proportionate to this, with the NMF concentration increasing rapidly 
shortly after the stratum corneum layer begins and remaining relatively constantly 
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through the thickness of the stratum corneum itself, aside from the region closest to 
the surface of the skin, likely due to environmental factors (Caspers et al, 2003). 
As mentioned earlier, filaggrin monomers are essential to the NMF as the substrates 
for deimination and proteolysis. Filaggrin, along with Keratin 1 and other proteins in 
collapsed keratinocytes, undergoes deimination - the conversion of arginine into 
citrulline residues by peptidylarginine deiminases (PAD) (Sandilands et al, 2009). 
After deimination, enzymes such as caspase 14, caplain 1 and bleomycin hydrolase 
(Kamata et al, 2009) degrade filaggrin peptides into free amino acids (Kezic et al, 
2009) that are subsequently converted into trans-urocanic acid (UCA) and 
pyrrolidone carboxylic acid (PCA) (O'regan et al, 2009 Roelandt et al, 2011). NMFs 
are formed during the final stages of terminal differentiation at the layers of granular 
to stratum corneum transition. FLG2 (filaggrin 2) is a member of the S100 fused-
type protein family located within profilaggrin lamellar bodies and is involved in 
barrier maintenance and natural moisturising factor formation (de Koning et al, 
2012). 
Filaggrin breakdown products comprise approximately 50% of the natural 
moisturising factors with the remainder formed by lactate, other sugars, urea and 
many ions including chloride, sodium, potassium and calcium (Rawlings and 
Harding, 2004). Some of these other products such as urea and lactate arise from 
sweat glands, and all NMFs can also be diluted in sweat (Caspers et al, 2003). All of 
the NMF compounds identified so far are water-soluble and low molecular weight, 
allowing the stratum corneum to effectively "bind" water from the atmosphere and 
from water evaporating from the cellular epidermis, thus forming a waterproof 
barrier (Bouwstra et al, 2003). Excessive hydration of the stratum corneum disrupts 
this ability and increases epidermal permeability (Warner et al, 2003). 
NMF formation is a tightly regulated process which is precisely timed to maintain 
optimal barrier function. Intact filaggrin is present in only 2-3 layers of the granular-
stratum corneum and has a half life of roughly six hours in keratinocytes (Kamata et 
al, 2009). When keratins bind filaggrin during the collapse of the keratinocyte 
cytoskeleton, they protect it from degradation, but when corneocyte cornified 
envelopes have sufficiently strengthened and the stratum corneum is sufficiently dry, 
filaggrin is subject to proteolysis and NMFs are rapidly released. If corneocytes are 
not sufficiently dried and strengthened by cornified envelopes, osmotic pressures 
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caused by NMF release may disrupt barrier function rather than improving it 
(O'Regan et al, 2009). Caspases are ubiquitously expressed, but caspase-14 appears 
unique to the cornified epithelia, with caspase-14 activation levels correlated with the 
degree of cornification (Denecker et al, 2008). Caspase-14(-/-) mice show 
accumulation of filaggrin fragments and a reduction in NMF in the stratum corneum 
(Hoste et al, 2012). Histidine from filaggrin degradation is converted into urocanic 
acid which has been shown to play a role in UV radiation protection (Mildner et al, 
2000).  
Many other factors can affect NMF content of the stratum corneum including 
reduced profilaggrin synthesis with aging, removal of NMFs by repeated washing or 
reduction in NMFs by UV exposure (O'Regan et al, 2009). As described earlier, 
mutations in filaggrin are relatively common and are associated with epidermal 
structural defects found in ichthyosis vulgaris and atopic dermatitis. However, the 
structure of filaggrin itself is important as a precursor for the production of NMFs 
and filaggrin mutations have been associated with abnormalities of filaggrin 
breakdown products, including NMFs (Kezic et al, 2008). Even in atopic dermatitis 
patients without any filaggrin mutation present, NMF concentration was significantly 
reduced due to downregulation of filaggrin (Kezic et al, 2011). In atopic dermatitis 
patients with filaggrin mutations, NMF concentration was correlated with the 
severity of the clinical condition and so NMFs were proposed as a marker for 
measuring patient clinical progression and response to treatment. NMFs have 
typically been measured by tape stripping or biopsy, which is clearly not ideal for 
patients already presenting with epidermal barrier defects, but recently more non-
invasive methods are being developed (Takada et al, 2012). 
1.3.4.2 Desquamation of the Stratum Corneum 
Cornified envelopes of the stratum corneum are linked by corneodesmosomes which 
are formed during the granular to stratum corneum layer transition (Ishida-
Yamamoto et al, 2011). In the cytoplasm of differentiating keratinocytes, 
desmosomal attachment plaques become integrated into the forming cornified cell 
envelope itself and corneodesmosomes express a unique protein, corneodesmosin, 
which is synthesised by granular cells and packaged into lamellar bodies. After 
secretion, corneodesmosin is cross-linked with cornified envelope proteins and likely 
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mediates binding to adjacent corneocytes in the presence of calcium  (Jonca et al, 
2002).  
Desquamation of cornified envelopes is essential for the proper turnover of the 
epidermis. In the desquamating stratum corneum, corneodesmosin is cleaved by 
kallikrein-related peptidases (KLKs) and cathepsins. At least 8 different KLK 
enzymes are expressed in the epidermis and secreted by lamellar bodies, which 
function as a proteolytic cascade (Komatsu et al, 2006). These KLKs, along with at 
least three different cathepsins regulate the balance between desquamation and 
keratinisation, and therefore are expressed differently in various body sites in 
accordance with varying thicknesses of the stratum corneum (Ishida-Yamamoto et al, 
2011). A number of protein inhibitors such as LEKTI, SKALP and SLPI which act 
on KLKs or cathepsins are also present, further aiding in the regulation of 
desquamation (Brattsand et al, 2009). These protease inhibitors also act as part of a 
cascade (Fortugno et al, 2011) and are implicated in disorders, for instance Netherton 
Syndrome, a skin disorder caused by LEKTI mutation, characterised by ichthyosis 
due to reduced desquamation (Komatsu et al, 2008). However, as shown earlier 
(Sevilla et al, 2007), downregulation of desquamation enzymes can rescue the barrier 
function of mice lacking key structural components of the cornified envelope. 
The acidity of the stratum corneum also plays a role in desquamation, with higher pH 
conditions being associated with increased proteolysis and increased 
corneodesmolysis (Fluhr and Elias, 2002, Kezic et al 2012). NMFs, discussed 
previously, may be partly responsible for maintaining the acidic pH of the stratum 
corneum (O'Regan et al, 2009). The water content of the stratum corneum also plays 
a role in desquamation, with low humidity environments reducing the action of 
hydrolase enzymes and reducing the rate of corneodesmolysis (Rawlings et al, 1995). 
Watkinson and colleagues, 2001, showed that relative humidity regulates the activity 
of stratum corneum chymotryptic enzyme, with lower desquamation rates occurring 
in reduced humidity. This was further demonstrated using in vitro epidermal models 
(Bouwstra et al, 2008). 
1.3.4.3 Epidermal Lipids  
Ceramides represent approximately 35-50% of epidermal lipids by dry weight, and 
are essential for barrier function (Suhonen et al, 2003, Mizutani et al, 2009). 
Ceramide upregulation begins in the suprabasal layers of the epidermis and continues 
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throughout until the stratum corneum which is largely composed of ceramides 
(Suhonen et al, 2003). Reduced ceramide content of the epidermis causes increased 
TEWL and barrier dysfunction (Holleran et al, 2006, Zuo et al, 2008). There are four 
steps towards ceramide-based barrier function - ceramide synthesis, packaging in 
lamellar bodies, secretion from those lamellar bodies, and processing into final 
hydrophobic compounds. 
As of 2011, there are 12 known ceramides in human skin, although this number 
increases year-on-year (Smeden et al, 2011). Ceramides basically comprise a 
sphingoid base and an ester-linked fatty acid and vary depending on which sphingoid 
base is used and the length of the fatty acid chain attached. These ceramides are 
given nomenclature N, A and EO indicating non-hydroxy, alpha-hydroxy or ω-
hydroxy amide-linked fatty acids, and S, DS, P, H denoting sphingosine (Sph), 
dihydro-Sph, phyto-Sph or 6-hydroxy-Sph respectively. The ceramides EOS, EOH 
and EOP (so-called ω-O-acylCer (acylCer)) are unique to epidermis and essential for 
barrier function due to their  extra ester-linked fatty acid chains (primarily linoleic 
acid) attached to the existing fatty acid chain attached to the sphingol base. This 
naming system as structural diagrams of each ceramide are reviewed by Mizutani et 
al, 2009.  
The acylCer are bound to involucrin on the external surface of corneocytes, forming 
the lipid component of the cornified envelope. In essential fatty acid deficiency, 
linoleic acid in the acylCer is replaced by non-essential fatty acids such as oleic acid, 
resulting in barrier defects, indicating the importance of these unique ceramides 
(Uchida et al, 2008).  
Epidermal ceramides are synthesised by keratinocytes from basic components 
(including serine, palmitoyl-CoA and recycled sphingosine from ceramide 
breakdown) in a multiple-step conversion pathway involving serine 
palmitoyltransferase, FVT-1, and ceramides synthases 1-6 (CerS1-6) (Mizutani et al, 
2009) which occurs primarily at the endoplasmic reticulum membranes (Uchida et al, 
2008). CerS3 is the most abundant ceramide synthase enzyme found in keratinocytes, 
and expression increases dramatically during differentiation (Mizutani et al, 2008). 
Newly synthesised ceramides are then converted to glucosylceramides by GlcCer 
synthase and to sphingomyelin by SM synthase at the golgi apparatus. These 
precursors are then packaged into lamellar granules as described previously (Zuo et 
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al, 2008) and can act as precursors for stratum corneum ceramide synthesis after 
excretion at the granular-stratum corneum interface (Uchida et al, 2008). 
After excretion from lamellar bodies, β-glucocerebrosidase and sphingomyelinase 
(SMase) enzymes hydrolyse these precursors into mature barrier ceramides 
(Mizutani et al, 2009). Mutations in SMase result in a less serious barrier defective 
phenotype (Holleran et al, 2006b). Deficiencies in β-glucocerebrosidase causes 
barrier dysfunction (Gaucher disease) as all stratum corneum ceramides can be 
synthesised from glucosylceramides, whereas only two epidermal ceramides (AS and 
NS) can be synthesised from sphingomyelin by SMase. Gaucher Disease is a 
neurological disorder which also presents with ichthyosis and poor epidermal barrier 
function resulting from defective ceramide production (Holleran et al, 1994, 2006). 
Ceramides vary by their sphingoid bases and by their amide-linked fatty acid 
attachments. The 6 known CerS enzymes are each responsible for assembling 
ceramides with different chain lengths, with CerS2 and CerS3 displaying preference 
for longer fatty acid chain lengths (Mizutani et al, 2006). Ceramides are located 
throughout the body but the epidermis is the only location in the body known to have 
extra long (C28-32) fatty acid chain ceramides. Ceramide NS (Cer 2, or 
nonhydroxysphingosine) particularly contains these very long fatty acid chains 
(Mizutani et al, 2009).  
As well as barrier function to water loss and compound entry, there is evidence that 
ceramides also act as signalling molecules in the epidermis. High intracellular 
ceramides induce apoptosis in keratinocytes which have been exposed to excess UV 
radiation. This is regulated by ceramide hydrolysis (by ceramidase enzymes) or 
conversion to non-proapoptotic GluCer which protects against this apoptosis (Uchida 
et al, 2010). 
The most common family of epidermal diseases are termed ichthyoses, which can 
arise directly from epidermal protein mutations such as filaggrin and keratin or from 
mutations in enzymes involved in the conversion of precursor lipids into mature 
barrier lipids (Elias et al, 2012). Therefore, epidermal barriers in patients with 
ichthyoses display an immature lipid profile such as excessive triglyceride content, 
inadequate FFA content, insufficient ceramide content paired with high 
glucosylceramide and reduced cholesterol content (Elias et al, 2012).  
43 
 
For example, X-linked ichthyosis (XLI) is caused by mutations in the steroid 
sulphatase enzyme and results in elevated cholesterol sulphate levels in the 
epidermis, coupled with insufficient cholesterol content (Elias et al, 1984 and 2012). 
More recent studies (Hoppe et al, 2012) have shown altered expression of 27 
different genes with a resulting phenotype of corneocyte retention, dry and scaly 
skin, with impaired barrier function that was not restored by moisturisers. Another 
ichythosis is neutral lipid storage disease with ichthyosis (NLSDI), also called 
Dorfman–Chanarin syndrome (DCS). This disorder is often caused by a mutation in 
CGI-58, an activator of the adipose triglyceride lipase (ATGL) enzyme. This results 
in an accumulation of triglyceride and a reduction of free fatty acid in the epidermis 
and has been linked to impaired barrier function (Uchihara et al, 2010).  
 
1.3.5 Calcium as a Driver of Differentiation 
Calcium has been mentioned several times in the previous pages as a key regulator of 
protein synthesis and cell behaviour throughout the epidermis. It is essential for 
many aspects of differentiation such as keratin, involucrin, and loricrin transcription, 
activation of transglutaminase enzymes (Hitomi, 2005), the processing of pro-
filaggrin to filaggrin, triggering of lamellar body release (Elias et al, 2002) and 
formation of adherens junctions (Gniadecki et al, 2001). Influx of calcium into 
keratinocytes also activates enzymes responsible for epidermal barrier lipid synthesis 
and subsequent conversion to more hydrophobic derivatives (Micallef et al, 2008). 
Calcium is located in the epidermis in three distinct locations - in the extracellular 
fluid, in the keratinocyte cytosol and inside keratinocyte intracellular organelles such 
as the endoplasmic reticulum and the Golgi apparatus (Pillai and Bikle, 1991, Celli et 
al, 2010). 
The cellular epidermis contains an extracellular calcium gradient with a low calcium 
concentration in the basal epidermis rising to the highest concentration in the 
granular layer at the lower boundary of the stratum corneum (Cornelissen et al, 
2007). The calcium ion concentration in the stratum corneum itself is very low due to 
its dry nature and the inability of corneocytes to dissolve the ions (Baroni et al, 
2012). It is not fully understood how this epidermal gradient is formed - i.e. whether 
it is actively created by calcium pumps in keratinocyte cell membranes (Elias et al, 
2002) or tight junction activity (Kurusawa et al, 2011) or whether it is passively 
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created by the dry upper surface of the stratum corneum causing a water gradient 
(Adams et al, 2012).  
Rising extracellular calcium concentration is detected by CaR calcium receptors on 
the surface of the keratinocyte. This receptor is essential for proper epidermal 
differentiation, indicating the importance of extracellular calcium signalling. Cells 
lacking this CaR do not raise intracellular calcium in a normal manner (Tu et al, 
2001) and mice lacking this receptor display abnormal epidermal differentiation 
(Komuves et al, 2002). Rising extracellular calcium triggers a set of events shown in 
Figure 1.3, initially activated by the CaR. Calcium ions bind the CaR and through 
second messenger signalling increases intracellular diacylglycerol (DAG) and 
inositol triphosphate (IP3). Rising intercellular IP3 triggers the golgi and 
endoplasmic reticulum to release calcium stores, further increasing intracellular 
calcium concentration. This rising intracellular calcium causes protein kinase C to 
bind the RACK receptor which in turn activates the keratinocyte calcium ion 
channels to open and increase intracellular calcium even further as well as activating 
AP-1 transcription factors (Bilke, 2004). During terminal differentiation, 
keratinocytes flatten in the granular layer releasing intracellular calcium stores into 
the surrounding tissue, thus further increasing extracellular calcium concentration 
(Menon and Elias, 1991). Rising extracellular calcium and subsequent increasing 
intracellular calcium concentration is also involved in differentiation by action of the 
Raf/MEK/ERK kinase cascade pathway (Schmidt et al, 2000) as well as inducing 
growth arrest by inducing p21 (Sakaguchi et al, 2003). 
Under in vitro conditions, 0.06-0.09mM Ca
2+
 is commonly used as "low calcium" 
culture conditions for normal cell maintenance and proliferation, as keratinocytes 
will not proliferate in <0.03mM Ca
2+
. In low calcium conditions, desmosome 
formation is inhibited and so cells grow as a monolayer (Hennings et al, 1980). 1.1-
1.5mM is used as "high calcium" in order to induce differentiation in cell culture 
conditions (Micallef et al, 2008). However, in the native epidermis, free calcium 
concentration ranges from only 0.5µM to >20µM, as most calcium is bound to 
proteins or cellular organelles (Adams et al, 2012). Human free calcium 
concentration in serum is approximately 1.1-1.4mM, and therefore the concentration 
referred to as "high" in keratinocyte cell culture closely represents physiological 
calcium concentration. 
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Calcium is not the only player in keratinocyte differentiation. Studies mentioned 
earlier have shown that detachment from the basement membrane (Zhu and Watt, 
1996) and increased cell-cell contact (Kolly et al, 2005) are also key players in 
keratinocyte differentiation, at least in vitro. Kolly et al, 2005 found when cultured 
keratinocytes become confluent, in either high or low calcium conditions, c-Myc is 
downregulated. High calcium concentration alone was not sufficient to induce cell 
cycle arrest but adding c-Myc inhibitor to the culture media resulted in immediate 
cell cycle arrest, indicating the importance of cell-cell contacts in differentiation. 
Vitamin D also plays a role in differentiation and keratinocytes are the only cell type 
in the human body with a full profile of vitamin D conversion pathways. They are 
capable of fully producing the active form of Vitamin D, 1,25(OH)2D3 from 7-
dehydrocholesterol (7-DHC) via 1OHase, utilising UV light. Keratinocytes in the 
stratum basale contain vitamin D receptors and produce their own Vitamin D in 
levels inversely proportional to their level of differentiation as well as in accordance 
with regulation by parathyroid hormone (Bikle et al, 1986 and 2004). Calcium, along 
with AP-1 and Vitamin D metabolites all act in the nucleus to induce transcription 
and expression of proteins such as involucrin, loricrin and transglutaminase enzymes 
(which themselves are activated by calcium ions).  
However, despite the role of other molecules in the initiation differentiation, calcium 
is still required for the formation of cornified envelopes, activation of 
transglutaminase and many other aspects of differentiation discussed previously.  
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Figure 1.3. Schematic Diagram of Extra/Intracellular Calcium Signalling 
Rising extracellular calcium (Ca
2+
(e)) is detected by the membrane-bound CaR 
calcium receptor. Through second messenger signalling, the golgi are stimulated to 
release calcium stores into the cytoplasm. Simultaneously, keratinocyte membrane-
bound calcium channels open, allowing a further increase in intracellular calcium 
(Ca
2+
(i))concentration. Calcium acts in the nucleus on calcium response elements 
(CaREs) and AP-1 to activate transcription of cornified envelope components. Figure 
based on Bikle et al, 2004.  
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1.3.6 Factors Affecting Epidermal Barrier Function 
Several factors can alter epidermal barrier function, including chemical exposure 
(Kwak et al, 2012), hydration (Warner et al, 2003), moisturisation (de Paépe et al, 
2001) and biological molecules. Retinoids are Vitamin A analogues which are 
involved in proliferation, differentiation and apoptosis in many cell types (Lee et al, 
2009). Retinoids have been known to regulate differentiation in the epidermis since 
Fuchs and Green, 1981. In the epidermis, both natural and synthetic retinoids are 
known to increase epidermal proliferation and inhibit differentiation - suppressing 
biosynthesis of epidermal lipids, cholesterol, and long-chain fatty acids as well as 
cornification (Lee et al, 2009). Retinoids also increase corneodemosomal degradation 
and downregulation of corneodesmosomal cadherins, thus increasing desquamation 
(Kim et al, 2011), leading to their consideration and use as therapeutic agents.  
Retinoids bind nuclear RXRs (retinoid X receptors) and RARs (retinoic acid 
receptors), each with multiple isoforms. These receptors form RXR-RAR 
heterodimers or RXR-RXR homodimers after activation, and then bind DNA retinoid 
acid response element (RARE) sequences which regulate target genes (Lee et al, 
2009). Topical retinoids have been used for the treatment of many skin disorders 
including psoriasis, acne and even cancers. However therapeutic benefits are often 
offset by undesired side effects such as scaling, dryness and excessive desquamation, 
due to increased proliferation of keratinocytes and reduction of lipid content in the 
epidermis (Lee et al, 2009). Keratinocyte response to retinoids is very rapid, with 
changes in gene  regulation occurring after one hour. Naturally-occurring all-trans 
retinoic acid (ATRA) has been most commonly used, but is unstable and quickly 
oxidises under UV light (Barnard et al, 2009). 
Due to this, many synthetic retinoid analogues have been developed for possible 
therapeutic use (Odorisio et al, 2012) and in vitro experimentation. The 3D scaffold 
or other 3D cell culture models represent suitable substrates for testing of compounds 
such as synthetic retinoids for their effect on cell behaviour before in vivo testing is 
carried out, as in Jean et al, 2011. Such models also represent potential cost-savings 
for testing, as basic parameters such as speed of action, duration of action and dosage 
may be calculated using large numbers of in vitro models before carrying out 
smaller-scale in vivo testing. 
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1.3.7 Epidermal Permeability and Permeation Enhancers 
Transepidermal drug delivery is an appealing method for drug delivery for many 
reasons. It is non-invasive and can deliver a steady dose of drug, avoiding spikes in 
bloodstream  concentration which is useful in hormone replacement (testosterone 
gels or oestrogen/progesterone birth control patches), nicotine delivery (skin patches) 
and steady long-term pain relief (Fentanyl patches) allowing lower doses to be used. 
Transepidermal delivery also avoids stomach digestion and first pass liver 
metabolism which are often pharmacokinetic problems in drug design (Chantasart et 
al, 2007, BNF volume 63). 
There are three major routes through the epidermis - transcellular (through 
corneocytes themselves), paracellular/intercellular (between corneocytes) and 
appendageal (through hair follicles, sebbaceous glands and sweat glands) (Jampilek 
and Brychtova, 2010). The appendageal route is a minor route, as these structures 
occupy only a small fraction of epidermal surface area. However, they represent the 
most feasible route for passage of large molecular weight compounds (Oshizaka et 
al, 2012). The transcellular route requires a compound to pass through tough, cross-
linked protein matrices, intercellular lipids, cell membranes and natural moisturising 
factors, all of which confer resistance to most types of compound. However, this is 
shortest and most direct route through the epidermis (Vavrova et al, 2005). 
Comparatively, the paracellular route requires compounds to wind their way through 
the intercellular lipid "cement" between many layers of flattened corneocytes. This 
increases a 20µm thick stratum corneum into a diffusion pathway of approximately 
400µm (Hadgraft, 2001), drastically reducing permeation. Although these routes 
have historically been defined separately, in reality most compounds applied to the 
skin travel through a combination of both pathways (Jampilek and Brychtova, 2010). 
In order to overcome the epidermal obstacles to drug delivery, chemical penetration 
enhancers (CPEs) have been developed. Many compounds can increase epidermal 
permeability, such as dimethylsulphoxide (DMSO), sodium dodecyl sulphate (SDS), 
acetone, urea, alcohols and other chemicals. However, only a few compounds are 
commonplace in cosmetic or pharmaceutical products due to toxicity and undesirable 
side effects such as irritation, dryness or allergy (Ibrahim et al, 2009), as well as 
regulatory requirements. An ideal permeation enhancer will support the passage of a 
target compound through the epidermal barrier but only cause a short-term, minimal 
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disruption to the epidermis. The enhancer should also not pass into the bloodstream 
itself and also needs to be compatible with the target molecule that it is carrying.  
One of the first custom-designed permeation enhancers was Azone (1-
dodecylazacycloheptan-2-one), an oily, lipophilic liquid which was discovered in 
1976 (Hoogstraate et al, 1999). However, it is still not approved by the FDA for use 
in humans due to antiviral effects. Azone mechanism of action is still not fully 
elucidated but it is thought to insert itself and disrupt lamellar bilayers in the stratum 
corneum or to compete for hydrogen bonds between stratum corneum lipids, thus 
weakening their structure. As such, many Azone analogues have been developed 
aiming for the same effects without unwanted side effects (Jampilek and Brychtova, 
2010). 
Simply altering the pH of the formulation is an effective way of improving 
permeability of some drugs which are stable in a low pH carrier. For instance, 
Azeleic acid (an FDA-approved treatment for acne) passed through the epidermis 
five times more readily in a pH 3.9 formulation compared to the same dose in a pH 
4.9 carrier (Li et al, 2012). 
Many other compounds and drug carriers are under development, including sucrose 
laurate which acts as a surfactant (Csizmazia et al, 2011), Transkarbam 12 which 
degrades in low pH releasing two opposing molecules and CO2 which forms bubbles, 
interrupting stratum corneum lipid organisation (Novotný et al, 2011) and fluorescent 
enhancers for research purposes (Seto et al, 2012). Natural alternatives are also 
increasingly popular such as lemon essential oil, used to deliver water-soluble 
vitamin B6 and C and fat-soluble vitamins A and E across the epidermis (Vilgimigli 
et al, 2012). 
One direct approach is microneedling (Wu et al, 2006) which uses a roller covered 
with hundreds of 200-300µm long needles to create micro-pores in the stratum 
corneum. These needles are too short to stimulate nerves or damage blood vessels, 
but they increased permeation of large molecular weight anti-inflammatories such as 
ibuprofen, paracetamol and diclofenac by up to three-fold (Stahl et al, 2012).  
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1.4 Comparison of 2D and 3D Cell Culture 
The majority of current cell culture techniques grow cells in monolayers on the 
surface of flat, rigid 2D plastic dishes or flasks. 2D culture techniques are widespread 
due to their economy, convenience and generally high cell viability and 
reproducibility. Cell culture studies in 2D have contributed significantly towards 
scientific knowledge but if the purpose of cell culture is to draw conclusions about 
human biology, these flat surfaces are clearly not optimal for accurately portraying 
the complex native environments of different cell types in vivo. Cells in vivo form 
complex interactions with other cells and a tissue-specific extracellular matrix in 
order to form three-dimensional structures which cannot be represented fully in 2D. 
Cells cultured in 2D conditions only form external contacts within restricted 
dimensions and are forced to adopt polar attachments, forcing cells to adapt to their 
2D environment and enforcing a sort of natural selection onto primary cells which 
are cultured from tissues (Lee et al, 2008). This may alter cell metabolism and 
functionality in a way that may reduce the accuracy of in vitro testing. 
3D culture systems can be largely divided into two types - those for clinical use, such 
as restoring or maintaining injured tissues, and those for in vitro cell culture for 
systemic scientific investigation into cell function to model tissue physiology under 
normal and disease states. Tissue engineering and regenerative medicine are 
emerging fields of research, with several biodegradable, biocompatible 3D matrices 
used as templates for cultured cells which are then implanted back into patients. For 
instance, tissue engineered bladders formed from urothelial and smooth muscle cells 
cultured on a collagen/glycolic acid scaffold were successfully implanted into 
patients (Atala et al, 2006), and collagen/polymer nanofibres have been used to 
culture skeletal muscle myotubes for potential transplant (Choi et al, 2008). 
Of particular interest is clinical treatment of burns and chronic blistering using 
tissue-engineering. Treatment of burns often requires skin grafts, further injuring 
healthy portions of skin (which may not be available in severe burns) and increasing 
risks of infection (Wood et al, 2006). In cultured epithelial autografts (CEAs), 
combinations of keratinocytes and/or fibroblasts isolated from the patient have been 
cultured in the lab, then grafted back onto a patient to repair or replace epidermis, 
dermis or full-thickness skin (Boyce et al, 1999, Supp and Boyce, 2005, MacNeil, 
2007). These CEAs reduce the healing time and improve mortality rates of burn 
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victims. Keratinocytes have been cultured as thin cell sheets (Wood et al, 2005), 
applied on sub-confluent carrier sheets (Hernon et al, 2006), cultured on porcine 
dermis, fibrin matrices, or electrospun biodegradable polymers (Ronfard et al, 2000, 
Zhu et al, 2005, Blackwood et al, 2008, Powell and Boyce, 2009).  These electrospun 
collagen polymers have been shown to be beneficial compared to freeze dried 
collagen scaffolds in terms of wound healing after full thickness skin damage 
(Powell et al, 2008). These scaffolds can be used  
 
Recently, a "stem cell gun" and novel wound dressing by Stem Cell Systems, GmbH, 
has caught the attention of the press as it claims to regrow healthy skin within one 
week, but as of yet no published scientific data has emerged for this promising-
sounding technique. Keratinocytes have been previously sprayed onto wounded 
tissue (Grant et al, 2002, Zweifel et al, 2008) with positive results. 
The 3D scaffold used in this project is non-biodegradable polystyrene and is 
unsuitable for transplantation. Therefore discussion will focus primarily on in vitro 
3D models rather than regenerative medicine. 
1.4.1 Design of 3D Culture Materials 
There are several key factors in the design of a 3D material for cell culture including 
size and shape, porosity, pore size, surface topology, permeability, mechanics (i.e. 
flexibility, rigidity, degradability), wetability and microscopic surface characteristics 
(Lee et al, 2008). Surface characteristics include charge, polarity and surface 
chemistry which can alter the adherence of cells and the cellular deposition of 
synthesised matrix components (Zeyfert et al, 2009). Ideally, all of these factors 
would combine to form a 3D structure which models the native environment of those 
particular cells in vivo, bearing in mind that different tissues have specific ECM 
environments. These factors are best described on different scales - for instance the 
distribution of nano-scale collagen fibres and the material surface biochemistry are 
important for cell adhesion, the size of micro-scale pores are important for cell 
spatial organisation and the macroscopic size, shape and thickness of the whole 3D 
material itself is important for diffusion of culture media, oxygen and overall "tissue" 
morphology. Ideally, an in vitro 3D model replicates every scale of the in vivo 
environment for maximum relevance. 
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Several types of 3D culture materials including cell-encapsulating hydrogels, 
electrospun fibre matrices, fabric-based scaffolds and borosilicate glass matrices 
have been used for 3D cell culture. An overview is provided below: 
1.4.1.1 Encapsulating Gels for 3D Cell Culture 
One method of 3D cell culture is termed "encapsulation", where a hydrogel solution 
is mixed with a cell suspension, which then solidifies or polymerises around the 
cells, surrounding them with ECM proteins or structural polymer with no porous 
micro-structure. Similar to cells cultured in the 3D polystyrene scaffold (Bokhari et 
al, 2007), cells cultured in encapsulated spheroids form structures, and are more 
resistant to drug-induced apoptosis (Zahir and Weaver, 2004). 
Algimatrix (Invitrogen) is a biodegradable "sponge" matrix based on seaweed 
alginate which encapsulates cells (Shapiro and Cohen, 1997). This gel contains large 
(70-300µm) pores capable of holding cultured cells, similar to the 3D scaffold used 
in this project. Algimatrix is 3-4mm thick when fully hydrated (official product 
information, Invitrogen website) and as there is no porous structure, these gels rely 
on passive diffusion of molecules through the high water content material. The 
Algimatrix gel, and indeed most encapsulation-type culture material, is 
biodegradable (degradable by Versene alone) and highly permeable so that it can 
maintain cultures of cells inside. Algimatrix has been used to culture many cell types 
(Mooney et al, 1999, Dvir-Ginzberg et al, 2004) although a literature search revealed 
no evidence of keratinocyte culture with this product. These types of encapsulation 
matrix may be suitable for 3D culture of keratinocytes as encapsulated aggregates for 
other purposes (such as drug toxicity screening) but it would not be suitable for 
culturing a 3D culture with tissue-like morphology. Another 3D encapsulation 
product is Perfecta 3D
®
 (3D BioMatrix) hanging drop inserts which can be used to 
grow cells in 3D inside small pores (Takayama et al, 2011). This product also does 
not seem to have been tested with keratinocytes (source: 3D BioMatrix product 
website).  
Several forms of synthetic hydrogel have been developed, formed from self-
assembling peptides dispersed in water. For instance, DNA has been used to create a 
3D hydrogel, formed from a specific DNA sequence which can be repeatedly 
hybridised to each other by DNA ligase (Um et al, 2006). 
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Synthetic gels of polymers are able to be more reproducible and can be sterilised 
before use in tissue culture. However, it should be noted that not every cell type may 
be cultured inside gels. In order to form structures inside a 3D gel, cells need to 
cleave extracellular matrix proteins such as collagen and fibrin, but some cells (such 
as some tumour cells) do not express MMP enzymes, limiting their ability to 
proliferate, migrate or form structures inside a gel (Hotary et al, 2003). 
1.4.1.2 Gel-based Coatings for 3D Cell Culture 
MatriGel (BD Biosciences) is a gelatinous protein matrix secreted by EHS mouse 
tumour cells which was initially used to study cell differentiation (Baatout et al, 
1996). It has since been used as general support for cultured cells of many tissue 
origins as well as a tool to measure carcinoma cell invasion and tissue repair (Hughes 
et al, 2010). Matrigel is not technically a dermal equivalent or inherently a 3D 
culture surface, but it has also been used to support human 3D keratinocyte culture. 
For example, Matrigel was used to manufacture an artificial epidermis for in vitro 
burn modelling (Sobral et al, 2007). Although Matrigel contains many natural 
biological products, it is heterogenous and variable, and has also been found to 
contain viruses (Lee et al, 2008).  MaxGel (Sigma) is a similar product, forming a gel 
made of human extracellular matrix components such as collagen, laminin, elastin, 
proteoglycans and glycosaminoglycans for supporting cell culture. This gel is not 
inherently a 3D culture system, although it can be applied in a thick coat to a 2D 
culture dish. 
1.4.1.3 Non-biodegradable Scaffolds for 3D Cell Cultures 
The 3D scaffold used in this thesis is non-biodegradable. While biodegradable 
scaffolds are advantageous for some applications (i.e. for tissue engineering (Clark et 
al, 2007)) or for some laboratory techniques where the scaffold can be removed or 
digested) biodegradable scaffold are often disadvantageous in terms of practicality - 
such as instability under long-term culture, limited shelf life, and reduced quality due 
to improper storage conditions (Lee et al, 2008).  
Polymers made from poly(glycolic acid), poly(lactic acid) and co-polymers have 
been assembled to form 3D matrices where cells can attach and proliferate, similar to 
the polystyrene of the 3D scaffold (Mikos et al, 1993).  
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3D CellCarrier (Orlaproteins, UK) is a newly-developed borosilicate 3D glass matrix 
where cells can be cultured. This scaffold is rigid, non-biological, non-biodegradable 
and non-permeable, similar to the 3D scaffold used in this project. However, a glass 
scaffold would clearly not be compatible with some laboratory methods such as 
paraffin embedding and histology but it is compatible with light microscopy imaging 
of living cells. The glass scaffold is also thick (4mm) and so may be faced with 
issues concerning the diffusion of culture media, oxygen and clearance of waste 
products if the cells inside reach a high confluence. 
As described previously, the 3D scaffold is formed by a polyHIPE process. However, 
there are many other polymer-formation techniques which are capable of developing 
similar porous 3D structures. For instance, electrospinning can generate polymers 
formed from multiple layers of laid down fibres with finely controlled diameters, 
recreating an ECM-like environment (Sun et al, 2006b, Lee et al, 2008). Electrospun 
scaffolds formed from a variety of natural or synthetic materials have been used in 
several previous studies for 3D cell culture, and some are available commercially. A 
product named OrlaMatrix (Orlaproteins, UK), is made of electrospun polyester and 
appears similar to the 3D scaffold used in this project, however details about this 
product such as the thickness, pore size and culture mechanism remain unavailable. 
Another method of scaffold formation is "particulate leeching" which forms a 
polymer containing particles which can be dissolved after the polymer has formed, 
thus leaving a porous structure (often salt or sugar, which is then dissolved by water). 
However, this method provides problems in sufficient connectivity of the pores 
formed inside the scaffold, often making a structure which could be classified in 
between a fully porous structure and an encapsulating structure (Mikos et al, 1994). 
3D sponges have also been generated using freeze-drying techniques, which are 
more similar to the HIPE process used to form the 3D scaffold used in this project. In 
summary, a polymer solution is mixed with water and then freeze-dried or 
evaporated, leaving behind a polymer with empty "bubbles" which were previously 
occupied by water (Whang et al, 1995). Gas-foaming has also been used where high 
pressure forces gas bubbles into a polymer mixture which is then slowly cooled and 
gas is allowed to escape, leaving a porous structure behind (Mooney et al, 1996). 
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1.4.1.4 Mechanics of 3D Culture Materials 
The importance of 3D culture material mechanics was initially considered for use in 
tissue engineering applications, where implanted scaffolds need to withstand the 
stresses and strains placed onto them after transplantation. Ideally, these scaffolds 
need to strong enough to withstand stress and movement, but flexible in order to 
adapt to in vivo conditions without interfering with neighbouring tissues after 
implantation by being excessively rigid. These properties are clearly essential for 
tissues such as tissue engineered bone grafts, which is highly rigid but also dynamic, 
and for muscle (i.e. myocardial tissue) which is constantly undergoing contraction 
and movement (Lee et al, 2008). 
However, scientists are increasingly realising the importance of the stiffness, 
flexibility and compliance of the cellular environment on the behaviour of those cells 
in vitro. Cell surface integrin receptors attach to extracellular matrix and sense the 
compliance of the surrounding tissues by measuring stresses on the cytoskeleton 
(Yamada et al, 2007) and it is now becoming clear that these forces act as 
environmental cues which can alter cell metabolism and differentiation. For instance, 
human mesenchymal stem cells (MSCs) alter their differentiation lineage based on 
flexibility of surrounding materials (Engler et al, 2006, Haugh et al, 2011) and 
chondrocytes display improved viability when cultured on dynamically-loaded 
porous scaffolds, compared to static scaffolds (El-Ayoubi et al, 2011). The alignment 
of collagen or polymer fibres on the cell culture surface also appears to influence cell 
orientation, where skeletal muscle cells aligned to form myotubes on parallel fibres 
(Choi et al, 2008). In 2D culture, most surfaces are perfectly flat, rigid and have 
random surface microstructure. Therefore many levels of cellular interaction with the 
environment are completely lost under traditional culture conditions. 
The skin as a whole is clearly a strong but flexible tissue, subjected to constant 
physical forces such as stretching, compression and abrasions. Keratinocytes 
themselves are exceedingly strong cells, up to 70x stiffer than "typical" cells such as 
breast epithelial cells, circulating lymphocytes or connective tissue fibroblasts 
(Lulevich et al, 2010). Lulevich and colleagues measured the force needed to 
collapse cultured cells and noted that unfixed, viable keratinocytes were comparable 
to paraformaldehyde-fixed T-cells in terms of their rigidity and elasticity. This is due 
to the strength of the keratin cytoskeleton which adapts keratinocytes for their 
56 
 
protective role. It would be surprising if the impact of keratinocytes' cellular 
environment did not influence their proliferation, differentiation and protein 
expression as it does with other cell types. Skin clearly shows adaptive properties, 
such as during birth, pregnancy and wound healing and areas of the skin such as the 
soles of the feet experience significant mechanical pressure, and palmar 
keratinocytes express a unique profile of cytoskeletal proteins including keratin 9 
which enhances their mechanical strength (Swensson et al, 1998).   
Some analyses have been performed in this regard. If keratinocytes are grown to 
confluence on flexible silicone sheets and then stretched, they show increased 
proliferation and protein synthesis, aligning themselves in the direction of the force 
(Takei et al, 1997). Stretching also induces upregulation of adhesion molecules and 
cell-cell contacts (Knies et al, 2006), indicating that physical forces play a role in 
barrier formation. Stretched keratinocytes also show downregulation of K10, 
upregulation of hyperproliferative K6 and enhanced proliferation through EGF-R 
autophosphorylation and ERK, PI3K pathways in primary human or HaCaT cell line 
keratinocytes (Yano et al, 2004). However, all of these findings have been based on 
keratinocytes cultured on two dimensional flexible silicon sheets. Reichelt, 2007 
noted that "as fibroblasts show different cytoskeletal properties in 2D versus 3D 
culture, there is a need to develop experimental settings using 3D culture on 
mechanotransduction in keratinocytes." In a 3D environment with increased cell-cell 
contact and improved adhesions, it is likely that these effects initiated by the 
extracellular environment may be further enhanced. This has implications for the 
handling of 3D cultures in vitro and again shows the value of 3D analysis compared 
to 2D. 
Recently, it was demonstrated that the stiffness of ECM may be one of many factors 
which regulates epidermal stem cell fate (Trappmann et al, 2012), with cells pulling 
on the growth surface and sensing the degree of pliability. When stem cells were 
cultured in high stiffness hydrogels or glass surfaces, they spread out and did not 
differentiate, but on soft hydrogel substrates, cells rounded up and initiated 
differentiation. Trappmann and colleagues proposed two pathways through which 
this occurs - both from inhibition of focal adhesion assembly, reduced integrin 
clustering and decreased ERK phosphorylation on soft gels and from restricted 
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spreading on stiff substrates causing reduced G-actin, SRF transcription factor and 
AP-1 activation. 
1.4.1.5 The Effect of 3D Culture On Cell Shape 
Epithelial cells in vivo are often polarised by their connections to a two-dimensional 
basement membrane, important for tissue organisation and directional secretion of 
cellular products - for example in secretory glands or kidney glomeruli (Yamada et 
al, 2007). However, in 2D culture on flat structureless plastic, forced polarity of 
attachment causes cells to adopt an abnormal, spread-out morphology, altering their 
normal shape and secretory pathways (Yamada et al, 2007). Other cells such as 
fibroblasts are naturally lacking any polarity in vivo, but when cultured in 2D are 
forced to adopt polar attachments on their ventral surfaces, also disrupting their in 
vivo behaviour (Lee et al, 2008). In 2D culture, the ventral side of cells contact the 
glass or plastic and cells may only form minimal contacts with neighbouring cells 
that are also adhered to the 2D surface (Bokhari et al, 2007). 
Optimisations to 2D surfaces, such as coating with collagen or extracellular matrix 
components (Cooke et al, 2008), or commercial products such as Matrigel (BD 
Biosciences), have improved the environment for 2D cultured cells (Hughes et al, 
2010), but still do not come close to representing the native cellular environment in 
vivo. 
3D culture aims to improve mimic the native cellular environment so that cells 
function as they would in vivo. The importance of the 3D environment is 
demonstrated by Cukierman et al, 2001 who noted increased numbers of cell-matrix 
adhesions, enhanced proliferation and more in vivo-like morphology almost 
immediately when cells were cultured inside a 3D environment. When cells were 
cultured on the surface of same material flattened into a 2D surface, these benefits 
were lost, showing that the 3D environment itself was essential for cell behaviour. In 
depth analysis has shown that the scaffold structure, such as fibre thickness and the 
diameter of spaces between those fibres are important for cell attachment and 
motility (Sun et al, 2006b).  
Cells grown in 3D also display functional differences compared to their 2D 
counterparts including improved resistance to toxins and increased metabolism 
(Schmeichel and Bissell, 2003). For instance, keratinocytes were more resistant to 
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oxidative stress or heavy metal toxicity in 3D cultures compared to their 2D-cultured 
counterparts (Sun et al, 2006) and hepatocytes cultured in 3D display enhanced 
albumin production and reduced sensitivity to a hepatotoxic drug than an equal 
number of cells cultured in 2D monolayers (Bokhari et al, 2007). 
In order to more closely mimic the in vivo environment, multiple cell types can be 
cocultured where they participate in mutual cell signalling, improving survival and 
overall tissue morphology. For example, Sun et al, 2005b cultured combinations of 
fibroblasts, keratinocytes and endothelial cells in electrospun polystyrene scaffolds 
and found that when cultured alone in serum free conditions, none of the cells were 
viable. However, in coculture with fibroblasts but the absence of serum, 
keratinocytes and endothelial cells were proliferative, indicating the importance of 
fibroblast signalling in keratinocyte survival. Even more surprisingly, when cultured 
at the air-liquid interface the cells formed an organised structure even though they 
were added into the scaffold randomly. 
In comparison to animal models, 3D models are also more accessible, more 
affordable and more suitable for large-scale testing than animal models. They can be 
used as a surrogate to draw preliminary conclusions in a more realistic environment 
than 2D culture before carrying out further testing in vivo (Yamada et al, 2007). For 
experimentation where cell motility or cell-cell/cell-matrix interactions are critical 
(for example carcinoma cell invasion or wound healing), 3D models and co-cultures 
are ideal. Jacks and Weinberg, 2002 proclaimed that "[s]uddenly, the study of cancer 
cells in two dimensions seems quaint, if not archaic."  
The scaffold utilised in this thesis is a newly-developed porous polystyrene-based 
structure which enables the culture of cells in 3D (Knight et al, 2011). The structure 
and properties of the scaffold, as well as a brief overview of the manufacturing 
process, are described in Chapter Two. Briefly, this polystyrene material is similar to 
standard 2D culture plasticware, and cells attach directly to the polystyrene and 
proliferate, migrate and differentiate within pores and voids in the structure, forming 
three-dimensional connections and laying down extracellular matrix. 
This scaffold has been used previously to culture neuronal cells (Hayman et al, 2004 
and 2005), liver hepatocytes (Bokhari et al, 2007, Schutte et al, 2011) and adipose-
derived stem cells (Neofytou, 2011). In comparisons with 2D culture, all 
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aforementioned authors noted a more realistic cell morphology of cells cultured 
inside the 3D scaffold.  
1.4.2 Problems and Future Developments for 3D Cell Culture 
Although advantageous in many aspects, 3D cell culture is not without significant 
difficulties and challenges when compared to 2D cell culture. These difficulties can 
influence all aspects of cell culture experiments including cell seeding, cell 
maintenance (in terms of culture media), cell modifications (such as transfection) and 
experimental analysis (imaging and assays). As such, even though the advantages of 
3D culture are relatively clear and accepted, 3D models have yet to see widespread 
use. 
1.4.2.1 Cell Seeding into 3D Environments 
Cell seeding methodologies need to be altered in order to distribute a known number 
of cells homogenously throughout a 3D material which contains pores and voids of 
varying sizes. Cells need to adhere to the material quickly so that they are not 
disturbed or washed away by culture media, and they need to be present in a sub-
confluent density which is optimal for their proliferation. Factors such as the pore 
size, interconnect diameter, porosity and wetability of the 3D material are important 
for cell seeding, and protocols need to be optimised for individual cell types 
depending on their size, shape and growth characteristics (Lee et al, 2008). These 
issues were addressed in Chapter Three of this thesis.  
With any novel culture surface, whether glass, hydrogel, natural or artificial 
polymers or even different brands of standard plasticware, cell adhesion and 
proliferation may be unexpected, particularly with cells lines which can become 
"tolerant" to their existing 2D conditions over time (Cukierman et al, 2001, Lee et al, 
2008). Therefore, basic investigations need to be performed in order to optimise cell 
seeding and attachment. For instance, the HaCaT cells used in this thesis were seeded 
into the 3D scaffold and allowed to adhere for 30 minutes before a larger volume of 
culture media was added. MET1 squamous cell carcinoma cells, which proliferate 
rapidly on 2D culture plastic, would not adhere to or proliferate inside the 3D 
scaffold at all, whereas a different cell line from the same patient (MET4) adhered 
and proliferated rapidly in the material. Some cell types require surfaces coated with 
collagen or ECM components, and this will also be addressed in Chapter Three of 
this thesis. 
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1.4.2.2 Cell Maintenance in 3D Culture 
Cells cultured in 3D are more metabolically active than their 2D counterparts 
(Schutte et al, 2011), and so place greater stresses on the culture environment - 
namely the quality of culture media in terms of pH, lactate and glucose content. 3D 
culture systems are non-vascular and so rely on simple diffusion for transport of 
oxygen and glucose, as well as clearance of waste materials (Yamada et al, 2007). 
Therefore, hypoxia is also a real concern with 3D models. The main factors in 
hypoxia are the distance from the culture media and the number of cell layers 
separating the culture media from hypoxic cells (Lee et al, 2008).  
Standard 2D cultures in Petri dishes are submerged in a uniformly rich distribution of 
culture media with equal nutritional availability and oxygen concentration across all 
cells, unlike in vivo tissue or 3D cultures which can maintain gradients of nutrition 
(Yamada et al, 2007). Cells at different distances from culture media can be in 
different metabolic states (Keith and Simon, 2007) reducing the reproducibility of 
experiments conducted in 3D. Interestingly, this hypoxia of 3D culture has been 
useful in modelling some forms of tumour which are hypoxia due to poorly formed 
vasculature (Hicks et al, 2006). However, for keratinocytes, mild hypoxia has been 
observed (Weir et al, 2009) to reduce terminal differentiation and involucrin 
expression in cultured keratinocytes, and should therefore be avoided if a well-
differentiated barrier is to be formed. 
To address these issues, 3D models need to be designed appropriately for cell 
nutrition. Materials need to be thin enough (~0.3mm) to permit adequate oxygenation 
of the interior tissues (Yamada and Cukierman, 2007). As well as thickness, a 
number of other factors can influence mass transport through the 3D matrix - 
including the pore size, pore shape, interconnect size, distribution of pore sizes and 
pore openness (Lee et al, 2008). For instance, a scaffold consisting of large, open 
pores but small interconnects may have poorer mass transport capability than a 
scaffold with small pores but more evenly distributed, larger interconnects. 
To address these issues caused by lack of vascularisation, the most obvious courses 
of action are to use larger culture vessels or to change culture media more frequently. 
However, simply submerging a 3D culture in a larger volume of culture media is 
likely to have implications for oxygen diffusion unless there is a dedicated oxygen 
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infusion into the culture itself. Frequent changing of culture media can also upset the 
concentration soluble signaling molecules produced by the cells (Lee et al, 2008). 
Perfusion-type systems have been previously used and have clear benefits in terms of 
cell viability and reproducibility (Wendt et al, 2009). Such systems can also be used 
for culturing keratinocytes at an air-liquid interface (Sun et al, 2005a) and perfusion 
based systems are currently under investigation in our lab for use with the 3D 
scaffold. However, these systems often utilise custom-made apparatus, and the 
system needs to be optimised before use (i.e. flow rate, oxygen input rate etc) 
according to the properties of the culture material and the metabolic demands of the 
cells. Such systems also utilise greater volumes of culture media than equivalent 2D 
culture or static 3D culture, increasing the cost of experiments, especially if defined 
media is required. As previously mentioned, such systems also remove any 
concentration gradients or soluble signalling molecules which may affect cell 
behaviour. For 3D cell culture to become more prevalent and replace 2D cell culture 
as a routine laboratory technique, more standardised equipment and protocols are 
needed to improve the economy and reliability of cultures to the same level as 2D 
culture. 
1.4.2.3 Experimental Analysis Using 3D Culture Materials 
Many 3D culture systems present problems in compatibility with existing lab 
techniques. In routine 2D culture, the confluence and morphology of cells can be 
easily visualised with a simple inverted light microscope, but this is not always 
possible in 3D culture systems which are opaque and display poor optical 
transmission. Multiple layers of cells also make simple assessments like cell 
confluence more difficult. Many laboratory techniques such as measuring optical 
density, using immunofluorescence staining or confocal imaging depend on 
transparent samples.  
The 3D polystyrene scaffold used in this project is 200µm thick, opaque polystyrene 
and therefore incompatible with simple light microscopy of live cells. Recently, a 
technique using PicoGreen (Invitrogen, UK) has been developed within our lab for 
routine assessments of culture confluence, although this still requires creation of 
standardised protocols and standard curves for multiple cell types. Assays such as the 
MTS proliferation assay can also be used to measure cell viability in 3D. 
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In terms of imaging techniques, there are fewer methods for reliably staining and 
viewing cells cultured in a 3D environment than there are for 2D (Lee et al, 2008). 
For imaging in this thesis, 3D cultures were treated as pieces of extracted tissue - i.e. 
fixed, embedded in paraffin, sectioned and then stained with histological stains or 
immunofluorescence antibodies. While these techniques are suitable for visualising 
tissue morphology, they require samples to be fixed, thus destroying the viable 
culture. This places limitations on the use of some 3D materials for live monitoring 
of cell migration or time-lapse of viable cells. Imaging techniques compatible with 
3D culture systems are currently being developed such as multi-photo microscopy, 
X-ray tomography and optical coherence tomography (Smith et al, 2011, Pappinen et 
al, 2012). Recently in our lab, techniques have been devised for fluorescent stained 
confocal imaging of living cells without fixation, as well as Z-stacking techniques to 
show 3D architecture. Again, more easily accessible standard protocols for culture 
assessment and imaging are needed if 3D culture is to replace 2D culture as a 
laboratory standard. However, most of the problems associated with 3D culture 
imaging are also true for in vivo samples which can rarely be analysed without prior 
excision. 
3D culture scaffolds also may reduce the availability of cells for analytical 
techniques such as protein, DNA or RNA extraction. Where there are multiple cell 
layers, extraction by simple cell scraping is not possible, and care needs to be taken 
to ensure that all cells within a 3D material are subjected to equal extraction. The 
same is true for transfections, where access to cells inside a 3D material may be 
reduced. 
Care must also be taken with regard to interactions between the 3D substrate and lab 
techniques. For instance, biodegradable protein-based scaffolds may contaminate 
protein extracts or plastic-based scaffolds may potentially leech plasticisers when 
exposed to solvents (for instance during lipid extraction).  Any 3D culture device 
must therefore be considered in experimental controls with the empty culture 
materials being subjected to the same extraction protocols as those containing 
cultured cells. 
Compared to 2D, detachment or removal of viable cells for techniques such as FACS 
or flow cytometry is almost more difficult. With the 3D scaffold used in this thesis, 
some cells could be easily trypsinised out from the 3D culture and then re-seeded 
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onto new material. However, if these scaffolds were then fixed and stained with 
H&E, most cells in the central portion of the scaffold remained inside. This may be 
then bias a cell extraction towards those cells with less developed adhesions to the 
material, or it may simply be due to physical constraints of cells trapped inside a 
complex porous structure. As prolonged exposure to trypsin enzymes is toxic to 
cells, other methods for cell detachment using non-enzymatic methods are under 
investigation in our lab. 
1.4.3 In vitro Models of Epidermis 
Since the work of Reinwald and Green in 1975-1977, keratinocytes have been 
cultured in vitro for the purpose of studying the epidermis. Keratinocyte culture has 
been used to provide therapies for skin disorders such as cultured epithelial 
autografts for treatment of burns or chronic blisters as described earlier. However, 
the 3D scaffold utilised in this thesis is not suitable for autografting techniques due to 
its rigid, non-biodegradable nature. 
Shortly after keratinocytes were cultured in 2D, Fusenig, 1978, Regnier, 1981 and 
Prunieras et al, 1983 cultured keratinocytes at an air-liquid interface using de-
epidermised dermis (DED) or contracted collagen and fibroblast gels as a support 
and noted improved keratinisation, stratification and epidermal-like morphology. The 
air-liquid interface partially replicates in vivo conditions where basal keratinocytes 
are fed from the dermal blood supply on the ventral side and the skin (or in vitro 
model) is exposed to the dry atmosphere on the outer side. Keratinocytes grown in 
this manner form a stratified epidermis-like structure. Fibroblasts were found to 
induce keratinocytes to produce basement membrane components (Lee and Cho, 
2005) and keratinocyte-fibroblast interactions were found to dictate many aspects of 
keratinocyte behaviour such as MMP expression (Nova et al, 2003) and 
differentiation (Mak et al, 1991). 
Since those early studies, numerous models of three-dimensional keratinocyte culture 
have been developed which have provided an invaluable tool for the investigation of 
keratinocyte function and skin biology under more suitable conditions than 
submerged 2D culture. Even recently, collagen gel and DED-based organotypic 
cultures are still in widespread use (Lee and Cho, 2005, Ojeh et al, 2008).  
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These cultures have been used to investigate keratinocyte cell signalling (Liang et al, 
2012), disease modelling (Barker et al, 2004, Semlin et al, 2010, Mildner et al, 
2010), irritancy testing (Netzaff et al, 2005), growth factor interactions (Amjad et al, 
2007), protein interactions (Vermeij et al, 2010, Yoneda et al, 2012), stromal 
interactions (Maas-Szabowski et al, 2003, Ikuta et al, 2006), bacterial colonisation 
(de Breij et al, 2012) and many more investigations. 
The focus of this thesis is the study of epidermal barrier function and in this regard 
numerous models have been developed in laboratories and several are sold 
commercially for in vitro testing of epidermal permeability (Pasonen-Seppanen et al, 
2001, Netzaff et al, 2005, Yan-feng Xu et al, 2005, Pappinen et al, 2008 and 2012, 
Vilgimigli et al, 2012).  
Commercial demand for epidermal equivalents for use in vitro is increasing, due to 
public perception of animal testing as well as European Union legislation. For 
instance, EU Directive 2010/63/EU article 4 states "Member States shall ensure that, 
wherever possible, a scientifically satisfactory method or testing strategy, not 
entailing the use of live animals, shall be used instead of a procedure." Article 
86/609/EEC states that " Member States should actively support the development, 
validation and acceptance of methods which could reduce, refine or replace the use 
of laboratory animals." The European Reference Laboratory On Alternatives To 
Animal Testing (EURL ECVAM) are responsible for assessing in vitro models and 
their suitability for replacing animal or human studies. They have recognised and 
validated some models for use in epidermal barrier permeability studies, including 
EpiDerm (Mattek, USA) and Episkin/RHE (SkinEthic/L'Oreal) which have been 
approved for use in preliminary epidermal toxicity testing by the OECD and 
ECVAM (ESAC peer review, 2006).  
Epidermal models are designed to replicate as many aspects of native epidermis as 
possible - namely morphology, a stratum corneum, expression of barrier proteins and 
a lipid profile representative of native epidermis. However, to date, no organotypic 
model is able to fully replicate the structure and properties of human epidermis. Most 
in vitro models form a thick stratum corneum (Ponec et al, 2000, Poumay and 
Coquette, 2007) but stratum corneum thickness is not necessarily related to barrier 
permeability, with conflicting studies in the area (Stahl et al, 2009). Studies have 
shown mixed results with in vitro equivalents showing either variability and some 
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unreliability (Ponec et al, 2000) or showing excellent reproducibility and 
comparability with human and porcine epidermis (Schäfer-Korting, 2008). Native 
human tissue is also variable in properties, depending on age, gender, race and body 
sample site (Darlenski and Fluhr, 2012), leading to wide definitions of "normal" 
epidermis in terms of thickness, lipid composition and barrier permeability.  
In order to provide a reliable substrate for testing of novel compounds, in vitro 
equivalents need to be stable and reproducible, as well as successful in predicting the 
action of a compound on human skin - whether in terms of permeability, irritation or 
physiological effect. Efforts are now concentrating on culture systems which can be 
duplicated in large scale and repeated by multiple labs (Poumay and Coquette, 2007). 
Many other commercial keratinocyte culture models utilising collagen gels are 
available, such as EpiDermFT (MatTek, USA), TestSkin (LSE, USA) and AST-2000 
(CellSystems, Germany). All models are based on similar principles of culturing 
human keratinocytes on a collagen-contracted gel at the air-liquid interface. Other 
models utilise a 2D collagen-coated surface, such as a well-developed rat 
keratinocyte organotypic culture model which has shown reliable prediction of native 
human skin penetration (Pappinen et al, 2012). 
Keratinocytes have also been cultured in 3D without a cellular dermal equivalent. 
Commercial models such as EpiDerm (Mattek, USA), SkinEthic (Skinethic Labs, 
France), EST-1000 (CellSystems, Germany) (recently renamed epiCS) have cultured 
keratinocytes on polycarbonate membranes to form in vitro epidermal equivalents 
and use supplemented culture media rather than fibroblast feeder cells. These models 
have been used to study keratinocyte differentiation (Chaturvedi et al, 2006), skin 
irritation (Welss et al, 2003) or barrier permeability (Pappinen et al, 2003).  
 
Table 1.1 Summary of Leading Commercial and Non-commercial Epidermal Models 
Model Culture material Cell type(s) used Information References 
Commercial Models 
*/**Epiderm 
(MatTek, USA) 
Inert polycarbonate 
membrane 
NKEH  6-8 living cell layers (28-43µm) with 16-25 
layers (12-28µm) of stratum corneum 
(Netzlaff et al, 2005). Manufacturer, 8-12 
viable layers and 10-15 stratum corneum. 
This is the longest standing commercial 
model (since 1992) and the first to be 
ECVAM validated. 
Poumay and Coquette, 
2007, Netzlaff et al, 
2005, Ponec et al, 2000 
*/**SkinEthic Rhe 
(Laboratoire 
Skinethic, France) 
(SkinEthic are 
subsidiary of L'Oreal) 
Inert polycarbonate 
membrane 
NKEH air-lifted for 17 
days 
5-9 living cell layers (23-59µm) with 14-24 
layers (15-32µm) of stratum corneum 
Netzlaff et al, 2005, 
Ponec et al, 2000 
*/**EpiSkin/Invitrosk
in (Episkin SNC, 
France)  
Type I bovine 
collagen matrix 
topped with Type IV 
human collagen 
NKEH submerged for 3 
days and air-lifted for 
13-20 days 
15-24 living cell layers with 600-100 layers 
(73-102µm) stratum corneum 
Netzlaff et al, 2005, 
Ponec et al, 2000 
67 
 
StrataTest, 
(Stratatech, USA) 
NHDF in collagen I 
on hyaluronic acid 
membranes in well-
inserts 
NIKS keratinocyte 
progenitor cell line and 
NHDF-collagen based 
dermal equivalent 
NIKS (normal immortalised keratinocytes) 
are a spontaneously immortal neonatal 
foreskin-derived cell line. The model shows 
a thick, highly stratified epithelium (>20 
layers) which stains positive for 
differentiation markers 
Slavik et al, 2007, 
Rasmussen et al, 2010. 
Zhang and Michniak-
Kohn, 2012 
Epiderm FT (MatTek, 
USA) 
Collagen matrix in 
cell culture membrane 
insert 
NKEK and NHDF Full thickness model. Produces 8-12 
epidermal cell layers, not including stratum 
corneum. Includes well developed basement 
membrane and hemidesmosomes at DEJ 
Hayden et al, 2005. 
Manufacturer product 
information 
*epiCS/ Epidermal 
Skin Test 1000 
(EST1000), 
(CellSystems 
Biotechnologie 
GmbH) 
Permeable cell culture 
membrane insert 
NHEK More than 4 viable layers, more than 5 
cornified layers. ECVAM validated for 
corrositivity. Model shows accurate 
locations of major differentiation markers 
(K10, profilaggrin, TGase and involucrin) 
and K14, organised into well-defined layers 
Hoffman et al, 2005. 
Manufacturer product 
information 
Non-Commercial Models 
ROC (Rat 
Organotypic Culture) 
Collagen gel Rat keratinocytes air-
lifted for 21 days with 
Well-characterised model with 
physiologically similar lipid profile and 
Suhonen et al, 2003 
Kuntsche et al, 2008 
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40µg/ml ascorbic acid predictable barrier properties which have 
been tested against an extensive range of 
permeants 
Pappinen et al, 2007 
Pappinen et al, 2008 
Michniak group HSE Bovine collagen 
matrix 
NHDF and NHEK Full thickness model. Overestimates 
caffeine and hydrocortisone permeability 
Batheja et al, 2009 
LHE (Leiden Human 
Epidermal) Model 
PEGT/PBT 
biodegradable scaffold 
300µm thick, 70-80% 
porosity with 50-
210µm pore diameter. 
With or without 
collagen 
NHDF and NHEK Cultured in presence of lipid supplement and 
40µg/ml ascorbic acid 
El Ghalbzouri et al, 2005 
HaCaT-based model Contracted collagen 
type I gel containing 
2-3x10
5
 
fibroblasts/ml. 
L929 murine dermal 
fibroblasts and HaCaT 
keratinocytes. 7 days 
submerged, 14 days air-
liquid interface 
Model shows positive staining for 
differentiation markers and has been used 
for permeability testing. Results for the 
compounds tested (ibuprofen) showed 
permeability approximately 20x higher than 
native epidermis. 
Specht et al, 1998 
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RHE (Reconstructed 
human epidermis) 
Inert polycarbonate 
filter 
NHEK cultured for 14 
days at air-liquid 
interface in high 
calcium 
Model displays differentiation markers and 
clear progression of epidermal layers. TEM 
analysis reveals lamellar bodies and 
keratohyalin granules 
Poumay et al, 2004 
RE-DED De-epidermised 
dermis 
NHEK cultured for 5 
days submerged and 14 
days at air-liquid 
interface, supplemented 
with 50µg/ml ascorbic 
acid 
Displayed many similarities with in-vivo 
epidermis including SC organisation and 
presence of physiological lipids, including 
ceramide profile 
Ponec et al, 1997 
CSS (Cultured Skin 
Substitute) 
Collagen-GAG matrix NHDF added to 
collagen-GAG matrix 
and NHEK seeded onto 
surface 
When cultured submerged or without 
additional supplements (such as ascorbic 
acid, linoleic acid etc), these models 
displayed an incomplete set of barrier lipids, 
poor lamellar body formation and lipid 
vacuoles present inside keratinocytes. 
Addition of supplements restored normality 
to the cultures.  
Boyce and Williams, 
1993 
* = ECVAM validated for OECD Test Guideline 431 (Skin corrosivity), ** = ECVAM validated for OECD Test Guideline 439 (Skin irritation) 
*** = lipid supplement of 20µM palmitic acid, 15µM linoleic acid, 7µM arachodonic acid and 2.4x10
-5 
BSA 
Detailed analysis of many epidermal equivalents are presented by Pappinen et al, 
2012, Zhang et al, 2012, Poumay and Coquette, 2007, Ponec et al, 2000 and Ponec et 
al, 1997. It is also worth noting that some models such as Skin2TM, (Advanced 
Tissue Sciences, USA) (Rheins et al, 1994) and EpiSkin (L'Oreal, France) are no 
longer commercially available. The withdrawl of these commercial models have 
likely incentivised some active research groups to develop their own reproducible in-
house models where future access and consistency can be guaranteed (Poumay and 
Coquette, 2007). 
The 3D scaffold used in this thesis is a porous 3D material and cells remain inside 
the structure throughout the entire culture period, which makes it considerably 
different to the models mentioned previously. This material has been used previously 
for culture of neuronal cells (Hayman et al, 2004 and 2005), liver hepatocytes 
(Bokhari et al, 2007, Schutte et al, 2011) and adipose-derived stem cells (Neofytou, 
2011) but not yet keratinocytes. Therefore, this thesis will by evaluating the potential 
of this new material as the basis for forming an in vitro epidermal model with a 
suitable barrier function for permeability testing. 
1.5 Hypotheses  
In this project I will examine the following hypotheses: 
 Keratinocytes are able to proliferate and differentiate inside a porous 3D 
polystyrene scaffold, given suitable culture conditions 
 Keratinocytes are capable of producing cornified envelopes and a lipid profile 
similar to native epidermis, given optimal culture conditions 
 Keratinocytes can form a specialised epidermal barrier inside this porous 3D 
scaffold 
 The created model will be useful for testing compounds which affect 
keratinocyte behaviour 
 Differentiation in the 3D environment can be accelerated by inhibition of the 
JNK pathway, which has been previously shown to increase differentiation in 
2D cell culture. This increased differentiation is hypothesised to increase the 
barrier function of the 3D cultured keratinocytes. 
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1.6 Aims of the Current Project 
 To modify existing laboratory analytical techniques for use with the 3D 
scaffold. This includes integrating collagen gels or coatings into the material 
and establishing optimal culture conditions such as the number of cells to be 
seeded, culture duration and culture media volume. 
 
 To utilise the 3D polystyrene scaffold as a cell culture device to induce 
keratinocyte differentiation at the air-liquid interface. This will involve 
further modification to the culture conditions and checking cell viability, 
morphology and differentiation under different conditions. 
 
 To characterise the 3D model in terms of viability, differentiation and 
proliferation, morphology (including ultrastructure) and barrier lipid profile 
under various conditions. Methods of optimising keratinocyte behaviour from 
published literature will be tested against the new model 
 
 To form a reproducible keratinocyte model by consistently applying the 
optimised culture conditions. The stable nature of the polystyrene scaffold 
and of HaCaT cells will help to accomplish this. 
 
 To assess the epidermal barrier function by functional testing using a 
diffusion chamber and a common, biologically relevant permeant. The 
permeability coefficient can then be compared against published data for 
human epidermis and other in vitro epidermal models. 
 
 To use the newly created model to examine the effect of compounds known 
to affect keratinocyte differentiation. This will show whether the model is 
useful for predicting the action of unknown compounds. 
 
 Throughout the thesis, results 2D cell culture and 3D cell culture will be 
compared 
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2 Chapter 2  
 
 
 
 
 
 
 
 
Materials and Methods 
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All materials were purchased from Sigma, UK unless otherwise stated. 
2.1 Routine 2D Cell Culture 
2.1.1 Cell Maintenance 
2.1.1.1 HaCaT Cells 
HaCaT cells, isolated by Fusenig et al, 1978, were obtained via Cell Line Services, 
GmbH, Eppelheim, Germany. HaCaT cells were grown routinely in T75 flasks 
(Greiner, Bio-One, UK) in Dulbecco’s Modified Essential Medium (DMEM) with 
10% fetal bovine serum (FBS) and 1% Penicillin/Streptomycin (P/S) at 37°C in 5% 
CO2. This medium is pre-supplemented with stabilised L-glutamine. For routine 
passaging, cells were washed twice with PBS, trypsinised with 0.25% v/v 
trypsin/EDTA and split at a 1:4 ratio into new flasks following standard cell culture 
methods. Cells were maintained between 20-80% confluence and discarded if over-
confluent. For long-term storage, cells were trypsinised as stated above and 
centrifuged at 1000g for 5 minutes, then re-suspended at 10
6 
cells per 900µl culture 
media and mixed with 100µl dimethyl sulphoxide (DMSO) in a cryovial. Cryovials 
were mixed thoroughly, then placed in an insulated container in a -80°C freezer for 
up to six months of storage and -130°C for long-term storage. For thawing, vials 
were defrosted in a 37°C water bath, then mixed with fresh culture media, 
centrifuged at 1000g for 5 minutes and re-suspended in fresh cell culture media and 
seeded into a T25 flask. When 80% confluent, cells were then trypsinised and seeded 
into T75 flasks. 
2.1.1.2 3T3 Cells 
3T3-NIH cells were grown routinely in T75 flasks in Dulbecco’s Modified Essential 
Medium (DMEM) with 10% v/v bovine serum and 1% v/v penicillin/streptomycin at 
37°C in 5% CO2. For routine passaging, cells were washed twice with PBS, 
trypsinised with Versene (Invitrogen, UK) and seeded at a 1:5 ratio. Cells were not 
allowed to reach >90% confluence. Cells were stored and thawed in the same way as 
HaCaT cells. 
2.1.1.3 Mouse Wild Type Keratinocyte (WTK) Culture 
Mouse keratinocytes, originally isolated from the back epidermis of 3 month old C57 
black mice were donated by Dr Carrie Ambler, Durham University. These cells were 
originally cultured with 3T3-J2 mouse fibroblast "feeder" cells  in T25 flasks 
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although for the purpose of this study they were cultured independently so that they 
could be grown in the 3D scaffold without the complication of a supporting feeder 
layer. Mouse keratinocytes cells do not grow in DMEM and were more sensitive to 
calcium concentration than HaCaT cells. The optimal growth conditions were 
determined to be calcium free Epilife culture medium (Cascade, UK and Invitrogen, 
UK) supplemented with 0.06mM Ca
2+
 and 1% v/v Epilife Defined Growth 
Supplement (Invitrogen, UK). Undifferentiated cell morphology was preserved, but 
the rate of growth was very slow. Addition of FBS provided quicker growth but 
induced differentiation. Addition of chelexed, calcium free FBS (cFBS) preserved 
normal cell morphology while increasing the rate of proliferation to a usable level. 
1% v/v antibiotic/antimycotic was later added to the culture media and showed no 
detrimental effect on cell morphology or behaviour. After 40 passages, cells were 
deemed a stable cell line continuously maintaining normal cell morphology and 
differentiation potential. Cells were frozen, stored and thawed in the same way as 
HaCaT cells. 
2.1.1.4 MET Cell Culture 
MET1 and MET4 squamous cell carcinoma cell lines (Proby et al, 2000) were 
cultured, subcultured and stored frozen in the same way as HaCaT cells although 
subcultured more frequently due to their rapid proliferation. 
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2.1.2 Cell Culture Media Preparation 
2.1.2.1 Cell Culture Media Additives 
During the course of this project, several modifications to standard culture media 
were made. A list of additives and concentrations are summarised below. More 
information is discussed where appropriate alongside relevant data in the results 
chapters. 
Table 2.1. Summary of Cell Culture Additives 
Additive Concentration Supplier Notes 
Calcium 0.06/1.5mM Sigma, UK Diluted with PBS, sterile 
filtered. Stored at -20°C 
SP600125 JNK 
inhibitor  
0.5-100µM Calbiochem/ 
Sigma, UK 
Stock solution in DMSO. 
0.1% v/v DMSO added to 
culture media for every 
10µM concentration. 
Stored at -20°C in the dark 
Ascorbic Acid 100µg/ml Sigma, UK Diluted with PBS, sterile 
filtered. Stored at -20°C 
Linoleic Acid 10µM Sigma, UK  
As used in Ponec et al, 
2003 
Palmitic Acid 25µM Sigma, UK 
Arachadonic Acid 7µM Sigma, UK 
Bovine Serum 
Albumin (BSA) 
2.4mM Sigma, UK Diluted with PBS, sterile 
filtered. Stored at -20°C 
EpiLife Defined 
Growth 
Supplement 
(EDGS) 
1% Cascade, UK/ 
Invitrogen,UK 
Stored at -20°C in the 
dark.  
*SP600125 is a selective, reversible, competitive inhibitor of cJun N-terminal kinase 
(JNK) with respect to ATP, designed and characterised by Bennett et al, 2001. 
SP600125 inhibits all three isoforms of JNK and displays at least a 100-fold 
selectivity for JNK as opposed to a panel of other inflammatory or stress-related 
kinase enzymes. SP600125 is poorly soluble in water and so was diluted in DMSO, 
stored and used at concentrations recommended by the manufacturer (Calbiochem, 
UK) and Bennett et al, 2001. Controls were given the appropriate amount of DMSO. 
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2.1.2.2 Calcium Chelated FBS (cFBS) 
To generate cFBS,  200g “Chelex 100” resin was washed by stirring into 1.3L Milli-
Q ddH2O and adjusting to pH7.4 with 6M HCl. Resin was then allowed to settle for 
30 minutes and water removed. The washing procedure, minus pH adjustment, was 
carried out a further two times with ddH2O and a further two times with sterile PBS. 
1L of 4
o
C FBS was mixed with the washed resin and stirred in the dark at 4
o
C for 1 
hour to bind calcium in the serum. To remove Chelex from the media, the solution 
was filtered through a 0.45µm filter, then again through a 0.22µm filter for 
sterilisation. cFBS was then aliquoted and stored at -20
o
C until use (Turksen et al, 
2005). Before routine use, the cFBS-based media was tested on WTK cells grown on 
coverslips and checked for cell viability and examined for differentiation markers. 
 
2.2 3D Cell Culture 
2.2.1 The 3D Polystyrene Scaffold 
The 3D scaffold utilised and referred to throughout this thesis is a porous, 
polystyrene-based disc, 25mm in diameter and 200µm thick. It is designed and 
manufactured by Reinnervate, UK, who are the CASE industrial partner and partial 
sponsor for the work carried out in this thesis. All 3D scaffold materials used in this 
thesis were provided by Reinnervate, or by their academic partners at Durham 
University. 
Cells adhere to the 3D scaffold material and are cultured inside the pores of the 
material in three dimensions. Scaffolds were manufactured by technicians in our lab 
or in an external facility. A brief outline of the manufacture process is outlined 
below. 
2.2.1.1 Manufacture of the 3D Scaffold 
3D scaffolds were manufactured by a high internal phase emulsion (HIPE) process as 
detailed in Hayman et al, 2005, Bokhari et al, 2007 and Zeyfert et al, 2009. Briefly, 
styrene, divinylbenzene (DVB) and sorbitan monoleate were mixed into an oil phase. 
This was stirred into a solution of dH2O with surfactants and mixed vigorously into 
an emulsion. This mixture was poured into a 25mm diameter tube and allowed to 
solidify at 60°C for 5 hours. This solid monolith was washed in ddH2O followed by 
several changes of isopropyl alcohol (later modified to acetone). The monolith 
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cylinder of hardened polymer was then sectioned into 200µm thick slices using a 
Leica Vibratome. Properties of the scaffold such as pore size, void diameter and 
overall porosity can be varied by changing the concentration of surfactants or 
altering the stirring speed and duration, as described in Bokhari et al, 2007
a 
,2007
 b 
and Carnachan et al, 2008. 
Figure 2.1 shows the structure of the 3D scaffold used throughout this project. Image 
A shows a 25mm diameter monolith before sectioning and image B shows a single 
200µm thick section. Image C shows an SEM image of the 3D scaffold, showing 
numerous pores and voids forming a 3D structure. Cells attach to the surface and are 
cultured inside the pores and voids. Voids inside the 3D scaffold are approximately 
30-80µm which is large enough to accommodate cells, and all voids show several 
10-20µm interconnects, allowing cell infiltration and migration into the material. 
As the pores voids of the 3D scaffold are formed by vigorously mixing oil and water 
phases, the distribution and size of pores is essentially random, but can be controlled 
within a certain range of specifications. This is opposed to a synthetic scaffold 
formed from regular repeating subunits which would be uniform in structure and 
distribution, such as those formed by solid free-form (SFF) fabrication (Hollister, 
2006). Therefore, quality control (QC) steps were taken to monitor the size and 
overall porosity of each batch of polyHIPE scaffolds. QC was carried out internally 
by our technicians, using SEM imaging to measure pore diameter and mercury 
porisimitery to measure porosity. Results were shared within the lab and batches of 
scaffolds which failed QC analysis were discarded. All 3D scaffolds used in this 
study conformed to internal specifications for porosity (shown in Figure 2.2) and 
morphology, visualised by SEM. In later stages of development, each batch of 3D 
scaffold was tested for cell culture by MTS assay after 48 hours of a number of 
different cell lines. Batches which failed QC testing were discarded. All scaffolds 
used in this study were from batches which had passed cell culture QC. 
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Figure 2.1. Ultrastructure of the 3D Polystyrene Scaffold  
A) 22mm diameter polystyrene monolith, from which the 200µm sections are cut 
with a vibratome; B) 22mm diameter scaffold, formed from cutting a 200µm thick 
section of the monolith; C) Scanning Electron Micrograph of 3D scaffold showing 
pores and voids (indicated) in which cells can proliferate. The highly porous 
structure of the scaffold is clearly visible. Scale bar 200µm; D) SEM image of 3D 
scaffold with HaCaT keratinocytes cultured for 7 days, showing that cells have filled 
the pores through the full depth of the scaffold. Scale bar 100µm.   
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2.2.1.2 Development of the 3D Scaffold 
The 3D scaffold is a developing commercial product which has undergone changes 
for several years, continued throughout the duration of this project. During this time, 
the process for manufacturing the 3D scaffold, and therefore the properties of the 
scaffold itself, have altered. Initially, 3D scaffolds were manufactured in the 
laboratory in one-off quantities (the "in-house" phase). These showed pinholes and 
variable porosity, indicated in Figure 2.2. Production was later scaled up to a larger-
scale manufacturing process utilising larger mixing vessels, a new stirring speed and 
modified washing procedures using acetone rather than isopropyl alcohol. QC was 
also introduced at this stage (the "1G" phase). These scaffolds showed an increased 
total porosity, and smaller, more tightly controlled pore sizes.  Finally, production 
was moved to an external manufacturing facility and the procedure was fully adapted 
for large-scale manufacture (the "2G" phase). These scaffolds have smaller 
interconnect and pore sizes and a narrower variability in size. A summary of these 
three main phases along with changes to the scaffold properties and culture apparatus 
are detailed in Figure 2.2. For instance, moving from in-house to 1G scaffold, the 
pore size reduced from 60-80µm to 40-65µm, which may reduce infiltration and 
migration of some cell types. However, the porosity of the scaffold increased from 
73% to 93%, which would allow better diffusion of culture media and oxygen 
through the 3D culture as well as allowing more cell-cell contact due to less 
polystyrene material. 
In order to obtain consistency of results, all replicates and repeats of the same 
experiment in this project were performed with scaffolds from the same 
manufacturing batch. Where possible, the series of related experiments were carried 
out using the same batch of 3D scaffolds, although this was not always possible due 
to the timing of experiments and availability of materials. 
In order to address issues surrounding cell maintenance in 3D (discussed in Chapter 
Three), several different culture methodologies were utilised over the course of this 
study, including custom-designed plasticware to hold the 3D scaffold and deeper 
well plates or dishes to hold a greater volume of culture media. An overview of the 
different 3D scaffolds and culture apparatus used in this study is shown in Figure 2.3 
and 2.4.  
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Figure 2.2. Timeline of 3D Scaffold Development 
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Figure 2.3. 3D Culture System Well-inserts 
A) Well insert type 1 with a solid seal between the upper and lower sides of scaffold, 
shown inverted. The scaffold is slightly recessed on the underside and does not lie 
flat with media while at air-liquid interface (indicated with arrow); B) Well insert 
type 2 with three “windows” (labelled W) to allow culture media exchange between 
the upper and lower sides of the scaffold or separate media compartments on the 
upper and lower sides of the scaffold. The underside of the insert is less recessed and 
so the scaffold can maintain flat contact with media at the air-liquid interface. 
Scaffold diameter 22mm. 
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Figure 2.4. Custom Cell Culture Apparatus 
A) Well insert type 2 set to three different media levels showing how culture media 
passes through the window of the well-insert when the scaffold is submerged. B) 
Well inserts type 1 and 2 can both be set to high, medium and low levels. This allows 
different amounts of culture media to be placed underneath the scaffold at the air-
liquid interface (20ml, 34ml and 48ml respectively) or 70ml, 80ml and 92ml when 
submerged; C) Tri-well insert which holds three well-inserts inside a 86mm diameter 
25mm deep Petri dish. Images reproduced with permission from Reinnervate Ltd, 
UK. 
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2.2.2 Preparation of the 3D Scaffold for Cell Growth 
The polystyrene material that forms the 3D scaffold is very hydrophobic and 
solutions of water, PBS or cell culture media will simply form a bead on top. 
Therefore the scaffold must be prepared for cell culture by either pre-wetting with 
ethanol or by plasma treatment. 
2.2.2.1 Ethanol Pre-wetting of the 3D Scaffold 
70% v/v ethanol was added to the scaffold for 10 minutes under sterile conditions, 
then washed away by 3 washes of tissue culture grade PBS, without the scaffold 
being allowed to dry. The scaffold was then stored under PBS until use. This 
treatment also sterilises the scaffold for cell culture. Before seeding cells, the 
scaffold was removed from PBS, and a cell suspension immediately added before the 
scaffold becomes dry and hydrophobic. 
2.2.2.2 Plasma Treatment of the 3D Scaffold 
To plasma treat the 3D scaffold, a 12 well plate or a plate of scaffolds in 6-well sizes 
inserts were oxygen plasma treated individually with an Emitech Plasma Asher 
(K1050X) for 5 minutes at 40W, 30ml/min O2 for same-day use, or 30 minutes at 
10W, 30ml/min O2 for long term (maximum one week) storage. This method of 
plasma treatment shows no detrimental effect on the scaffold structure (confirmed by 
in-house SEM analysis) although higher energy plasma treatment can adversely 
affect the structure of the scaffold by “melting” some surface voids, blocking cells 
from successfully entering the scaffold. Internal QC showed that plasma treatment 
also suitably sterilises the scaffolds and plasticware for cell culture. Plasma treatment 
of this 3D scaffold is discussed in more depth in Zeyfert et al, 2007. 
In this study, both ethanol pre-wetted and plasma treated scaffolds were used. During 
the course of this project plasma treatment of the scaffold was still undergoing 
development and QC testing. In a comparison of ethanol wetting against plasma 
treatment shown in Chapter Three, plasma treatment was found to provide better cell 
growth. Where possible, plasma treated scaffolds were used preferentially in this 
study. However, due to the developmental nature of this project as well as time and 
equipment constraints, this was not always possible. However, all scaffolds used 
within one particular experiment, or in three repeats of the same experiment were 
always prepared by the same method. The preparation method will be noted where 
relevant throughout this thesis. 
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2.2.3 Cell Seeding in the 3D Scaffold 
The 3D scaffold is a novel culture device and so a seeding method, quantity and 
density of cells needed to be determined. These were analysed in Chapter Three.  
2.2.3.1 Concentrated Cell Seeding Method 
Cells were suspended at high density in a small volume of media and added to the 
centre of a scaffold. It was hypothesised that capillary action will draw the media and 
cells into the scaffold and fill the thickness of the scaffold. The approximate fluid 
volume of a 200µm thick, 25mm diameter scaffold is 68µL (in-house QC data) and 
so 50-100µl was typically used as the volume for seeding cells. This results in a high 
density of cells in the centre area of the scaffold. 
2.2.3.2 Diffuse Cell Seeding Method 
In order to achieve a more even distribution of cells, cells were suspended into 2ml 
for a 12-well plate or 4ml for a 6 well plate and added to the scaffold. This would 
result in a more even distribution of cells over the surface area of the scaffold but 
potentially less penetration inside the scaffold. 
2.2.4 Collagen Coating of the 3D Scaffold 
In order to optimise the 3D scaffold as a dermal equivalent, it was combined with 
collagen in a variety of ways to form a gel, film or a filbrillar network. Type I rat tail 
collagen supplied at 2.12mg/ml in 0.6% acetic acid, (First Link,UK) was used. When 
the pH of the solution is neutralised by NaOH and the temperature is raised, the 
collagen can form a gel. The following five methods for collagen gel formation were 
used in this study: 
1) Fibroblast-contracted Gel. 7:1:1:1 collagen, 1M NaOH, MEM and 3T3 cells 
(5x10
5
 per ml) were mixed on ice and pipetted onto a prepared scaffold. All pipette 
tips were pre-cooled on ice to prevent early solidification of the gel. Scaffolds with 
collagen mixture were incubated at 37°C for 15 minutes to form a soft gel, then 
submerged in media and grown for 10 days with media changes every two days in 
accordance with Ojeh et al, 2008. 
2) Stable Chondroitin Sulphate and Collagen Gel. A more stable gel was formed 
by mixing, on ice, 10:1:1 parts collagen, 1M NaOH, DMEM containing chondroitin-
6-sulphate (final concentration of choindroitin 10% w/v) and pipetting onto a 
plasma-treated or ethanol-washed scaffold, based on a modification of the method by 
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Osborne et al, 2008. This forms a thick gel which solidifies quickly. This is discussed 
in more detail in Chapter Three. 
3) Ammonium Chamber Collagen Coating. An ammonium chamber was used to 
form collagen fibres inside the scaffold rather than forming a sheet around the 
outside surfaces. Collagen solution was kept on ice and diluted in ice cold 0.6% 
acetic acid to 0.2mg/ml. To coat a scaffold, it was submerged in this mixture on ice 
for 15 minutes, then moved to a Petri dish containing a cotton ball soaked in 
ammonia. This was air-sealed at room temperature for 15 minutes to solidify. 
4) Collagen Coating in PBS or Ethanol. Collagen was diluted into 1xPBS or 70% 
ethanol. 500µl was added to the scaffold in a 12 well plate. The solution was allowed 
to evaporate under sterile culture conditions. 
5) Pre-Neutralising with NaOH. In order to prevent the collagen solution gelling 
prematurely outside of the scaffold, 100µl 1M NaOH solution was added to the 
scaffold and evaporated to leave a coating of NaOH throughout the scaffold. A dilute 
collagen concentration of 0.2mg/ml was then added to the dry scaffold and incubated 
at 37°C for 3 hours. 
2.2.4.1 Coomassie Brilliant Blue Staining for Collagen Coating 
Collagen coating of the scaffold was quickly assessed by staining with Coommassie 
Brilliant Blue (40% v/v methanol, 10% v/v acetic acid, 0.1% v/v Coomassie Brilliant 
Blue G-250) for 5 minutes and removing excess with with de-stain solution (40% v/v 
methanol, 10% v/v acetic acid in dH2O). As a control, an un-coated scaffold was 
used and all samples were washed in destain until the control showed no blue 
staining. 
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2.3 Analytical Methods 
2.3.1 Imaging Methods 
2.3.1.1 Immunofluorescence Staining 
Cells were seeded and grown on glass coverslips (VWR, UK) with one coverslip per 
24 well plate submerged in 1.5ml cell culture media. To fix cells for analysis, cell 
culture media was aspirated and adherent cells were washed 3x with PBS then fixed 
in 2ml 4% w/v paraformaldehyde (Agar Scientific, UK) per well for 15 minutes at 
room temperature. Fixed coverslips were then washed 3x with sterile PBS and stored 
at 4°C in PBS for a maximum of 7 days before analysis.  
For immunofluorescence staining, cells were permeabilised with 0.5% or 1.0% v/v 
Triton X-100 (Fisher Scientific, UK) for 15 minutes then blocked with a mixture of 
0.5% v/v fish skin gelatin, 0.1% v/v Triton X-100 and 1% w/v Bovine Serum 
Albumin (BSA). Primary antibodies shown in Table 2.2 were then diluted to 
manufacturer specifications in blocking solution and added to coverslips for 1 hour at 
room temperature, or overnight at 4°C in a humidified chamber. Coverslips were 
then washed 4x 5 minutes with PBS to remove non-specific primary antibody, then 
inclubated for 1 hour at room temperature in appropriate secondary antibodies 
conjugated to a fluorophore i.e. Alexa488/594. Controls coverslips were stained with 
secondary antibody only. Coverslips were then mounted, cell side down, onto glass 
microscope slides with ImmuMount (Thermo Scientific, UK) with 1:1000 4', 6-
Diamidino-2-phenylindole, (Invitrogen, UK).  
2.3.1.2 3D Scaffold Fixation, Embedding and Paraffin Sectioning 
The following protocol was developed in-house for the 3D scaffold. 3D cultures 
were removed from culture vessels, fixed in 4% PFA overnight, then washed 3x in 
PBS for 5 minutes each. The central strip of the scaffold was then cut out and 
dehydrated through 30%, 50%, 70%, 80%, 90%, 95% and two washes of 100% v/v 
ethanol for 15 minutes each, cleared in Histoclear II for 15 minutes and embedded 
vertically in paraffin wax. Wax blocks were allowed to dry overnight. 10µm sections 
were cut as standard for histology and immunofluorescence staining with a Leica 
microtome, floated onto a waterbath at 45°C and adhered to histobond glass 
microscope slides. Sections were dried overnight on a slide drier at 40°C. 
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2.3.1.3 Haematoxylin and Eosin (H&E) Staining 
10µm thick, paraffin-embedded sections were de-waxed in Histoclear II (RA Lamb, 
UK) for 10 minutes. If sections were not fully de-waxed, they were placed into a 
second Histoclear II bath for 5 minutes. Sections were then re-hydrated through 
100%, 95%, 80%, 70% v/v ethanols for 2 minutes each and moved into dH2O for 2 
minutes. Sections were then stained in Mayers Hematoxylin for 6 minutes, washed in 
dH2O for 30 seconds, nuclei differentiated in alkaline alcohol (70% ethanol with 1% 
v/v ammonia) for 15 seconds, moved through 70% and 90% v/v ethanols and 
counterstained in 1% eosin solution for 15 seconds. Sections were then washed twice 
in 95% v/v ethanol and twice in 100% v/v ethanol for 30 seconds each. Finally, 
sections were cleared in Histoclear II for 5 minutes each, then mounted with a 
coverslip in DePeX (VWR, UK). 
2.3.1.4 Immunofluorescence Staining of 3D Cultures 
The following protocol was developed in-house for the 3D scaffold. 10µm thick, 
paraffin-embedded sections were de-waxed with Histoclear II and rehydrated 
through graded ethanols and dH2O as above. In order to retrieve antigens blocked 
during fixation, sections were then subjected to antigen retrieval in citrate buffer at 
pH 6.5 with 6 minutes in the microwave at 900W, 5 minutes of cooling at room 
temperature, and a further 2 minutes at 900W. Sections were left to cool for 10 
minutes, then washed in three changes of room temperature PBS for 10 minutes 
each. Sections were marked off with an ImmuEdge hydrophobic marker pen (Vector 
Scientific, UK), permeabilised with 0.5% v/v Triton-X100 in PBS for 15 minutes and 
blocked with blocking buffer (PBS/1% w/v bovine serum albumin/ 5% v/v fish skin 
gelatin, v/v 0.1% Triton-X100). Samples were incubated with primary antibodies in a 
humidified chamber at room temperature for 1 hour or overnight at 4°C depending 
on manufacturer reccommendations, washed 3x with PBS for 10 minutes each and 
then incubated with AlexaFluor 488 or 594 labelled secondary antibodies in a dark, 
humidified chamber for 1 hour at room temperature, following manufacturer 
reccommendations. Control sections were stained with secondary antibody only. 
Sections were then washed in PBS with 5 minutes and mounted with coverslips using 
ImmuMount mounting media with 1:1000 DAPI.  
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A summary of antibodies used for 2D and/or 3D immunofluorescence staining is 
shown in Table 2.2: 
Table 2.2. Summary of Antibodies Used in this Project 
Antibodies Target Manufacturer Type Dilution 
Primary Filaggrin Abcam ab24584  Rabbit Polyclonal 1:1000 
 Involucrin Abcam ab28057 Rabbit Polyclonal 1:1000 
 Desmoplakin Abcam ab71690 Rabbit Polyclonal 1:200 
 ZO-1 Zymed 61-7300 Rabbit Polyclonal 1:100 
 Periplakin In-house* Rabbit Polyclonal 1:500 
 E-cadherin BD Bioscience Mouse 
Monoclonal 
1:500 
 Ki67 Novacastra NCL-L-
Ki67-MM1 
Mouse 
Monoclonal 
1:100 
 Keratin 1 Abcam ab93652 Rabbit polyclonal 1:500 
 Keratin 14 Abcam ab53115 Rabbit polyclonal  
Secondary AlexaFluor 
594 
Invitrogen A21207 Donkey anti-rabbit 1:800 
AlexaFluor 
488 
Invitrogen  A11059 Rabbit anti-mouse 1:800 
Other DAPI Sigma, UK  1:1000 
* BOCZ-1 antibody generated by Boczonadi and Määttä, 2012, pending publication. 
All fluorescent slides were then imaged on a Zeiss Axioskop 40 microscope 
equipped with 10x, 20x and 40x NEOFLUAR objectives. Images were taken with a 
AxioCam MRm camera and AxioVision 3.1 software. Scale bars were added in 
ImageJ using the "Spatial Calibration" plug-in for ImageJ (available at http:// 
rsbweb.nih.gov/ij/download.htm) and composite images and panels created in Adobe 
Photoshop CS4 or Microsoft Powerpoint. Linear adjustments to brightness and/or 
contrast were made where necessary.  
2.3.1.5 Scanning Electron Microscopy (SEM) 
Karnovsky's Fixative was freshly prepared before use as follows: 25ml ddH2O was 
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heated at 60°C and 2g paraformaldehyde and 4 drops 1M NaOH were added. The 
solution was cooled and 5ml 50% w/v glutaraldehyde and 20ml 0.2M sodium 
cacodylate buffer were added. The solution was adjusted to pH 7.2-7.4 and stored 
frozen before use. 3D scaffold cultures were fixed in Karnovsky's fixative for 1 hour 
at room temperature, washed 3x in PBS and fixed for a further 30 minutes in osmium 
tetroxide at room temperature. Samples were cut into smaller pieces for analysis and 
dehydrated through graded ethanol series (30%, 50%, 70%, 80%, 90%, 95%, 
2x100% v/v) for 30 minutes each, then critical point dried from 100% ethanol. 
Samples were gold-coated and observed using a Philips XL30 ESEM. 
2.3.1.6 Transmission Electron Microscopy (TEM) 
Samples were fixed in Karnovsky's Fixative and osmium tetroxide and dehydrated as 
above. Small sections of samples were then embedded in LR White resin and cut into 
ultrathin sections by technicians using a Leica microtome. Samples were observed 
using a Hitachi H7600 TEM. Composite images were made in Adobe Photoshop or 
Microsoft Powerpoint. 
 
2.3.2 Cell Viability Assays 
2.3.2.1 MTS Assay for Cell Metabolic Activity 
3D cultures were removed from their culture vessels, washed 3x with sterile PBS and 
placed into 12 well plates. 2ml fresh DMEM/10% v/v FBS was mixed with 100µl 
MTS reagent (CellTiter 96 AQueous One Solution Cell Proliferation Assay, Promega 
UK) to make a final solution of 159µg/ml MTS reagent. 2ml of this MTS reagent 
was added to each 3D culture in a well of a 12 well plate. Empty 3D scaffolds were 
used as negative controls. Plates were placed into the cell culture incubator at 37°C 
for 2 hours. After 2 hours, the solution in each well was mixed thoroughly and 100µl 
samples pipetted into 96 well plates in triplicate. The plate was then read 
immediately on an Anthos Lucy-1 96-well plate reader at 490nm. The mean of three 
readings was then calculated. Assays on 2D cultured cells were performed as above, 
although MTS reagent was added directly onto cells cultured on the bottom of 24 or 
12 well plates. All experimental MTS assays were repeated a minimum of three 
times. The MTS reagent contains a tetrazolium compound which is bioreduced by 
viable cells into a soluble formazan product which absorbs at 490nm. Absorbance is 
directly proportional to the metabolic activity of living cells in the scaffold. Graphs 
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were plotted as either absorbance at 490nm, or as percentage change against a 
control. 
2.3.2.2 Viacount Assay for Apoptosis 
ViaCount assay uses a two membrane-permeable DNA dyes in combination with 
flow cytometry. The primary dye stains all nucleated cells, but ignores anucleate or 
dead cells and the secondary dye stains only damaged cells with breaches in the 
plasma membrane, indicating apoptosis or cell death. Media containing floating cells 
was centrifuged at 1000g for 5 minutes and adherent cells were trypsinised, re-
suspended into PBS and pooled with non-adhered cells. Cells were counted and re-
suspended into 1.0ml PBS and kept on ice. The Guava ViaCount analyser was auto-
cleaned and passed relevant QC procedures before use. Cells in PBS were diluted 
1:10 in ViaCount assay reagent into 96-well plates. The assay was then performed, 
with the machine counting individual cells for 120 seconds or until a minimum of 
1000 cells had been counted. Wells which contained a small number of cells (<200) 
were rejected. After performing analysis on control beads provided by the 
manufacturer, the apoptosis gate was set manually. Results were exported as a 
Microsoft Excel spreadsheet for further analysis.  
 
2.3.3 Assessment of Epidermal Barrier Maturity 
2.3.3.1 Cornified Envelope Extraction from 2D Cultures 
Cornified envelopes were extracted according to methods in Määttä et al, 2001 and 
Sevilla et al, 2007. Culture media from 2D cultures in T25 or T75 flasks was 
collected and centrifuged at 1000g for 5 minutes to pellet differentiated and non-
adhered cells in the culture media. Cells adhered to culture flasks or dishes were 
scraped into PBS and pooled with pelleted non-adhered cells. Floating and adherent 
cells were resuspended and centrifuged for a further 5 minutes at 1000g. The pellet 
was re-suspended in cornified envelope extraction buffer (20mM TrisHCl, 5mM 
Ethylenediaminetetraacetic acid (EDTA), 10mM dithiothreitol (DTT) and 2% w/v 
Sodium Dodecyl Sulphate (SDS) and boiled at 95°C for 20 minutes. This mixture 
was repeatedly washed by centrifugation at 5000g for 5 minutes, removing the 
supernatant and re-suspending in cornified envelope extraction buffer with 0.2% w/v 
SDS. Finally, the pellet was resuspended in 50µl of PBS for imaging. Cornified 
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envelopes are imaged by dropping 10µl of extract onto a glass slide and observing 
using phase contrast microscopy. For imaging with Nile Red, cornified envelopes 
were spotted onto a glass microscope slide, then mounted in ImmuMount with 
0.5mg/ml Nile Red in acetone, adapted from Hirao et al, 2001 and Rawlings, 2003. 
2.3.3.2 Cornified Envelope Extraction from 3D Cultures or Tissue 
For 3D cultures, culture media was collected and centrifuged as above. The 3D 
scaffold or mouse ear tip tissue samples were cut into smaller pieces using sterile 
scissors and added to cornified envelope extraction buffer for 20 minutes at 95°C. 3D 
scaffolds were pooled with pelleted cells from the culture media. The pieces of 
polystyrene scaffold were then removed, and the mixture was centrifuged at 1000G 
for 5 minutes. The rest of the extraction was carried out as described for 2D 
extractions. 
2.3.3.3 Protein Extraction and Quantification 
For 2D or 3D cultures, flasks of cells or 3D culture dishes were placed on ice. 
Culture media was removed and spun at 1000g for 5 minutes to pellet floating cells. 
3D cultures were removed from culture apparatus and placed into 6 well plates. Cells 
adhered to flasks or 3D scaffolds in 6 well plates were washed 3x with ice cold PBS. 
A drop of 2x Laemmli (Laemmli, 1970) protein lysis buffer with DTT (50mM Tris-
HCl pH6.5, 20% v/v glycerol, 1mM EDTA, 1% SDS, 1M DTT) was added to re-
suspend the cell pellet while 600µl cell lysis buffer was added per T75, 10cm dish or 
scaffold in a 6 well plate. Cells were scraped into lysis buffer using a cell scraper. 
For scaffolds, a sterile pestle and mortar was used to break up the scaffold with 
protein lysis buffer. The resulting mixture was pipetted into a 1.5ml Eppendorf tube 
and boiled for 5 minutes. After boiling, the mixture was passed back and forth 
through a 25 gauge needle, transferred to a new tube and frozen at -20°C. An empty 
scaffold was used as a control.  
The total of proteins extracted as above was quantified with the bicinchoninic acid 
(BCA) assay reagent kit (Pierce, UK). This kit uses the reduction of Cu
+2
 to Cu
+1 
by 
protein in an alkaline medium (Biuret reaction) and detects the Cu
+1
 with a 
colorimetric reagent. Ten standards between 0.0-2.5mg/ml protein were made using a 
provided bovine serum albumin solution. Standards were mixed with the colorimetric 
reagent, incubated at 37°C for 30 minutes and cooled before absorbance was 
measured at 562nm. A standard curve of absorbance vs concentration was generated. 
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Samples were analysed with the same methodology and diluted if necessary to fit 
within the linear range of the assay. These protein concentrations were then used to 
standardise the amount of lipid extract applied to TLC plates. 
2.3.3.4 Lipid Extraction from 2D Cell Culture 
HPLC-grade reagents, MilliQ water and glass tubes and pipettes were used 
throughout. Flasks of cells were washed twice in PBS for 2 minutes, then scraped 
into 1ml ice-cold PBS. This was then added to 4ml 2:1 methanol:chloroform and 
placed onto a rotator at room temperature for 1 hour, then spun at 5000g for 5 
minutes. The supernatant was discarded and the pellet resuspended in 4ml 1:1:1 
50mM citric acid: ddH2O: chloroform. This mixture separates into three phases and 
was vigorously mixed on a shaker for 1 hour at room temperature then spun at 5000g 
for 20 minutes to fully separate different layers. The top layer (water/methanol) and 
the solid layer of protein were discarded. A fresh, glass pipette was then used to 
move the lower phase containing chloroform and extracted lipids (approx 1ml) into a 
new glass tube. The solvent was then evaporated under sterile conditions, leaving an 
opaque coating of lipid in the tube. This was re-suspended in 2:1 
chloroform:methanol and stored, double-sealed to prevent evaporation, at -20°C until 
required.  
2.3.3.5 Lipid Extraction 3D Cell Culture 
3D cultures were removed from culture vessels, washed in PBS and added to 2:1 
methanol:chloroform with 1ml PBS. The scaffolds were then broken apart with 
sterile, chloroform-methanol washed metal tweezers and mixed for 1 hour at room 
temperature. The mixture was then centrifuged at 5000g for 5 minutes. The 
supernatant and pieces of scaffold were removed and discarded, and pellet 
resuspended in 4ml 1:1:1 50mM citric acid: ddH2O: chloroform. The procedure was 
then carried out and samples were stored as above. An empty scaffold was used as a 
control in each batch of extractions to ensure that chloroform:methanol was not 
leeching styrene or other plastics from the scaffold. No bands or streaks were visible 
on TLC plate with the development and staining protocols used. 
2.3.3.6 Lipid Extraction Mouse Epidermis 
C57BL/6 mice were shaved, killed by cervical dislocation and skin samples removed 
from the back. Samples were handled to avoid folding and contamination of the 
epidermis with subcutaneous fat. Skin sections were washed for 30 seconds in 
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hexane to remove surface lipids, then adhered to Whatmann filter paper and stored in 
2x PBS with 2% antibiotic/antimycotic. To separate the epidermis from intact skin 
samples, sections of skin were floated onto 0.25% trypsin at 4°C overnight. The 
epidermis was then peeled and scraped off. Alternatively, skin samples were floated 
onto a 70°C waterbath for 20 seconds, then sandwiched between two pieces of filter 
paper and twisted to separate the epidermis. The epidermis was then scraped off into 
an eppendorf tube and lipid extraction carried out as above. 
2.3.3.7 Thin Layer Chromatography 
A 20x20cm 0.25mm silica gel-coated TLC plate (Merck, UK) was divided into 
separate 1cm wide lanes by scraping off the silica gel coating. Extracted lipids, 
standards and control samples (from empty scaffolds) were suspended in 2:1 
chloroform:methanol were spotted into each lane 2.5cm from the bottom edge of the 
plate, using calibrated 2µl glass capillary tubes. Samples were added in 2µl spots in 
total amounts equalised against protein concentration from samples of the same 
treatment group. Solvent was allowed to evaporate between each 2µl application in 
order to apply a small, concentrated spot of lipid into the silica coating. All markings 
on the TLC plate were made in pencil. 
A three-phase development profile (Wertz and Downing, 1990, Pappinen et al, 2008) 
was chosen for best separation of epidermal lipids - particularly ceramides, free fatty 
acids and cholesterol as shown in Table 2.3: 
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Table 2.3. Three-phase Development Protocol for TLC Lipid Separation 
Solution Solvents Distance run 
A 40:10:1 chloroform:methanol:water 0-10cm 
B 190:9:1 chloroform:methanol:acetic acid 0-16cm 
C 70:30:1 hexane, diethylether and acetic acid 0-20cm 
 
HPLC-grade solvents and glass pipettes were used throughout all lipid analyses. A 
large glass TLC development tank was filled with 200ml (approximately 1cm deep) 
of solvent along with blotting paper soaked in that solvent. The tank was then sealed 
and allowed to fill with vapours for five minutes before the TLC plate was then 
added to the tank and the tank was air-sealed. Each solvent was allowed to run up the 
plate to the distances shown above. Between each solvent run, the plate was removed 
and allowed to dry thoroughly in a fume hood. After the final run, a 2µl spot of each 
extracted sample was added to an unused area of the plate. A schematic diagram is 
shown in Figure 2.5. 
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Figure 2.5. Thin Layer Chromatography Development  
Schematic diagram of TLC development tank containing 20x20cm TLC plate. The 
tank was filled to 1cm depth with solvent and the lid was attached. The insides of the 
tank are lined with absorbent filter paper soaked in solvent and the tank was allowed 
to fill with solvent vapours. Samples are applied to the plate 2.5cm from the bottom, 
and then submerged into 1cm of solvent. The lid was replaced and the solvent runs 
up the TLC plate. After the solvent front reaches a certain distance on the plate, the 
plate was removed and dried, and the solvent and filter paper replaced with the next 
solvent. The chamber was then allowed to fill with vapour and the process repeated 
until the plate was fully developed by all three phases. 
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2.3.3.8 Lipid Quantification 
In order to visualise lipids on the plate, the plate was dipped into a solution of 
0.001% Phloxine B in 70% ethanol and allowed to dry overnight at room 
temperature in the dark. The plate was then visualised face-down under UV light and 
images were captured using a BioRad GelDoc with QuantityOne software. The 
image was flipped horizontally, inverted and background-reduced in ImageJ. Band 
density was quantitated by a rectangular selection around the entire lane. "Plot 
profile" was then used to generate a plot of peaks for the entire lane. The area of each 
peak was then used to calculate the relative amount of lipid contained in that peak. 
An example of this is shown in Figure 2.6. For individual spots of lipid applied 
directly to the plate from extracted samples, the measure tool was used to measure 
the integrated density of each selection. 
2.3.3.9 Lipid Identification 
Bands on the plate were identified by the known standards Cholesterol, Cholesterol 
Oleate and Sodium Cholesterol Sulphate (Sigma UK). These standards were applied 
at 10µg/ml to the TLC plate alongside extracted lipid samples. They were then 
separated and visualised with the same procedures as extracted samples. The 
retardation factor (Rf) value was then calculated as the distance which the standard 
travelled, divided by 20cm. Rf values were recorded, and used to identify bands on 
the TLC plate arising from lipid sample separation. Other bands were identified by 
ASAP-MS and reference to published literature. 
2.3.3.10 Atmospheric Solids Analysis Probe-Mass Spectrometry 
In order to further confirm the identity of separated lipids, lipid standards suspended 
in chloroform were also analysed by atmospheric solids analysis probde - mass 
spectrometry (ASAP-MS). Bands of silica gel containing lipids were scraped from 
the glass TLC plate into a glass sample tube, then vortex mixed with chloroform for 
5 minutes to resuspend the lipid into solution. These samples were then immediately 
analysed by ASAP-MS on a Waters Xevo QTOF analyser. Analysis was performed 
by technicians using the appropriate methods for each sample. m/z values and peaks 
from standards were compared bands scraped from the TLC plate and to those found 
in published literature (Duh et al, 1992, Masahiro and Masao, 2007, Tachi and 
Iwamori, 2008). Phloxine B was also tested and found not to interact or interfere 
with the ASAP-MS identification of lipids.  
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Figure 2.6. Quantification of TLC Bands 
ImageJ “plot profile” of selected band (left). The plot profile is viewed from right to 
left and the TLC plate is run from top to bottom. Each peak corresponds to a lipid on 
the TLC plate and the area under each peak corresponds to the integrated density of 
that peak, as shown. Therefore the amount of lipid present in that band can be 
calculated. In ImageJ, the line tool was used to separate each band, then the 
“measure” tool used to calculate the area inside that peak. Background was 
subtracted by a horizontal line forming a new X-axis, as shown by the dotted line.  
98 
 
2.3.4 Measuring Epidermal Barrier Permeability  
2.3.4.1 Diffusion Chamber Analysis 
A custom-made side-by-side diffusion cell (PermeGear, USA) was used to measure 
barrier permeability of 3D cultures. The diffusion cell comprises two 4ml capacity 
glass chambers with opposing ground glass interfaces and a 6mm diameter diffusion 
portal between them. Photographs and a schematic diagram of the diffusion cell are 
shown in Figure 2.7.  
To assess permeability, samples were clamped firmly between the two chambers and 
sealed with waterproof silicon annealing tape. The diffusion cell was placed onto a 
magnetic stirrer with white paper underneath to visualise any leaking of culture 
media from either chamber. Donor and recipient sides of the chamber were each 
filled with 4ml of sterile DMEM culture media at 37°C as diluent, with a permeant 
compound of 15,000pg/ml corticosterone present in the donor side. Both sides of the 
chamber were mixed equally on a customised magnetic stirrer for the full duration of 
the experiment.   
Diffusion experiments were initially carried out at 37°C until equilibrium was 
reached, but due to the long time-frame of these experiments (>48 hours), results 
became variable due to the degrading quality of the submerged cultures. Therefore, 
all diffusion experiments presented in this thesis were carried out at 37°C and both 
donor and recipient sides were both sampled (100µl) every hour for three hours and 
the removed volume was replaced with DMEM. This short-sample technique has 
been used in published studies (Schreiber et al, 2005) to measure epidermal 
permeability. Cultures were monitored for air bubbles, and cultures where DMEM 
leaked from the seal between the two chambers were discarded. Aliquoted samples 
from donor and recipient chambers were frozen at -20°C until used.  
2.3.4.2 Corticosterone Assay 
Corticosterone concentrations were calculated using a Corticosterone EIA kit (Enzo 
Scientific ADI-900-097) in a 96 well plate. Standard solutions of 20,000, 4,000, 800, 
160 and 32pg/ml were made in DMEM culture media then 100µl added to wells of 
the 96 well plate in triplicate with 100µl of diluent. 50µl of each assay buffer, 
conjugate and antibody were added to each well. Internal controls were performed 
for maximum and minimum absorbance. The plate was incubated at room 
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temperature for 2 hours on a shaker. Wells were then emptied and washed three 
times with 400µl wash solution. Wells were aspirated and dried, then 200µl pNpp 
substrate added to each well and incubated for 1 hour. Finally, 50µl of stop solution 
was added per well and the plate read immediately after at 405nm. Absorbance 
readings were corrected against blank wells and the percentage of bound antibody 
was calculated from the maximum absorbance control wells. A standard curve of 
percentage bound against concentration was made using standards, and unknown 
samples calculated from the equation of the line of best fit.  
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Figure 2.7. Side-by-side Diffusion Chamber 
A) Diagram of side-by-side diffusion chamber from PermeGear, USA. Each side 
contains 4ml of cell culture media with a 6mm diameter diffusion orifice separating 
the two chambers. Each side has a dual sampling ports which are sealed to prevent 
evaporation during the experiment. The apparatus sits on a custom dual magnetic 
stirrer so that both chambers are continuously mixed. B) Photograph of the apparatus 
on magnetic stirrer with blue dye added to visualise the barrier effect of the 3D 
culture between the two chambers; C) Photograph of separated diffusion chambers 
with 6mm orifice visible. 22mm diameter scaffold size and placement shown for 
reference. 
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2.3.4.3 Calculation of Permeability Coefficient 
The permeability coefficient for each culture was calculated by plotting a graph of 
the cumulative amount (µg) of permeant in the recipient chamber versus time 
(seconds). Permeability coefficient was then calculated as follows 
 
 
P =   permeability coefficient (cm/s) 
A =   Diffusional area (cm
2
). Diameter of diffusion orifice in the chamber 
  6mm = 0.2827cm
2
 
CD =   Initial concentration in donor chamber (µg/ml) = 0.015µg/ml 
dQ/dt =  Slope of linear region of cumulative permeant amount (µg) over time 
  (s) where r
2
 = 0.941-1.000. Equation y=mx+c used to determine slope.  
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3 Chapter 3 
 
 
 
 
 
 
 
 
 
 
Development of a 3D Culture System for HaCaT 
Keratinocytes 
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3.1 Introduction 
3.1.1 Aims, Objectives and Overview 
The long-term aim of this project was to engineer an in vitro 3D epidermal 
equivalent using a 3D polystyrene scaffold. This epidermal equivalent can be used 
for in vitro investigations into keratinocyte differentiation, with emphasis on 
epidermal barrier function. The aim of this chapter was to establish a culture method 
for keratinocytes using the 3D scaffold which had not previously been cultured on 
this material. To this end, an experimental approach involving optimization of 
several different aspects of cell culture was adopted.  
Previous experiments have demonstrated that HepG2 hepatocytes (Bokhari et al, 
2008) and TERA2.cl.SP12 cells (Hayman et al, 2005) cells can be cultured within the 
polystyrene scaffold, but the growth of keratinocytes in this porous polymer structure 
had not been analysed in depth previously. It should be possible to utilise the scaffold 
as the basis for 3D organotypic culture of keratinocytes, given optimised conditions. 
Therefore, fundamental procedures such as the type and number of cells to be 
seeded, the method of seeding and the length of culture period were addressed 
initially. As mentioned in Chapter Two, the scaffold and 3D culture system were 
under development throughout the course of this project and initial investigations 
were performed using wire grids to raise the scaffold to the air-liquid interface. 
These were later followed by use of a custom well-insert device. These culture 
methods were compared experimentally in this chapter. 
Another optimisation step involved the preparation of the scaffold itself before the 
use. The polystyrene-based material is highly hydrophobic and requires pre-wetting 
with ethanol and washing with PBS before use (Hayman et al, 2005, Bokhari et al, 
2007). However, this has inherent disadvantages to well-distributed cell seeding and 
therefore a more recently developed technique of plasma treatment (Zeyfert et al, 
2009) was investigated as means to generate a uniform surface hydrophilicity in the 
scaffold. 
Many cell lines, particularly primary cells, require culture surfaces coated with 
collagen for attachment and proliferation. Collagen gels also represent the current 
standard for the dermal component in 3D full thickness in vitro skin models. 
Likewise, co-culturing keratinocytes with fibroblasts is also required for some 
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primary keratinocytes and has been shown to improve the growth of HaCaT 
keratinocytes in un-supplemented 3D cultures (Ikuta et al, 2006, Schoop et al, 1999). 
Therefore, preliminary experiments with collagen coating and fibroblast co-cultures 
were set up to explore the full potential of the 3D scaffold system. 
Due to the number of different conditions tested, the outcomes were assessed by 
histology and MTS cell viability assays. Once optimised culture conditions were 
established, more in-depth analyses into investigate barrier assembly and barrier 
function were performed in Chapter Four and Chapter Five. A summary of culture 
conditions investigated in this chapter are summarised in Table 3.1. 
Table 3.1. Culture Conditions Testing in this Chapter 
Condition Tested Comparison Methodology 
Collagen coatings and gels Gel recipe and methods 
of applying gel to 3D 
material 
Collagen gel tested for 
morphology 
Collagen/Chondroitin gel Gel thickness and method 
of application 
Tested for gel 
morphology and ability to 
support cell culture 
Pre-treatment of scaffold Plasma treatment 
compared to ethanol pre-
washing 
Tested based on collagen 
deposition 
Cell-seeding number and 
method 
Diffuse and concentrated 
seeding methods. Cell 
numbers ranging from 
0.5-4.0x10
6 
per scaffold 
Assessed based on 
morphology, MTS assay 
and immunofluorescence 
staining 
Growth Period Duration submerged and 
at the air-liquid interface 
Assessed based on MTS 
assay and morphology 
Culture Method Wire grids compared to 
well inserts 
Assessed based on cell 
morphology 
Culture of skin cells 3T3 fibroblasts, MET 
cells and mouse 
keratinocytes 
Tested for morphology in 
3D scaffold 
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3.1.2 HaCaT Cells as an Experimental Model for Epidermal 
Keratinocytes 
HaCaT cells are a stable, immortal human keratinocyte cell line first derived by 
Boukamp et al (1988) from the outside periphery of a melanoma from a 62yr old 
man - although HaCaT cells themselves are non-tumorigenic. HaCaT cells were 
shown to maintain the ability to proliferate beyond passage 140 while retaining the 
ability to differentiate indicating that this cell line offers a stable model for studies on 
keratinisation and differentiation (Boukamp et al, 1988). In a following study,  the 
original authors (Boukamp et al, 1997) reported culturing HaCaT cells to beyond 
passage 300 with the majority of changes (i.e. increasing serum dependence, reduced 
population doubling time, increasing chromosomal translocations) occurring after 
passage 100. HaCaT cells tested at passage 80 could still form an organised, 
differentiated epidermis in organotypic culture. In the studies presented in this thesis, 
all HaCaT cells were earlier than p65. It should be noted that HaCaT cells are not a 
complete replication of normal human keratinocytes primary cells (NHK), which are 
typically isolated from human neonatal foreskin.  
Maas-Szabowski and colleagues, 2003 showed that NHK cells form a more ordered 
3D epidermis under in vitro organotypic co-culture conditions than HaCaT cells. 
This was shown to be because of reduced interactions with dermal fibroblasts, 
initiated by the HaCaT cells. HaCaT cells produce significantly less IL-1 than NHK 
cells, therefore reducing the production of KGF/FGF and GM-CSF from fibroblasts. 
HaCaT cells also produced less TGF-alpha. Addition of IL-1, KGF, FGF and TGF-
alpha to culture media enabled HaCaT cells to produce an epidermis more similar to 
NHK cells. In this thesis, serum-containing culture media or growth factor 
supplemented media was used for maintaining cultured cells and in all experimental 
studies, aside from where indicated.  
In a direct comparison with NHK cells, Micallef et al, 2008 showed that HaCaT cells 
have a delayed response to calcium concentration, and that they present 
abnormalities in their cell cycle. Under low calcium conditions, HaCaT cells and 
NHK cells showed similar behaviour in terms of cell cycle distribution and the 
balance between proliferation and differentiation (i.e. expression or basal keratins 
and differentiation markers). Upon stimulation with high (1.3mM) calcium, NHK 
cells were much more rapid in their calcium-induced responses such as 
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morphological changes, formation of stratified sheets and increased cell-cell contact 
when compared to HaCaT cells. The same is true for the expression of differentiation 
markers. NHK cells showed a more rapid increase in mRNA and protein expression 
of involucrin, K1 and K10. However, importantly, HaCaT cells still showed full 
terminal differentiation capacity when stimulated by high calcium, albeit more 
slowly than NHK cells. 
One further note is that HaCaT cells also begin to undergo structural changes 
associated with differentiation when grown at high confluence (Boukamp et al, 
1988). Therefore, HaCaT cells shown in this study were always sub-cultured at a 
confluence of 70-80% in 2D and not allowed to become too confluent. 
Bearing these differences to NHKs in mind, HaCaT cells were selected for the 
majority of analyses in this chapter. Despite differences when compared to NHK 
cells, HaCaT cells have been shown to exhibit all major functional activity and 
characteristics of NHK cells including the ability to differentiate and form stratified 
epidermal structures (Boukamp et al, 1998). Furthermore, HaCaT cells have been 
previously used successfully over many years for the three-dimensional organotypic 
culture of epidermis in vitro (Rosdy, 1990, Smola et al, 1998, Schoop et al, 1999, 
Zinn et al, 2006, Ojeh et al 2008). These data support the concept of using HaCaT 
cells for 3D culture with the aim of engineering an epidermal barrier.  
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3.2 Results 
3.2.1 Assessment of the HaCaT Clone Used in this Study 
Extracellular calcium concentration has been shown to modulate the activation of 
keratinocyte differentiation (Micallef et al, 2008). Namely, keratinocytes can be 
maintained in a proliferative state at low calcium (<0.1mM) concentration and 
differentiated by the presence of a high calcium (>1.0mM) concentration in the 
culture media. During differentiation, HaCaT cells undergo morphological changes, 
altered protein expression (increased K1/K10, involucrin etc) and the formation of 
desmosomes and adherens junctions. (Micallef et al, 2008). 
As the main aim of this project was to engineer an epidermal barrier model, reliant 
on cell differentiation, it was important to ensure that the HaCaT clone used in the 
study had retained its differentiation capacity and the ability to express epidermal 
barrier proteins. To this end, HaCaT cells were allowed to proliferate in low calcium 
(0.06mM) DKSFM culture media on glass coverslips, then switched to 1.5mM 
calcium media as described  (Ojeh et al, 2008). Live cells were examined by light 
microscopy (Figure 3.1), then fixed and stained at various time points for 
differentiation markers as described in Chapter Two.  
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Figure 3.1. Characterisation of HaCaT Clone in 2D Culture 
A) Light microscopy images of HaCaT cells grown in low (0.06mM) and high 
(1.5mM) calcium for 48 hours; B) Immunofluorescence staining of HaCaT cells 
grown for 24 hours, 72 hours and 5 days in high calcium culture media on 2D glass 
coverslips. Control cells were grown in low calcium culture media for 5 days.  Scale 
bars 50µm. 
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Light microscopy images of HaCaT cells in low calcium (0.06mM) and high calcium 
(1.5mM) conditions (Figure 3.1A) show a marked difference in morphology between 
the two growth conditions. Under low calcium conditions, the HaCaT cells have 
formed a confluent monolayer of elongated or oblong shaped cells, with occasional 
rounded cells undergoing cell division. Boundaries between the cells are clearly 
visible and cells appear darker and opaque. Under high calcium conditions, the 
HaCaT cells have formed a layer of flattened, more transparent (thinner) cells which 
occupy a larger surface area of the coverslip. Boundaries between the cells are also 
less clearly visible by light microscopy and the number of detached cells floating in 
the culture media has increased. It also appears that the number of cells present may 
have increased. This would be in line with previous findings by Walker et al, 2006 
and Micallef et al, 2008, who unexpectedly found that HaCaTs were more 
proliferative in media containing high calcium than when cultured in low calcium 
conditions. 
Immunofluorescence staining (Figure 3.1B) shows clear changes in cell morphology 
after 5 days in the high calcium culture medium. Involucrin, an early differentiation 
marker, usually located in keratinocytes of the spinous and granular layers of the 
epidermis, shows a pronounced increase in expression and a re-distribution in the 
cytoplasm over time. E-cadherin, a cell adhesion protein, shows increased expression 
as expected as well as re-location to the cell-cell boundaries as time in high calcium 
media increases. After 5 days, E-cadherin expression is present at almost all cell-cell 
boundaries. Some E-cadherin staining at cell borders is visible after 5 days in low 
calcium media. Desmoplakin, a desmosomal plaque protein involved in the 
connection of keratin intermediate filaments to the desmosomal cadherins, also 
shows a similar change in expression and re-location to cell boundaries. This is 
important for the growth of the HaCaT cells in the 3D environment - showing that 
they are able to form adherence junctions and desmosomes with other cells, vital for 
the barrier acquisition. K14, a keratin found predominantly in proliferative basal 
layers of the epidermis, shows a decrease but not a total loss in expression over 5 
days in high calcium, owing to the long half-life of the protein. Similarly, K1, a 
differentiation marker in keratinocytes, shows a general increase in expression but is 
not found in every cell. This confirms that this HaCaT cell line may be suitable for 
growth in the 3D scaffold with the intention of forming an epidermal barrier and is in 
line with other published studies in HaCaT cell differentiation.  
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3.2.2 Integration of Collagen Coatings into the 3D Scaffold  
Many cell types, including keratinocytes, may benefit from being cultured on 
collagen coated surfaces or on collagen itself. Contracted collagen gels and collagen-
fibroblast gels have been used to culture keratinocytes in 3D since the 1980's 
(Prunieras et al, 1982, Bell et al, 1983,) and are still used currently (Ng et al, 2011). 
They, along with de-epidermalised dermis (Cumpstone et al, 1989, Mak et al, 1991), 
represent the gold standard in organotypic culture of keratinocytes. Therefore 
methods of combining the 3D scaffold with collagen coatings and collagen gels were 
investigated. Two different approaches for collagen coating of the 3D scaffold were 
tested: 
1) Deposition of collagen fibres within the scaffold. This involves coating the 
surfaces of the polystyrene scaffold and allowing better attachment and proliferation 
of cells. This is similar to coating of a 2D surface such as a Petri dish or cell culture 
flask.  
2) Using the scaffold as a solid base for a contracted collagen gel. Cells are then 
cultured on the surface of the gel at the air-liquid interface. This is similar to using a 
porous membrane (often made of porous acetate cellulose, polycarbonate or PTFE) 
such as the Nucell (Nucleopore), Transwell (Costar) or MilliCell (MilliPore) as a 
collagen support. These supports function as a stable and culture media-permeable 
base for the contraction of a semi-solid collagen gel, which may also include 
fibroblasts as feeder cells. Keratinocytes can then be seeded into the surface of the 
collagen gel and lifted to the air-liquid interface for organotypic culture.  Typically 
wire grids or raised well-inserts are used for lifting cultures to the air-liquid interface. 
A solution of Type I rat tail collagen provided in 0.6% acetic acid can be solidified 
into a stable gel by neutralising with NaOH and warming to 37°C. Collagen solution 
was diluted to various concentrations in 0.6% acetic acid, then added to ethanol/PBS 
pre-wetted scaffolds and warmed to 37°C for 30 minutes. Scaffolds were then 
stained with Coomassie Brilliant Blue and de-stained to visualise collagen deposited 
in the scaffold. A negative control was performed by using a scaffold submerged into 
0.6% acetic acid without collagen, which was also stained and then de-stained along 
with the other samples, until it showed no residual staining. All other scaffolds were 
then removed from de-staining at this point and the amount and distribution of 
collagen deposition can be approximated by the blue staining. However, this staining 
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does not show the depth of penentration of collagen fibres and was only used to 
determine a starting point for further collagen experimentation. Penetration will be 
assesed by more advanced methods in subsequent experiments.  
112 
 
 
Figure 3.2. Collagen Coating of Ethanol-Washed and Plasma Treated Scaffolds 
A) Ethanol-washed, 200µm thick, 22mm diameter 3D scaffolds coated with collagen 
by addition of 200µl neutralised collagen solution diluted to concentrations between 
0.00-2.00mg/ml. Scaffolds were then stained with Coomassie Brilliant Blue and de-
stained until the control scaffold (0.00mg/ml) was fully de-stained. Blue staining 
shows the location of collagen deposition on top or inside the scaffold. 1.00mgml 
and 0.50mg/ml of collagen show the best deposition of collagen. It is likely that 
2.00mg/ml is too viscous to properly coat the scaffold, and less than 0.50mg/ml is 
too dilute; B) Plasma treated scaffolds show better collagen deposition than ethanol 
washed scaffolds, as indicated by stronger, more evenly distributed staining. 
1.00mg/ml provides the optimal collagen deposition. 
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The staining in Figure 3.2A shows that the most even deposition of collagen is when 
the solution is diluted to between 0.50mg/ml and 1.00mg/ml. With an undiluted 
sample of 2.00mg/ml, it is likely that the collagen solution is too viscous to penetrate 
the 3D structure of the scaffold. Before de-staining, large clumps of blue staining 
were observed on the surface of the scaffold, which then washed off during de-
staining. With 0.50mg/ml or 1.00mg/ml collagen concentrations, the collagen is 
optimally diluted and reasonably well distributed throughout the scaffold. At 
0.20mg/ml and 0.10mg/ml concentrations the solution is likely to be too dilute to 
deposit sufficient fibres within the scaffold. The negative control only shows slight 
background staining.  
One observed problem was that even with the optimal collagen concentrations of 
1.00mg/ml and 0.50mg/ml, the collagen was unevenly distributed within the 
scaffold. One potential reason for this maybe that the scaffold is already wet due to 
the pre-wetting with ethanol and PBS before use. Therefore, when a solution of 
neutralised collagen solution is added, it needs to displace the PBS which is already 
in the scaffold. Due to the random distribution of pores and voids within the 3D 
scaffold, the distribution of collagen may become uneven because the collagen 
solution is viscous and begins to solidify quickly before it can displace the PBS. It 
may also be that liquids already present inside the scaffold are further diluting the 
collagen solution, or altering the pH and interrupting gelation. 
To overcome these problems, the collagen coatings were repeated with 
concentrations of 0.50mg/ml and 1.00mg/ml using 3D scaffolds which had been 
plasma-treated as described in Chapter Two. Therefore, collagen solution was 
applied to dry plasma-treated scaffolds and these were compared with scaffolds 
prepared by the pre-wetting and washing method. A negative control for each group 
was carried out as above. Results are shown in Figure 3.2B.  The results clearly 
shows a more even distribution of collagen in the plasma treated scaffolds compared 
to ethanol washed scaffolds. Ethanol washed scaffolds show a distribution of 
collagen similar to the previous experiment, as expected. However, at 0.50mg/ml the 
staining of the plasma treated scaffold is more even than the ethanol pre-wetted 
scaffold, although still uneven. At 1.00mg/ml the staining is evenly distributed and 
noticeably more strongly stained than the other samples. This indicates that the 
plasma treatment is a better method for the preparation of the scaffold, allowing 
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solution to be added to a dry scaffold where capillary action will draw it inside. This 
also confirms that 1.00mg/ml collagen is optimal for distribution of collagen inside 
the scaffold. 
It is likely that the penetration of collagen can act as a proxy for the penetration of 
cells into the 3D scaffold. When seeding cells into the scaffold, liquid inside the 
scaffold will reduce the penetration and distribution of cells, whereas with plasma 
treatment, cells suspended in culture media can more easily penetrate the dry plasma-
treated scaffold.  
3.2.2.1 Organisation of Collagen Coatings 
Staining with Coomassie Brilliant Blue shows the gross coverage of collagen fibres 
and approximate amount of deposition, but it cannot be used to determine the 
structure of collagen or the depth of penetration inside the scaffold. Therefore, 
plasma treated scaffolds coated with 1.0mg/ml of collagen solution were fixed and 
prepared for SEM analysis. In the results, shown in Figure 3.3A, collagen fibres are 
clearly visible within the 3D scaffold with a relatively even distribution. They appear 
to be deposited along surfaces of the scaffold although some webs of collagen (panel 
B) are deposited inside the scaffold in a way which may restrict cells from entering 
the voids.  
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Figure 3.3. Organisation of Collagen Coated Scaffolds 
1.0mg/ml collagen neutralised with NaOH and added to plasma treated scaffold for 
30 minutes at 37°C. A) Image showing collagen fibres (indicated with white arrows) 
coating surfaces of the scaffold. Scale bar 20µm; B) Image showing collagen fibres 
blocking void within scaffold. Scale bar 10µm.  
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3.2.2.2 Integration of Collagen Gels with 3D Scaffold 
In order to create a solid gel and use the scaffold as a base similar to a porous 
membrane, a number of different gel formulas from published literature were 
utilised. One standard formula used is a 7:1:1:1 ratio of collagen:1M 
NaOH:MEM:3T3 cells (6x 10
5
 fibroblasts/ml gel, determined to be the optimal 
number for organotypic HaCaT growth by Maas-Szabowski et al, 2003). 300µl of 
this solution was added to a plasma treated scaffold, allowed to contract initially for 
30 minutes at 37°C, then gently submerged in culture media and cultured for 7d at 
37°C to allow contraction of the gel. Samples were then fixed and visualised by 
SEM. A representative image of the structure of this gel is shown in Figure 3.4B.  
The low magnification SEM image (Figure 3.4D) shows that the collagen has formed 
a sheet on top of the scaffold but has not penetrated inside the scaffold. One problem 
observed with the collagen gel formation was that much of the solution simply 
passed through the 3D scaffold when it was initially added. Permeable culture 
membranes such as MilliCell utilise pore sizes of 0.4µm, 1.0µm, 3.0µm or 8.0µm 
(MilliPore website). These pores sizes are too small for cells to fall through the 
membrane, and will slow down the penetration of viscous liquids, allowing the 
collagen solution time to gel before it can pass through the membrane. However, the 
3D scaffold is highly porous, designed to contain pores and voids of up to 80µm, 
which are large enough to accommodate multiple cells. This means that the majority 
of the collagen solution may be passing through the scaffold when it is initially 
added. When the scaffold is then submerged in culture media, the collagen solution 
may be diluted or simply washed out of the scaffold. 
Other methods to integrate collagen gels with the 3D scaffold were utilised and 
representative images shown in Figure 3.4. A collagen solution was diluted in 70% 
ethanol, pipetted onto the scaffold and allowed to evaporate in a tissue culture 
cabinet (Figure 3.4A). This method is similar to the standard methods for coating of 
2D plasticware. Ethanol is also able to penetrate the scaffold without pre-wetting. 
However, SEM analysis showed very little deposition of collagen inside the scaffold.  
1M NaOH solution was added to the scaffold, evaporated, then collagen solution was 
added in acetic acid and the scaffold placed into an incubator at 37°C. This was 
designed to delay gel formation until the collagen solution fully entered the scaffold, 
where it will combine with NaOH, neutralise and being to form a gel inside the 
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scaffold. The SEM analysis in Figure 3.4C shows that most collagen gel formation is 
on the lower surface of the scaffold. It is likely that the solution still did not gel 
immediately and began to fall to the bottom of the scaffold. Through surface tension, 
the solution clings to the bottom of the scaffold where it begins to gel. 
In a fourth method, the collagen solution was applied to the scaffold without being 
neutralised by NaOH. The whole scaffold coated with collagen solution was 
incubated in a chamber containing ammonium vapours. Neutralising the collagen 
solution a with a gas rather than a liquid was theorised to allow the collagen to gel 
inside the scaffold by removing problems associated with poor mixing of the gel or 
the gel solidifying before penetrating the scaffold fully. However, the SEM analysis 
shown in Figure 3.4B, the gel formed on the upper and lower surfaces of the 
scaffold, and higher magnification showed no collagen present inside the 3D 
scaffold. This surface should still be able to support keratinocyte culture, with the 
polystyrene scaffold structurally supporting the collagen gel and acting as a wick to 
take up culture media. 
 
3.2.2.3 Stable Gels Containing Chondroitin-6-Sulphate 
The collagen formula was modified to include 20% chondroitin-6-sulphate (C6S). 
After optimising the ratio of collagen and C6S, a solution of 10:1:1 collagen solution 
in 0.6% acetic acid:1M NaOH: DMEM with 20% C6S was determined to provide the 
quickest gelation time. This solution was prepared on ice using cooled tissue culture 
equipment to slow down gelation, then 500µl was added to the scaffold and allowed 
to solidify for 30 minutes at 37°C. This solution formed a much thicker and more 
solid gel. This was then fixed and prepared for SEM analysis. 
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Figure 3.4. Morphology of Collagen Gels On the 3D Scaffold 
Low magnification SEM micrgraph showing (A) collagen solution added in 70% 
then evaporated. Very little collagen is observed inside the pores and voids of the 
scaffold. Scale bar 20µm; (B) Collagen solution was neutralised in an ammonium 
chamber and has formed a sheet on the upper and lower surfaces of the scaffold, but 
not penetrated inside. Scale bar 200µm; (C) NaOH added to the scaffold, then 
evaporated and collagen added. Most collagen is visible on the upper surface, 
indicated with a black arrow. Collagen has not penetrated inside the scaffold. Scale 
bar 100µm; D) Low magnification SEM showing a sheet of collagen (C) on the 
surface of the 3D scaffold (S). This sheet was present across the entire surface of the 
scaffold and appears smooth and uniform, which should be capable of supporting 
cultured keratinocytes. Scale bar 500µm.  
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Figure 3.5. Formulation of Chondroitin-6-Sulphate Collagen Gel on 3D Scaffold 
A) 4mm thick collagen and chondroitin-6-sulphate gel on top of 22mm diameter 3D 
scaffold inside well-insert; B) The scaffold and well-insert is inverted, showing the 
high stability of the gel; C) SEM image of collagen and chondroitin-6-sulphate gel 
on top of a scaffold. The solid gel completely covers the surface of the scaffold and 
should provide a surface for keratinocytes to adhere and proliferate. Scale bar 
100µm; D) SEM image showing gel on the surface of the 3D scaffold and sparse 
collagen fibres (indicated by white arrow) inside the porous scaffold structure. Scale 
bar 20µm; E) Low magnification image showing coverage of collagen gel. Scale bar 
1mm; F) Collagen and chondroitin-6-sulphate gel (G) on 3D scaffold (S), with 10
6
 
HaCaT cells (H) grown at the air-liquid interface for 14 days. The cells are clearly 
shrunken and disorganised, with no signs of stratification. Scale bar 200µm.   
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Collagen-C6S gels formed on top of the scaffold inside the well insert were stable  
and approximately 4mm thick (Figure 3.5A and B). The surface of the gels was 
relatively rigid but semi-permeable, tested by the addition of a drop of culture media 
which slowly soaked into the gel (data not shown). The stability of the gels is 
demonstrated by inverting the 3D scaffold in panel B and  the surface of the gel 
appears solid and covers the whole 3D scaffold Figure 3.5C-E). In some preparations 
(Figure 3.5D) the collagen gel appears to be in a thin, shrunken layer on the surface 
of the scaffold. This shrinkage is likely due to the fixation, ethanol dehydration and 
critical point drying involved in preparation for SEM which removes the water 
content of the gel. Overall, however, this surface appears to be stable and distributed 
well enough to maintain a culture of keratinocytes. 
To test the ability of the scaffold-supported collagen gels to function as a dermal 
equivalent, 1x10
6 
HaCaT cells were seeded in a spot of 100µl culture media into the 
centre of the top surface of collagen/C6S gel prepared under sterile tissue culture 
conditions by the method above. The keratinocytes were allowed to settle for 30 
minutes in the culture incubator at 37°C, before culture media was gently added. The 
culture was then submerged for 2 days and raised to the air-liquid interface for 14 
days, then fixed and prepared for H&E staining, shown in Figure 3.5F. Cell growth 
on top of the gel is very poor, with only a small amount of shrunken cells remaining. 
It is not clear whether these cells are viable or not and there is no evidence of any 
stratification of the cells. The thick collagen gel is visible on both the upper and 
lower surfaces of the 3D scaffold, approximately 200µm either side. This means that 
the cells are approximately 0.6mm away from the culture media when at the air-
liquid interface. Although the collagen gel appeared semi-permeable to initial testing, 
it is possible that the gel is too thick and impermeable for the cells to be sufficiently 
supplied by the culture media when at the air-liquid interface. As shown in Figure 
3.5 by SEM, there is no evidence of collagen inside the scaffold itself. 
Therefore a thinner collagen coating was then made by diluting the solution 2:1 in 
DMEM and applying 150µl of solution to the scaffold, rather than 500µl. This gel 
formed more slowly than the previous model but still appeared stable. SEM revealed 
that there was a thin film of collagen deposited on the surface of the scaffold which 
was considerably thinner than those shown in Figure 3.5. However, these cultures 
also showed showed sporadic cell growth on top of the scaffold.   
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3.2.3 Generation of Keratinocyte-Only Epidermal Model 
As a result of the previous experiments, no further work with collagen gels with the 
3D scaffold was carried out. Simultaneous experiments utilising keratinocytes with 
the 3D scaffold alone were promising - showing that keratinocytes could be cultured 
directly inside the 3D scaffold. This is a more rapid method than contraction of a 
collagen gel before keratinocyte seeding. Therefore, the remainder of this project 
focused on creating a 3D culture model using the 3D scaffold and keratinocytes only. 
3.2.3.1 3D Cell Culture of HaCaT Keratinocytes 
In order to culture HaCaT cells in the 3D scaffold, the cells need to be in a high 
enough density to proliferate and form an inter-linked layer of cells. In the paper 
where HaCaT cells were first described (Boukamp et al, 1988), confluence was 
described as a key factor in the proliferation and differentiation of HaCaT cells. For 
the purposes of these experiment in the 3D scaffold, it is preferential for the cells to 
be added in a uniform manner, in order to improve the reproducibility of the cultures.  
The scaffold is a 22mm diameter circular disc, occupying the same two-dimensional 
surface area as a 12-well plate, (3.8cm
2
). The scaffold is 200m thick, which roughly 
corresponds to 15-20 cell layers. The 3D scaffold is also around 90% porous (i.e. 
10% of the total dimensions of the scaffold is made from solid material). At a 
seeding density of 20,000 cells per cm
2
, this equates to a capacity of roughly 1.3x 10
6 
cells per scaffold. Therefore, a range of seeding densities were chosen either side of 
this number. 
One recognised difficulty with a rigid, non-biodegradable 3D scaffold is achieving 
even cell distribution (Wendt et al, 2009). Cells were seeded at varying densities 
using the traditional "diffuse" method and alternatively a "concentrated" method, as 
described in Chapter Two. The "diffuse" method seeds cells into a large volume of 
culture media allows cells to settle onto the scaffold and fall inside by gravity in the 
same way that cells are subcultured in 2D, whereas the "concentrated" seeding 
method adds cells in a highly concentrated spot of 100µl culture media. This allows 
cells to be rapidly drawn inside the 3D scaffold by capillary action. In order to 
determine the optimal seeding density for HaCaT cells in the 3D scaffold, the 
following conditions were set up in triplicate. 
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Table 3.2. Seeding Densities of HaCaT cells for 3D Cell Culture 
Diffuse method Concentrated Method 
0.25x 10
6
 cells 0.25x 10
6
 cells 
0.5x 10
6 
cells 0.5x 10
6 
cells 
1x 10
6 
cells 1x 10
6 
cells 
2x 10
6 
cells 2x 10
6 
cells 
4x 10
6 
cells 4x 10
6 
cells 
NB: Pre-1G scaffolds were used for this experiment. The air-liquid interface was reached using wire 
grids. 
Cells were grown in the scaffold under standard culture conditions for 2 days 
submerged. Media was then removed and the cultures lifted to the air-liquid interface 
on 6-well-sized wire grids. Approximately 2ml media was added to the well, 
underneath the wire grids until the air-liquid interface was achieved. Media was 
replaced every two days. After each time point, cultures were removed from the grid 
and placed into a 12 well plate and the MTS assay was performed. Each culture was 
grown in triplicate, and the experiment was repeated three times. Duplicate cultures 
were also fixed and processed for H&E staining. MTS analysis results are shown in 
Figure 3.6A. 
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Figure 3.6. MTS Assays of Different Seeding Densities for 3D Culture 
A) MTS cell viability of different 3D culture seeding methods of HaCaT cells. MTS 
assays were performed on 3D cultures after 2, 7 and 14 days. Concentrated and 
diffuse seeding methologies have similar viability and all cultures have higher 
viability after 7 days than after 2 days. 4x10
6
 keratinocytes have lower viability than 
other cultures; B) MTS cell viability over time of 1x10
6
, 2x10
6
 and 4x10
6
 HaCaT 
cells in the 3D scaffold seeded by the concentrated method; C) 4x10
6
 spot-seeded 
HaCaT cells seeded in 3D scaffold and grown for 7 days at the air-liquid interface. 
Large white areas of suspected cell necrosis are visible, encompassed by dotted black 
lines. An area of unknown pink cytoplasmic eosin staining are indicated with black 
arrow. These are possible cell remnants. Scale bar 100µm. Error bars show SEM. 
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The MTS assay results in Figure 3.6A show that after two days, 10
6
 or 2x10
6 
cells 
show the most cell viability in 3D cultures. Predictably, lower initial seeding 
densities showed lower MTS assay activity than higher densities. Interestingly, 2x10
6 
cells per scaffold seeded by the concentrated method showed a reduction in viability 
of the population of cells in the culture compared to the same number seeded by the 
diluted method. This may be because some areas within the scaffold become so 
densely populated that cells are unable to attach and proliferate normally. 
Alternatively, too many cells may have depleted the culture media prematurely. In 
2D, it has been shown that HaCaT cells which become too confluent undergo 
changes in cell morphology as if beginning early stages of differentiation (Gniadecki 
et al, 2001). This is also likely to be the case in a 3D environment, if not more 
pronounced due to improve cell-cell contact and communication. 
Cell growth within the 3D scaffold also requires sufficient penetration of culture 
media, diffusion of oxygen and clearance of waste products of metabolism. If cells 
are densely packed, the ability of cells to receive nutrition and clear waste products 
may be restricted, leading to a reduction in cell viability measured by MTS assay. 
After 7 days, proliferation has increased in all treatment groups, with most treatment 
groups showing roughly equal proliferation. The highest density seeding method 
again showed the lowest activity, and the 4x10
6
 diffuse seeding method showed 
much larger variability than other groups. This is predictable, as the distribution of a 
large number of cells through the scaffold is likely to be more variable. 
After 14 days, all culture groups show similar or less viability than at 7 days. This 
may be because cells have reached a high degree of confluence inside the scaffold 
and therefore slow down their rate of proliferation. This is similar to their behaviour 
in 2D cell culture. Alternatively, cells may be differentiating, and are therefore 
flattening, losing their nuclei and not able to metabolise the MTS reagent, resulting 
in a reduction of the measured viability. Alternatively, cells may have reached a 
density which becomes a limiting factor in terms of oxygen, nutrient and waste 
product diffusion, therefore limiting proliferation and reaching an equilibrium. It is 
expected that a culture of highly differentiated cells will result in a lower 
proliferation assay result. 
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The results show that for shorter periods of growth in the 3D scaffold, the number of 
cells initially seeded into the scaffold is a key factor. However, after longer culture 
periods at the air-liquid interface, this becomes less important. For instance, 0.25x10
6
 
cells showed the lowest proliferation after 2 days, but increased rapidly after 7 days 
of culture. This suggests that the limitation of cell proliferation rate is the culture 
system itself, rather than the number of cells seeded into the system. This may be 
because of the availability of culture media, diffusion of oxygen, or that the 
maximum density of cells in the scaffold has been reached. 
A simplified line graph of three seeding densities (0.5, 1.0 and 2.0 x 10
6
 cells) is 
presented in Figure 3.6B, showing that 1.0x10
6
 cells consistently show the most 
proliferative cultures with the least variation. 
An image of 4x10
6
 HaCaT cells after 7 days in the 3D scaffold is shown in Figure 
3.6C. This sample shows large white areas throughout the whole thickness of the 
scaffold, with shrunken nuclei and blotchy pink staining, possibly from cell 
remnants. This corresponds to reduced MTS assay activity seen in Figure 3.6A. It is 
likely that diffusion of nutrients, oxygen and waste products is limited by high cell 
numbers, causing some cells to become necrotic.  
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3.2.3.2 Optimisation of the 3D Scaffold Culture System 
As the scaffold is relatively thick and is constructed from a rigid, non-porous, non-
biodegradable polystyrene, there are several factors to bear in mind such as the 
availability of glucose, clearance of waste products, and the adequate diffusion of 
oxygen into the culture.  Growing 3D cultured keratinocytes on a wire grid in a 6 
well plate allows for approximately 2.0ml of culture media underneath the scaffold 
when at the air-liquid interface. Given that there are 1x10
6
 cells initially seeded in the 
scaffold, and subsequent cell divisions will increase this number, 2ml of culture 
media is likely to be inadequate for optimal proliferation and differentiation of the 
keratinocytes. 
In response to this, custom well inserts (shown in Figure 2.3A) were developed. 
These allow for a greater amount of culture media per scaffold and provides a more 
reproducible system (i.e. a horizontal, fixed height for every culture) for maintaining 
the air-liquid interface. They also allows for three 3D cultures to be maintained in the 
same deep Petri dish, in the same culture media which will improve the 
reproducibility of cultures by reducing experimental error. In the well insert system, 
three 3D scaffolds can be held in one holder and cultured in 45ml culture medium i.e. 
around 15ml per scaffold, as shown in Figure 2.4. This is 7.5 times more culture 
media per scaffold than the wire grid system allow, which should lead to improved 
cell growth and morphology. 
Therefore, the wire grid system was compared to the newly developed well insert 
system. 1.0x10
6
 HaCaT cells per 200µm thick, 22mm diameter 3D scaffold have 
been previously determined as the optimal seeding number. Therefore, 1x10
6
 cells 
were seeded in 100µl culture media per scaffold, grown submerged for 2 days and 
then lifted to the air-liquid interface for 14 days by either the wire grid or well insert 
method. Cultures were fixed and stained for H&E after 2, 7 and 14 days. 
Representative sample images for the wire grid system are shown in Figure 3.7 and 
for the well inserts in Figure 3.8. 
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Figure 3.7. 3D Scaffold Cultures Grown on Wire Grids 
A, C, E) 10
6
 spot-seeded HaCaT cells after 2 days submerged, 7 days at the air-liquid 
interface and 14 days at the air-liquid interface respectively. Cell penetration in the 
submerged sample (A) is marked by a dotted line and the bottom of the scaffold is 
approximated with a solid line. HaCaT cells have penetrated an average of 45% 
(90µm) into the 3D scaffold after 2 days. Areas of cellular staining with no nuclei are 
indicated with arrows. After 14 days at the air-liquid interface (E), there are less 
nucleated cells visible. It is unclear whether these cells are differentiated and have 
lost their nuclei, or have undergone necrosis; B, D, F) Keratin 1 staining of 10
6
 
HaCaT cells grown for 2 days submerged, 7 and 14 days air-liquid interface on wire 
grids. Arrows show areas of pink staining without visible nuclei. All scale bars 
100µm.  
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As seen in the H&E staining in Figure 3.7A, after two days the HaCaT cells are 
located mostly in the upper regions of the scaffold and have not fully penetrated the 
full 200µm depth of the scaffold. This depth is marked with a dotted line and was 
measured as an average of 45% (90µm) penetration by assessing various points along 
the length of the section. Noticeably, all cultures show cells with a shrunken 
appearance, with little cytoplasm surrounding the nuclei. After 7 days (Figure 3.7C), 
cells are now present through the whole depth of the scaffold, which corresponds to 
the increase in MTS cell counts (Figure 3.6). This shows that HaCaT cells are 
capable of proliferating to fill the three-dimensional area provided to them although 
it is not clear from these results alone whether cells have migrated throughout the 
scaffold, or have proliferated to fill the available space. Again, cells still show a 
slightly shrunken morphology with less cytoplasm surrounding the nucleus than 
would be expected. After 14 days (Figure 3.7E), there is little visible increase in the 
cellular bulk inside the scaffold, although there are larger areas of pink staining with 
no visible nuclei (indicated by black arrows). It is unclear from this staining alone 
whether this is cell necrosis or an area of differentiated cells which have flattened 
and lost their nuclei. 
The shrunken appearance of the cells may be explained by the low amount of culture 
media available to the cells. The culture media was changed frequently (every 48 
hours), but only 2ml of culture media was present at any one time, which may be 
limiting cell viability in the 3D environment. It is already known that cells grown in 
a 3D environment have higher metabolic requirements than those grown in 2D 
(Bokhari et al, 2008). Although 3D scaffolds were only in contact with the culture 
media from the underneath, no clearly visible differences between cells located at 
either the top or bottom of the scaffold in terms of morphology. 
Sections were also stained for the early proliferation marker keratin 1 (K1). This can 
give insight into the MTS data and show whether a drop in the cellular metabolism 
(measured by conversion of MTS substrate) of the culture is due to cell 
differentiation or from cell death related to poor media quality or necrosis.  
The K1 staining results show that after two days (Figure 3.7B), there are no cells 
staining positive for K1. This is expected, as the cells are still submerged and 
proliferative. This corresponds with earlier 2D data, showing that HaCaT cells do not 
express basal K1 staining. At 7 days (Figure 3.7D), there is some positive K1 
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staining, indicating that some cells are undergoing differentiation in the 3D 
environment. At 14 days (Figure 3.7F), K1 staining is clearly visible around the 
nuclei of many cells, and there is clearly more staining than after 7 days, indicating 
that more time at the air-liquid interface increases cell differentiation. However, there 
appears to be little organisation in K1 staining. In the stratified epidermis, K1 
staining is found in the suprabasal layers (Wallace et al, 2011), but in the 3D 
scaffold, K1 staining appears to have  no clear pattern of expression. It is clear from 
these results that 3D cell culture has been achieved in all samples, but there is room 
for improvement of cell morphology and the organisation of differentiation. 
  
130 
 
 
Figure 3.8. 3D Scaffold Cultures Grown in Custom Well-Inserts  
A, C, E) 10
6
 spot-seeded HaCaT cells after 2 days submerged, 7 days and 14 days at 
the air-liquid interface respectively. Cell penetration is marked by a dotted line and 
the bottom of the scaffold is indicated with a solid line. HaCaT cells have penetrated 
an average of 71% (142µm) into the depth of the 3D scaffold after 2 days; B, D, F) 
K1 stained sections from 2d submerged, 7 and 14d at air-liquid interface 
respectively; G, H) H&E and K1-stained cultures of 10
6
 HaCaT cells submerged for 
14d. K1 staining shows clearly less positive staining than 14d at the air-liquid 
interface.  All scale bars 100µm. 
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Compared to wire grid cultures (Figure 3.7), there is a noticeable change in cell 
morphology after all time points. After 2 days submerged (Figure 3.8A), cells still do 
not penetrate the entire depth of the scaffold, but they do show more penetration into 
the scaffold than the wire grid system (marked with a dotted line, and the bottom of 
the scaffold with a solid line). Cells have penetrated an average of 71% (142µm) into 
the scaffold using the well insert system compared to 45% (90µm) with the wire grid 
system. The cells pictured in H&E staining appear larger, with more visible stained 
cytoplasm than those grown in the wire grid culture system. Methodology for 
histological preparation was the same as previous samples and so it is likely that 
shrunken cells were caused by poor nutrition by the culture media rather than any 
artefact induced by dehydrating the cells too rapidly. K1 staining after 2 days 
submerged (Figure 3.8B) shows sporadic K1 positive cells, located mostly in the 
upper layers of the culture. 
After 7 days at the air-liquid interface (Figure 3.8C), H&E staining shows that the 
cells have filled the entire depth of the scaffold. The cells in the scaffold appear all to 
have similar morphology and there is a limited number of flattened cell layers on the 
surface of the scaffold. K1 staining (Figure 3.8D) reveals many differentiating cells. 
After 14 days at the air-liquid interface (Figure 3.8E), H&E staining shows that the 
cells are still occupying the entire scaffold and appear very similar to the 7d cultures. 
There are some flattened cells on the top of the scaffold, but no visible stratum 
corneum on the surface of the scaffold. However, there is more K1 staining in the 
14d air-liquid interface culture (Figure 3.8F) than in the 7d culture, indicating that 
time spent at the air-liquid interface increases the number of differentiated 
keratinocytes inside the 3D scaffold. 
Control samples were left submerged for the full 14 day time period, with media 
changes at the same time as cultures at the air-liquid interface. H&E staining (Figure 
3.8G) shows that cells have penetrated the full thickness of the scaffold but are 
slightly shrunken and are not filling voids as readily as in cultures lifted to the air-
liquid interface. K1 staining (Figure 3.8H) shows sporadic individual cells located 
randomly throughout the scaffold. This shows that submerged cultures of HaCaT 
cells do not generally differentiate, even after 14 days. Previous 2D experiments 
showed that occasional HaCaT cells express differentiation markers, even when 
submerged in 2D in low calcium culture media (Figure 3.1). 
132 
 
In overall comparison to the results on wire grids (Figure 3.7), it is clear that cultures 
grown with the well-inserts and deep cell culture dishes show a better morphology 
than those grown on wire grids as well as more keratinocyte differentiation. 
In all samples, it is clear that 3D cell growth has been achieved. HaCaT cells have 
proliferated to fill the thickness of the scaffold and areas of the section which cut 
through multiple adjacent cells show cells in contact with each other and a "tissue-
like" appearance. Interestingly, the K1 staining indicates that keratinocyte 
differentiation has occurred inside the scaffold, but there are no stratified cell layers 
on the upper air-exposed surface of the scaffold. 
For further investigation into the 3D culture of HaCaT cells, samples cultured in the 
deep well culture dishes at the air-liquid interface for 7d were fixed and prepared for 
SEM analysis, shown in Figure 3.9. SEM analysis confirms finding from H&E 
staining that cells can grow through the full thickness of the scaffold, and are capable 
of growing within voids. Low magnification SEM imaging (Figure 3.9A) shows cells 
occupying the full thickness of the scaffold in three dimensions. The overall 
appearance represents a "slab" of 3D cultured cells, with the keratinocytes and 3D 
scaffold closely integrated. Figure 3.9B shows a higher magnification transverse 
section of the 3D scaffold, showing that HaCaT cells are present at all depths of the 
scaffold after 7 days at the air-liquid interface, which corresponds with findings by 
H&E staining. These SEM images confirm that the cells are growing in a 3D manner 
and have attachments to the 3D scaffold and to other cells. 
For further characterisation of the model, cultures were grown using the optimised 
conditions and prepared for immunofluorescence staining of differentiation markers.  
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Figure 3.9. SEM of 3D Cultured HaCaT Cells 
Images from 10
6
 HaCaT cells grown in the 3D scaffold for 7 days showing evidence 
of 3D cell growth. A) Low magnification transverse section showing cells have 
penetrated through the full depth of the scaffold and are covering a large area of the 
scaffold. Scale bar 200µm; B) Intermediate magnification transverse section showing 
cell that cells have penetrated the full thickness of the scaffold. Scale bar 100µm; C) 
High magnification image showing cells throughout thickness of scaffold. Scale bar 
100µm.   
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Figure 3.10. Differentiation Markers of 3D Cultured HaCaT Cells 
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Immunofluorescence of 10
6
 spot-seeded HaCaT cells grown in the 3D scaffold for 2d 
submerged, then 14d at the ALI in deep well culture inserts. Stained for A) E-
cadherin; B) involucrin; C) desmoplakin; D) keratin 1 and E) keratin 14. All scale 
bars 100µm. Graphs underneath each image show relative intensity of staining for 
each marker, through the 200µm thickness of the 3D scaffold with 0 representing the 
upper surface and 200 representing the lower surface  
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Figure 3.10 shows the expression of the differentiation markers E-cadherin, 
involucrin, desmoplakin and keratin 1 in many cells inside the 3D scaffold, 
confirming that cell differentiation is occurring at the air-liquid interface. E-cadherin 
and involucrin staining are distributed throughout the 3D scaffold with no clearly 
stronger staining areas. Involucrin would normally be concentrated in the suprabasal 
layers of the epidermis. Desmoplakin staining (Figure 3.10) shows a more 
concentrated staining on the air-exposed surface although the staining does not look 
strongly desmosomal. Analysis of the gradient of staining intensity through the 
thickness of the scaffold shows Keratin 1 is stronger in the upper layers of the 3D 
scaffold, closer to the air-exposed surface and Keratin 14 staining shows some 
preference for the submerged lower areas of the 3D scaffold. This approximates the 
location of Kertain 1 and Keratin 14 in normal human epidermis where Keratin 1 is 
present in differentiating cells and Keratin 14 present in basal proliferative cells. This 
staining for differentiation markers shows that differentiation is clearly occurring, 
however it appears disorganised, with no clear gradients of differentiation markers 
towards the air-exposed surface of the culture, which would be expected in native 
epidermis. Nor are there any clearly divisible layers such as the basal or granular 
layers. The histology results alone do not show how differentiating HaCaT cells are 
organised within the scaffold or whether there are flattened cells layers on the air-
exposed surface of the culture. In the next chapter, SEM will be used to determine 
the organisation of cells within the scaffold and look for evidence of flattening 
keratinocytes. 
Figure 3.10E shows that the basal Keratin 14 is still found in the cultures, even after 
14 days at the air-liquid interface when numerous differentiation markers are 
observed. 
 
3.2.4 Growth of Other Skin Cells in the 3D Scaffold 
In order to test the 3D scaffold as a cell culture device, many other cell types were 
tested in our lab for their ability to proliferate and form tissue-like structures in this 
material. These cells types included Chinese Hamster Ovary (CHO-K1) cells, 
embryonal carcinoma (TERA2.cl.SP12.) cells, liver hepatocyte (HepG2) cells, 
osteoblasts (MG63) and breast cancer epithelial cells (MCF-7). I carried out some 
initial testing of other skin cell types in the 3D scaffold - specifically, squamous cell 
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carcinoma MET cells, primary mouse keratinocytes and 3T3-NIH mouse fibroblasts 
were cultured in the 3D scaffold using the protocols developed in this chapter. 
MET cells are a series of human cell lines derived from a squamous cell carcinoma 
(SCC) by Proby et al, 2000. The cells were named MET1, 2, 3 and 4 according to 
their various stages of SCC development from the same adult patient. MET1 cells 
originate from the primary cutaneous tumour on the hand, MET2 and MET3 from 
two local re-occurrences, and MET4 were isolated from a metastases on the axillary 
lymph nodes. MET cells are keratinocyte-like cells, with similar morphology and 
growth properties to normal human keratinocytes. However, after isolation from the 
patient they were shown to proliferate more quickly, and did not require feeder 
layers, even when initially isolated. Further experimentation showed that MET cells 
are unable to differentiate and that they express an altered keratin profile - for 
example no suprabasal K1/K10. As they cannot differentiate, they are unable to form 
an organised, stratified epidermis (Proby et al, 2000). 
Of the four MET cell lines, MET1 and MET4 cells represent the most different 
subtypes, and so they were selected to be cultured in the 3D scaffold. As they are 
similar to keratinocytes, they were cultured following the same protocols previously 
developed for HaCaT cells. 
Keratinocytes from the back skin of C57 mice were kindly donated by Dr Carrie 
Ambler, Durham University. These cells were initially supplied with fibroblast 
feeder layers but were subsequently cultured in defined keratinocyte media, Epilife, 
supplemented with 10% chelexed FBS, Epilife Defined Growth Supplement (EDGS)  
and 0.06mM calcium. Initial growth was slow, but after several passages, these cells 
improved in their proliferation rate while maintaining an unaltered basal keratinocyte 
morphology. After p>15, these keratinocytes were deemed to be a stable, immortal 
cell line and named WTK (wild type keratinocyte) cells. These WTK cells were then 
grown in the 3D scaffold utilising the same protocols as HaCaT cells.  
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Figure 3.11. Culture of Other Skin Cell Types in the 3D Scaffold 
2D light microscopy images and H&E stained images 3D cultures of MET1 (A,B); 
MET4 (C-D); 3T3-NIH (E, F) and Mouse Primary Keratinocytes (G,H) cells grown 
for 14 days in the 3D scaffold. MET1, MET4 and 3T3-NIH cultures were cultured 
submerged and mouse keratinocytes were grown at the air-liquid interface. Scale bar 
100µm. 
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As seen in Figure 3.11B, MET1 cells did not adhere to the 3D scaffold at all. The 
reason for this is unknown, although MET1 cells are noted to maintain very little 
cell-cell contact in 2D culture. They were also observed to proliferate poorly on glass 
cover slips (data not shown). A study by Margulin et al, 2006 found that when 
squamous cell carcinoma keratinocytes deficient in intercellular adhesion proteins 
(such as E-cadherin) were cultured in 3D, they displayed a more invasive phenotype. 
This lack of adhesion proteins might explain why MET1 cells showed poor adhesion 
to many materials, including the 3D scaffold. Interestingly, these findings do not 
correspond with the MET1 origin as the original tumour which had not yet become 
invasive.  
On the other hand, MET4 cells (Figure 3.11D) have proliferated very well inside the 
3D scaffold, and occupy the entire depth and width of the scaffold. When cultured in 
2D (panel C), MET4 cells continue to proliferate, even when confluent. When 100% 
confluence is reached it appears that MET4 cells "push" other cells off the surface of 
the culture dish and continue to proliferate. As MET4 cells are unable to differentiate 
they have continued to proliferate and fill the 3D scaffold. 
3T3 cells (Figure 3.11F) have shown moderate growth inside the 3D scaffold. They 
have occupied the full depth of the scaffold but are less "dense" than MET4 cells or 
HaCaT cells shown previously. 3T3 cells are substantially larger cells than 
keratinocytes and so the seeding methods utilised may not have been optimal and 
further optimisations may improve the morphology of the culture. Nevertheless, 3D 
growth has been achieved and many cells are present within the scaffold.  
WTK cells (Figure 3.11H) have proliferated well within the 3D scaffold, similar to 
HaCaT cells. In experiments similar to Figure 3.1, WTK cells maintained a 
proliferative phenotype when maintained in low calcium culture media and strongly 
expressed markers of differentiation when switched to high calcium. As mentioned 
earlier, HaCaT cells have limited differentiation capacity and continue to proliferate 
while differentiating, but they are convenient for experimentation due to their robust 
nature, non-fastidious growth requirements and stable behaviour. WTK cells require 
defined culture media with growth supplements and proliferate much more slowly. In 
future chapters, WTK cells will be used in experiments alongside HaCaT cells where 
relevant and where possible with regard to time and cost. 
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3.3 Discussion 
3.3.1 Results Summary 
This chapter investigated the 3D growth of the HaCaT human keratinocyte cell line 
with the goal of forming a differentiated 3D epidermal equivalent using a novel cell 
culture scaffold. This 3D culture aims to have a barrier function suitable for in vitro 
permeability testing of various compounds. It may also be used to investigate the 
effect of pharmacological agents on the proliferation and differentiation of 
keratinocytes. 
Investigations began by optimising basic culture conditions such as the number of 
cells to be seeded, the method of seeding and the length of the culture period. These 
were simple but essential steps in successful tissue engineering with any novel 
system. MTS assays were used to measure viability of cells in the 3D scaffold. 
Generally the populations of cells cultured in the 3D scaffold were sufficiently 
viable, unless cultures became too confluent or the media quality became 
insufficient. Another possible line of investigation would have been to examine the 
quality of the culture media by testing glucose utilisation, lactate concentration and 
pH of the culture media. However, the DMEM culture media utilised is pH buffered 
and contains phenol red indicator which changes colour if the pH falls below the 
specified range. Culture media was also changed frequently. 
The culture system itself underwent developments. Initially, wire grids were used to 
lift cultures to the air-liquid interface in 6 well plates. This method did achieve 3D 
growth of HaCaT cells but Figure 3.7 and Figure 3.8 demonstrate that a well-insert 
apparatus with deep culture wells providing more culture media to each scaffold is 
clearly a more effective system. Cells grown in this system maintained a better 
morphology with no cell shrinkage that was observed using the wire grid system. In 
terms of preparing the scaffold pre-culture, plasma treatment was preferable to 
ethanol and PBS pre-washing, although due to equipment constraints, it was not 
possible to use plasma treated scaffolds for every experiment. 
By the end of work presented in this chapter, an optimised system for 3D culture of 
HaCaT cells has now been developed. The resulting culture shows signs of epidermal 
differentiation which will be further investigated in the following chapters. 
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Table 3.3. Optimal Culture Conditions for 3D Scaffold Cultures 
Method Tested Optimal Condition Comments 
Pre-treatment of scaffold Plasma treatment More effective than ethanol 
pre-washing 
Cell seeding density 1x10
6 
cells per 200µm 
thick, 22mm diameter 
scaffold 
The most consistent viable 
cell number 
Cell seeding method Cells seeded in 100µl 
culture media to centre of 
scaffold 
Cells allowed to settle for 
30 minutes before culture 
media added 
Growth period 2d submerged. 14d at air-
liquid interface 
Filled the full 200µm 
scaffold depth and stained 
positive for differentiation 
markers 
Culture method Tri-well insert in deep 
Petri dish 
Better cell morphology than 
wire grids 
3.3.1.1 Summary of HaCaT Cell Culture in the 3D Scaffold 
The data gathered in this chapter have confirmed previous findings (Boukamp et al, 
1988, Micaleff et al, 2008) that HaCaT cells maintain the ability to proliferate in 
routine 2D culture and can be induced to differentiate when stimulated by high 
calcium or by culture at the air-liquid interface (Boelsma et al, 1999). The air-liquid 
interface was essential for differentiation, as found in previous studies (Koria and 
Andreadis, 2005). A summary of the optimal culture conditions is shown in Table 
3.3. 
HaCaT cells were seeded into the 3D scaffold using a concentrated method where 
10
6
 cells were suspended in 100µl culture media and applied to the centre of the 
scaffold. This overcame difficulties in achieving an even HaCaT cell distribution in 
the 3D material by using capillary action to draw the cells inside the material (Wendt 
et al, 2009). HaCaT cells adhered to the material and were able to proliferate inside 
the porous structures, as visualised by H&E staining and SEM imaging (Figure 3.8 
and Figure 3.9). Modification of the culture conditions with custom-designed well 
inserts and a larger volume of culture media improved the morphology of the 
keratinocytes in the scaffold. When cultured submerged, the cells remained 
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undifferentiated, but at the air-liquid interface, HaCaT cells expressed proteins such 
as involucrin, desmoplakin and keratin 1, as visualised by immunofluorescence 
staining.  
HaCaT cells cultured in this scaffold showed 3D growth and routine methods such as 
MTS assay, paraffin embedded histology and immunofluorescence staining were 
shown to be compatible with the material after some small modifications to standard 
lab methodologies. For instance Xylene, commonly used as a clearing or de-waxing 
agent, had an adverse effect on the polystyrene-based scaffold and Histoclear was 
used instead. 
Within the studied time period, it is unclear whether HaCaT cells fully acquired a 
flattened morphology. While the cells expressed differentiation markers visualised 
by immunofluorescence staining, there was no visible stratum corneum on the 
surface of the culture, and no clearly defined epidermal layers which are observed in 
some epidermal models (Ponec et al, 2000, Pasonen-Seppanen et al, 2001, Mazar et 
al, 2010). Instead, it appears that HaCaT cells are differentiating inside the porous 
3D scaffold structure, even when at the air-liquid interface. One possible reason for 
this is the fact that cells appear to remain adherent to the 3D scaffold through the 
culture period. 
HaCaT cells in the 3D scaffold also retained some characteristics of proliferating 
cells such as basal keratin 14 expression and a high cell viability when cultured at the 
air-liquid interface. This may be partly due to the choice of cell line, as HaCaT cells 
have been shown to maintain some elements of a proliferative phenotype (including 
K14 expression) during differentiation (Micallef et al, 2008). Nevertheless, HaCaT 
cells in the 3D scaffold are clearly differentiating when cultured at the air-liquid 
interface and the extent of this differentiation will be fully characterised in the 
following chapter. 
It was also possible to culture other cell types within this scaffold such as fibroblasts, 
MET squamous cell carcinoma cells and mouse keratinocytes (Figure 3.11). Each 
cell type displayed their own growth characteristics in the 3D scaffold and resulting 
cultures displayed morphological differences in line with the properties of the cell 
lines used. Mouse keratinocytes formed a 3D culture similar to HaCaT cells and in 
2D observations they appeared to be more similar to normal human keratinocytes 
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than HaCaTs. Therefore, these mouse keratinocytes were used in some future 
experiments when time permitted. 
 
3.3.2 Integration of Collagen Gel with the 3D Scaffold 
Bearing in mind the popularity and acceptance of collagen gel-based models for 
keratinocyte culture, initial experiments in this chapter focused on utilising the 3D 
scaffold in a similar way - namely as a support for a fibroblast-contracted collagen 
gel. Many different methods were utilised to integrate the 3D scaffold with collagen 
gels, but none of these methods fully achieved that goal. Using a standard collagen 
gel formula from published methodology (Turksen et al, 2005), the gel would simply 
run through the pores in the 3D scaffold, as the pore size (~80µm average) is much 
larger than semi-permeable membrane inserts which are typically used for this 
purpose. 
Increasing the solidity, gelation speed and stability of the gel was investigated as a 
way to form a contracted collagen gel around the 3D scaffold. The formula was 
altered to include choindroitin-6-sulphate (Ch6SO4). Chondroitin-6-sulphate is a 
glycosaminoglycan which acts as a cross-linker of collagen fibres and has been 
shown (Osborne et al, 1997) to increase the physical and biological stability of 
collagen gels. Incorporation of 20% C6S into a collagen gel was shown to increase 
the speed of collagen crosslinking and gelation, as well as increasing the proliferation 
of keratinocytes on the surface (Osborne et al, 1998). Another study showed that 
human keratinocyte and dermal fibroblast attachment to collagen matrices is 
improved by the addition of glycosaminoglycans (Grzesiak et al, 1997). In this 
chapter, collagen and C6S were introduced to the 3D scaffold and a highly stable, 
rigid gel was formed (Figure 3.5). When examined under SEM, this surface covered 
large areas of the scaffold and appeared relatively uniform. However, this gel would 
not support cell culture. This was theorised to be due to the thickness of the gel 
affecting culture media diffusion, but reducing the thickness and amount of the gel 
was still incompatible with cell culture. 
In preliminary experiments earlier scaffold prototypes (50-100µm thick with higher 
porosity) had been successfully used to culture keratinocytes on scaffold-supported 
collagen gels. However, these results were not repeatable with the current scaffold 
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model which is manufactured by different methodology. Therefore, it seems that the 
scaffold structure utilised in the experiments in this thesis is unsuitable for 
combining with a collagen gel to form an organotypic culture. It is likely that the 
manufacturing process for the scaffold could be altered to create a more optimal 
material for collagen coating, although this is beyond the scope of this thesis. A 
technique called "layer by layer" (LBL) coating may be appropriate, where a material 
is alternately submerged into oppositely charged solutions to sequentially coat it 
(Decher, 1997). Vapour phase deposition is another technique which could 
potentially be used to surface coat porous polymers such as the 3D scaffold (Chen et 
al, 2006). 
3.3.3 Culture of Keratinocytes without Dermal Component 
It is clear that in terms of keratinocyte culture, this 3D scaffold is best suited for the 
direct culture of cells, and not as a support for collagen matrices. The 3D scaffold 
allows the three dimensional culture of keratinocytes at an air-liquid interface 
without a dermal equivalent or fibroblasts. This is a faster method for 3D 
keratinocyte culture without waiting for collagen gel contraction before cell seeding. 
Secondly, collagen gels are inherently unstable with limited shelf life and stability in 
culture conditions, and thirdly, collagen gels are inherently variable in quality due to 
their reliance on cultured fibroblasts. 
However, there are some sortcomings of a model based on keratinocytes only; lack 
of dermal-epidermal (i.e. keratinocyte-fibroblast) interactions being the largest. 
Bearing this in mind, the following chapters will use supplemented culture media to 
promote optimal proliferation and differentiation of keratinocytes. The second clear 
shortcoming is that none of the cultures grown so far have shown evidence of layers 
of organised stratifying cells, as would be expected in human skin and are readily 
found in published epidermal models. This is because it appears that keratinocytes 
are differentiating inside the 3D scaffold rather than forming stratified layers on the 
air-exposed surface. The following chapter will investigate this in more detail, to 
determine whether keratinocytes are organised in the 3D scaffold and whether they 
are still able to produce barrier lipids and form cornified envelopes under these 
conditions. These experiments will investigate whether keratinocytes alone are 
capable of forming an epidermal barrier within the confines of the 3D scaffold.  
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3.3.4 Conclusion 
There are many different systems available for the 3D culture of keratinocytes - each 
with different properties, allowing for many different analytical methods and 
investigations, as well as the preferences of researchers. The 3D scaffold presented in 
this thesis has shown suitability for the rapid 3D culture of keratinocytes at the air-
liquid interface without a dermal equivalent. Keratinocytes  are contained within the 
scaffold, rather than forming multiple flattening layers on top of the culture. The 
resulting culture stains positive for differentiation markers, indicating that 
differentiation, and likely an epidermal barrier, is formed, although these markers 
were not distributed in an organised manner, such as in native epidermis. Chapter 
Four will use the information gained during Chapter Three (such as seeding method, 
cell number, duration of growth and culture apparatus) and progress to investigate 
the cell morphology and ultrastructure, cornified envelope formation and lipid 
synthesis of keratinocytes in 3D culture. These results will be compared to those 
from 2D culture and optimisations will be made to adapt the model for barrier 
permeability testing.  
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4 Chapter 4  
 
 
 
 
 
 
 
Characterisation of Barrier Components of the 3D 
Epidermal Culture System 
  
147 
 
4.1 Introduction 
4.1.1.1 Aims, Objectives and Overview 
Results in Chapter Three have shown that, under optimised conditions, HaCaT cells 
can be cultured inside a novel 3D scaffold and induced to differentiate by raising the 
culture to the air-liquid interface. In response to this, cells differentiated and 
expressed barrier proteins that were visualised by immunofluorescence staining. 
Expression of proteins such as involucrin, keratin 1 and filaggrin is in common with 
the majority of epidermal models in the commercial market (Pappinen et al, 2012). In 
this chapter, keratinocytes will be analysed in detail by TEM and SEM to reveal 
ultrastructure associated with differentiation. Lipid analysis will assess the barrier 
lipid profile of keratinocytes cultured under various conditions, including after the 
addition of supplements to the culture media in both 2D and 3D.  
4.1.1.2 Morphology and Ultrastructure of Cells in the 3D Scaffold 
The previous chapter showed that differentiation marker expression occurred 
throughout the thickness of the 3D model, but there was no clear organisation into 
definable epidermal layers. In most organotypic keratinocyte cultures, the resulting 
epidermal equivalent shows clearly defined layers - noticeably the granular and 
stratum corneum layers. However, this layered organisation is clearly not possible 
within the confines of a porous 3D polystyrene material. Therefore, this chapter 
further characterises the 3D scaffold keratinocyte model with scanning and 
transmission electron microscopy (SEM/TEM) techniques to visualise the 
organisation and ultrastructure of keratinocytes in this material. Cells were examined 
for changes in cell morphology associated with each epidermal layer, including 
keratin bundling, lamellar bodies, keratohyalin granules and cell flattening. These 
findings show the organisation of keratinocytes in the 3D scaffold as well as the 
extent of cell differentiation. The presence and location of desmosomes was also 
noted, due to their increasingly recognised importance in epidermal barrier function 
as well as their roles in diseases (Naoe et al, 2009). 
4.1.1.3 Cornified Envelopes as Evidence of Terminal Differentiation 
Cornified envelopes are insoluble protein and lipid structures formed during terminal 
keratinocyte differentiation by covalent attachment ceramides and fatty acids to a 
tough protein matrix formed from involucrin, loricrin and small proline-rich proteins 
(Proksh et al, 2008). Cornified envelopes can be visualised under the membrane of 
148 
 
flattened corneocytes and serve as markers of terminally differentiated keratinocytes. 
Therefore, 3D cultures were analysed for their ability to produce cornified envelopes, 
as other epidermal models have been assessed previously (Nolte et al, 1993). 
Cornified envelopes were extracted from cultures after different periods of grown at 
the air-liquid interface and compared to those from mouse epidermis and from 
differentiated 2D cultures. A Nile Red lipid stain was used to visualise the lipid 
content of the cornified envelopes and they were classified as mature or immature 
depending on their morphology.  
4.1.1.4 The Role of Lipid Metabolism in the Epidermis and in vitro Equivalents  
Although proteins such as involucrin are essential to barrier function, they alone are 
not enough to create a model with barrier permeability representative of in vivo 
epidermis. Investigations by Ponec et al, 2000, Netzlaff et al, 2005, Pappinen et al, 
2012 and others have compared commercially available in vitro epidermal 
equivalents to native human epidermis. In all cases, in vitro equivalents showed 
morphological evidence of differentiation (such as flattening and stratification) as 
well as protein markers of differentiation (involucrin, K1/K10). However, all 
epidermal equivalents had some form of defect in lipid composition such as 
abnormal ceramide profile, elevated triglyceride content or insufficient FFA content. 
Lipids are often the main area of weakness in the barrier permeability of 3D 
epidermal equivalents, limiting their usefulness as in vitro models of epidermal 
permeability (Pappinen et al, 2003, Netzlaff et al, 2007, Godin et al, 2007, Zhang and 
Michniak-Kohn, 2012). In most cases, in vitro epidermal equivalents contain more 
cell layers and are several times thicker than native human epidermis, yet most of 
these models still display poor barrier function (Schmook et al, 2001, Pappinen et al, 
2012). This highlights the importance of the lipid content of the epidermal equivalent 
as well as morphology. 
The overall epidermal lipid profile is formed as the end result of many complex lipid 
metabolic pathways in the body such as processing dietary triglyceride and 
cholesterol into precursors and providing essential fatty acids. In the epidermis, 
keratinocytes synthesise lipids from intermediate products of their own metabolism, 
as well as those supplied from the diet such as essential fatty acids (Elias, 2006, 
Duan et al, 2012).  
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4.1.1.5 Using the 3D Scaffold Model to Investigate Lipid Synthesis 
The lipid content of the epidermis is closely linked to epidermal barrier function and 
examining the lipid content of the epidermis can be used as a measure of maturity. 
To investigate further into the maturity of 3D culture lipid profiles, HaCaT cell lipid 
synthesis was measured by lipid extraction and thin layer chromatography (TLC) in 
both 2D and 3D conditions. The profile of 3D cultured HaCaTs was compared to 
mouse epidermis, as well as published literature concerning human epidermis. 
As part of this assessment, the 3D keratinocyte culture model was cultured with 
culture additives and pharmacological agents which have been shown to affect 
keratinocyte differentiation and lipid composition. The effect on cell morphology, 
viability and lipid synthesis in both 2D and 3D was analysed. This serves two 
purposes - firstly, to improve the existing model through modifying culture 
conditions for optimal barrier lipid production in vitro, and secondly to test the 
effects of culture additives on the 3D culture system in comparison to 2D cell 
culture.  
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4.2 Results 
4.2.1 Morphology of 3D Cultured HaCaT Cells 
3D cultures were grown with the protocol developed in the previous chapter, as 
follows: 10
6
 HaCaT keratinocytes were seeded in 100µl culture media into dry 
plasma-treated 3D scaffolds. Cultures were submerged for 48 hours, then raised to 
the air-liquid interface for 14 days in tri-well inserts in a deep cell culture dish. 
Culture media was replaced every three days for the duration of the experiments. 
For a detailed examination of the morphology of the 3D culture, cultures were 
processed for Toluidine Blue staining, as well as H&E staining. Toluidine Blue 
sections are embedded into a hard resin and are cut to 1µm thin sections, rather than 
10µm paraffin sections. Toluidine Blue stains nucleic acids and all proteins which 
also shows a sharper, more detailed cell morphology that H&E staining. 
Representative images of H&E and Toluidine Blue stained cultures are shown in 
Figure 4.1. 
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Figure 4.1.  Morphology of 3D Cultured HaCaT Cells 
A) H&E stained section of 10
6
 HaCaT cells cultured at the air-liquid interface with 
high magnification inset. Scale bars 100µm; B) Thin Toluidine Blue stained section 
of 10
6
 HaCaT cells cultured at the air-liquid interface. Flattened cells indicated; C) 
High magnification Toluidine Blue stained section showing cell morphology 
throughout the thickness of the scaffold. Scale bar 50µm; D) Schematic showing 
flattened cells inside a pore of the 3D scaffold; E) SEM image showing cells inside a 
pore of the 3D scaffold. Scale bar 40µm. 
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The H&E staining in Figure 4.1A show that HaCaT keratinocytes have completely 
filled the depth and length of the 3D scaffold. In this H&E section, there are no 
visible gaps or pores, indicating that the scaffold should be able to form a suitable 
epidermal barrier.  There is no evidence of cell necrosis or death visible in the H&E 
image and cells have a clearly defined nucleus and cytoplasm.  
The Toluidine Blue section (Figure 4.1B) shows more detailed cell morphology more 
clearly than the H&E section and shows keratinocytes inside the scaffold in various 
orientations. However, from these results alone it is not possible to tell whether 
HaCaT cells are undergoing differentiation, although previous immunofluorescence 
suggests that this is the case. In Figure 4.1C, a number of flattened cells are seen 
throughout the 3D culture, but it is unclear whether these cells are actually flattened, 
or this observed morphology is due to the orientation of the cells in the section. In 
real epidermis, flattening keratinocytes are oriented horizontally, in parallel to the 
skin surface, but inside the 3D scaffold the cells are likely to be adhering to the 
surface of the scaffold pores and voids and flattening along the surfaces in many 
orientations. It may be that the rigid nature of the 3D scaffold itself is constraining 
cell morphology and organisation. and keratinocytes are flattening inside the pores of 
the scaffold in various orientations. A schematic diagram of this is shown in Figure 
4.1D. SEM imaging, shown in Figure 4.1D supports this, with a pore inside the 
scaffold showing multiple flattened cells in various orientations along the inner 
surfaces of the pore. 
At the upper air-exposed surface of the scaffold, there is more evidence of 
horizontally oriented flat cells (indicated with arrows in Figure 4.1B), which would 
support positive differentiation marker staining seen previously. However, only 1-2 
layers of fully flattened cells are observed. These flattened cells are not present on 
the underside of the scaffold, showing that the flattened cells are in response to the 
dried upper surface from culture at the air-liquid interface and not simply from being 
at the edge of the 3D scaffold.  
4.2.1.1 SEM Imaging of 3D Culture Ultrastructure 
Therefore, higher magnification imaging was used to examine the upper surfaces of 
the scaffold for flattened keratinocytes and for examining the cells in the mid-
portions of the scaffold for signs of proliferation or differentiation. Representative 
images are shown in Figure 4.2.  
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Figure 4.2. SEM of Surface of  3D Cultured HaCaT Cells 
A) Low magnification SEM image of the surface of 3D scaffold showing wide 
coverage of cells. Scale bar 150µm; B, C) Intermediate magnification SEM image of 
the surface of 3D scaffold showing polygonal flattened corneocytes. Probable 
nuclear remnants indicated with arrows. Scale bars 20µm; D) High magnification 
SEM image showing three flattened corneocytes. Scale bar 10µm; E) High 
magnification image showing multiple layers of flattened corneocytes. Scale bar 
10µm; F) High magnification image showing tightly-assembled corneocytes. Scale 
bar 5µm. All cultures grown with 10
6
 HaCaT cells for 14 days at the air-liquid 
interface.   
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The low magnification image in Figure 4.2A shows the surface of the 3D scaffold 
after 10
6
 HaCaT cells were grown for 14 days at the air-liquid interface. The image 
shows cells consistently covering of an area approximately 700µm in diameter. 
There are large areas of flattened cells and with some areas of more rounded cells 
still present. This was observed over the central portion of the 22mm diameter 
scaffold. Intermediate magnification images in panels B and C show flattened 
pentagonal or hexagonal shaped corneocytes with distinct cell boundaries. The 
majority of these corneocytes are clearly anucleate, indicative of terminally 
differentiated corneocytes. These cells are flattened and covering an area 
approximately 40µm in diameter. Image B shows that a minority of cells were not 
completely differentiated. There are also flattened cells with remnants of nuclei 
remaining (panel C, indicated with white arrows). It is unclear from these images 
how many layers of flattened cells are on top of the scaffold, although there are at 
least two layers visible. 
The high magnification image in panel D shows flattened cells, one of which has 
remnants of the cell nucleus remaining. Corneocytes are attached by stitch-like 
connections around the periphery. Panels E and F show an area which appears more 
"cobblestone" with less clear corneocyte boundaries and "tighter" assembly of each 
corneocyte. The overall appearance of these areas is more smooth, and more similar 
to human cornified epidermis (Naoe et al, 2008). Patches of these "cobblestone" and 
"stitched" areas of corneocytes were found throughout the surface of the 3D scaffold 
with no identifiable patterns of distribution. This is perhaps due to processing for 
SEM, or from slight differences in exposure to the dry air-interface across the 
scaffold during culture. 
4.2.1.2 TEM Imaging of 3D Culture Ultrastructure 
In order to look more closely at the ultrastructure of cells and to determine the 
thickness of layers of flattened cells, cultures were fixed and processed into ultrathin 
sections for TEM. Representative images showing key observed features are shown 
in Figure 4.3, Figure 4.4 and Figure 4.5. 
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Figure 4.3. TEM of Keratinocytes on the Surface of Air-Exposed 3D Cultures 
Image showing flattened cells on air-exposed top of 3D scaffold structure. In this 
image, three cells at various stages of transition from normal to flattened morphology 
are clearly visible, labelled 1, 2 and 3. Scale bar 2µm; B) Higher magnification view 
of the area marked in image (A). The scaffold (S) is annotated, and flattened cells are 
seen attached to the surface (white arrow). Scale bar 2µm; C) High magnification 
image showing flattened keratinocyte with no visible nucleus. Keratin bundling is 
annotated with a white arrow and cornified envelope formation with black arrows, 
visualised by dark staining under the flattened corneocyte membrane. Scale bar 
500nm; D) Central region of the 3D scaffold showing cells with various 
morphologies around the scaffold (S). Scale bar 10µm.  
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Figure 4.3 shows TEM images of HaCaT cells at the air-exposed surface of the 3D 
culture. In panel A, a low magnification TEM image of the upper surface shows 
three cells at various stages of transition from normal to flattened morphology.  Cell 
(1) is rounded with a fully formed nucleus and cytoplasm, as well as cytoplasmic 
organelles. This cell is attached to the 3D scaffold and is similar in appearance to a 
proliferative HaCaT cells shown by Gniadecki et al, 2001. Cell (2) has a shrunken 
nucleus. Cell (3) is completely flattened and is anucleate. 
A higher magnification view of the area marked in panel A shows how cells are 
attached to multiple surfaces. As predicted from Toluidine Blue sections earlier, 
flattened cells are seen adhered to the surface of the scaffold. The cell annotated with 
a white arrow is approximately 1.0µm thick. In panel C flattened, anucleate cell 
ultrastructure is visible, showing evidence of keratin bundling, indicated with a white 
arrow. Keratin bundling increases the mechanical stability of the cells and occurs 
during keratinocyte differentiation (Windoffer et al, 2011). This cell is approximately 
1µm thick, which corresponds to the correct size for a corneocyte (Wickett and 
Visscher, 2006). It was not possible to see a clearly defined keratinocyte cornified 
envelope, but the dark line around the border of the cell, underneath the cell 
membrane (indicated by black arrows) is potentially indicative of cornified envelope 
formation. 
TEM analysis confirmed that differentiation is taking place deep within the scaffold. 
Figure 4.3D shows an area approximately 100µm deep inside the cross section of the 
scaffold. Here, several cells are pictured which match the descriptions of 
differentiating HaCaT cells according to Gniadecki et al, 2001. Cells appear with an 
irregular, dark edged nucleus with vacuoles in the cytoplasm. These are noted by 
Boelsma et al, 1999 to be indicative of differentiating HaCaT cells. This is opposed 
to proliferative cells which show a rounded/oval nucleus and organelle rich 
cytoplasm. It is also clear that cells are fully integrating with the 3D scaffold and are 
adapting their shape around the surface of the scaffold. These results support earlier 
immunofluorescence staining for differentiation markers which showed 
differentiation throughout the 3D scaffold and not just at the upper air-exposed 
surfaces (Figure 3.10). 
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Figure 4.4. TEM Imaging of HaCaT Cells inside 3D Scaffold 
A) HaCaT cell inside 3D scaffold showing large amounts of lamellar bodies (dotted 
area), lipid vacuoles (V) and keratohyalin granules (G) inside the cytoplasm; B) 
Keratin bundling (labelled) inside a flattening keratinocyte; C) Image showing 
emptied lamellar bodies and excreted lipid vacuoles (labelled with arrows). The 
nucleus is labelled (N) and the border marked with a dotted line; D) HaCaT cells 
growing inside 3D scaffold, attached to the scaffold (labelled (S)), showing several 
differentiated-associated organelles and lipid vacuoles. Organelles identified by 
images from Rosdy et al, 1990 Boeslma et al, 1999, Stark et al, 1999 All scale bars 
500nm.  
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Figure 4.5. Evidence of Desmosome Formation by HaCaT Cells in 3D Scaffold 
A) TEM image showing three flattened keratinocytes connected by desmosomes, 
indicated by white arrows. Scale bar 500nm; B) High magnification image of a 
desmosome. Scale bar 500nm; C) The interface between two cells shows several 
desmosomes, labelled with open headed arrows. The lower cell also shows a large 
volume of lamellar bodies and keratohyalin granules, labelled with black arrows. 
Scale bar 2µm. Similar images of desmosomes in 3D cultured epidermis are found in 
Smith et al, 2010.  
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In Figure 4.4, the ultrastructure of various cells from regions inside the 3D scaffold 
are presented. Panel A shows a high magnification image of keratinocyte located 
approximately 80µm deep inside the 3D scaffold. The cell cytoplasm shows 
extensive lamellar bodies (L), as well darkly stained ~400nm diameter rounded 
keratohyalin granules (G) and white, empty, lipid vacuoles (V), as identified by 
images in Rosdy et al, 1990 Boeslma et al, 1999, Stark et al, 1999 and descriptions in 
Ishida-Yamamoto et al, 2011. These organelles are indicative of a keratinocyte which 
is undergoing cell differentiation, corresponding to approximately the stratum 
granulosum layer of normal epidermal differentiation. This cell is likely to be 
capable of producing and excreting barrier components such as extracellular lipids 
into the surrounding area. Cytoplasmic lipid vacuoles will show as white unstained 
areas due to the solvent and ethanol washes involved in processing for TEM imaging 
(Ponec et al, 2000) and several such vacuoles were observed in cells throughout the 
3D culture.  
A high magnification section (Figure 4.4B) shows a keratinocyte located 
approximately 40µm deep inside the 3D scaffold. This cell is located closer to the 
air-interface and may be expected to be further along the pathway of differentiation 
than the previous cell in image A. This cell shows keratin fibre bundling and 
organisation inside the cytoplasm. This occurs during cell differentiation, when 
keratin fibres line up to contract and flatten the cells, confirming that cells are 
differentiating and flattening inside the 3D scaffold and not only at the air-exposed 
surface. An image from deeper inside the 3D scaffold (Figure 4.4C) shows a 
keratinocyte approximately 80µm deep which still has a nucleus, labelled "N" 
(border indicated) and shows darkly stained keratohyalin granules (G). There are also 
numerous lamellar bodies and excreted lipid vacuoles inside the cytoplasm, 
characteristic of the granular layer of normal epidermis. This again shows evidence 
of lipid production and excretion by the HaCaT cells grown in the 3D environment. 
Panel D shows another keratinocyte attached along the surface of the 3D scaffold 
with numerous cytoplasmic organelles. 
Many desmosomes were observed throughout the 3D culture. Figure 4.5A shows 
three anucleate HaCaT cells with flattened morphology, connected by desmosomes. 
These corneodesmosomes are essential for barrier function of the epidermis, 
although desmosomes are expected to degrade in fully differentiated cells, allowing 
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for desquamation. Panels B and C show high and intermediate magnification images 
of desmosomes observed in the nucleated cell portions of the 3D culture. Panel C 
shows two cells connected by several desmosomes in one plane. Similar images of 
desmosomes in 3D cultured epidermis are found in Smith et al, 2010. 
4.2.1.3 Conclusion of 3D Culture Morphology  
It is clear from examining these sections that after 14 days at the air-liquid interface, 
keratinocytes throughout the 3D scaffold are differentiating. On the upper, air-
exposed surface of the scaffold, keratinocytes are generally more differentiated (i.e. 
flat, anucleate) than those contained within the scaffold. Flattened cells were 
observed through the scaffold, but appeared to be more prevalent towards the upper 
air-exposed surface. The majority of non-flattened keratinocytes observed inside the 
3D scaffold still show signs of differentiation such as desmosomes, keratohyalin 
granules, lamellar bodies and keratin bundling. These organelles show a general 
trend showing a more differentiated morphology in closer proximity to the air-
interface however the whole 3D culture is not easily divided into distinctive layers 
such as the spinous, granular or stratum corneum layers.  
It is clear that the rigid, non-biodegradable nature of the scaffold itself is a key factor 
in keratinocyte behaviour. In most 3D in vitro epidermis equivalents utilising 
collagen gels or de-epidermalised dermis, and in samples of real human epidermis, 
cells can be clearly identified as being part of a greater architecture, with clearly 
divisible layers. However, in the 3D scaffold, differentiation is occurring but cells are 
differentiating inside the 3D scaffold itself rather than forming an series of layers of 
increasing differentiation.   
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4.2.2 Cornified Envelope Extraction and Characterisation 
Both TEM imaging in Figure 4.3C and Toluidine Blue staining of ultrathin sections 
(Figure 4.1) showed the presence of flattened corneocytes and possible cornified 
envelope formation located under the cell membranes of flattened cells. 
Therefore a series of cornified envelope extractions were performed on 3D cultures. 
Due to their resilient and insoluble nature, cornified envelopes can be isolated by 
treating whole epidermal sections (or 3D scaffold cultures) with reducing agents and 
surfactants (SDS and DTT), followed by boiling and repeated washing all soluble 
debris away. Cornified envelopes were extracted, imaged by phase contrast light 
microscopy, counted and classified as fragile or mature depending on their 
morphology. Objectivity was achieved by a colleague labeling each sample with a 
code before classification of cornified envelope morphology. Cornified envelopes 
were stained with 0.5mg/ml Nile Red lipid stain. Cornified envelopes from 2D 
cultures and from mouse ear tip epidermis were also extracted for comparison. 
Representative images from each experiment are shown in Figure 4.6 and Figure 4.7.  
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Figure 4.6. Properties of Cornified Envelopes From 3D Culture 
Phase contrast microscopy images of cornified envelopes from A) HaCaT cells 
cultured in the 3D scaffold for 14d at the air-liquid interface and B) mouse ear tip 
epidermis. White boxes show examples of cornified envelopes with fragile 
morphology. Scale bars 50µm; C) Graph showing percentage of fragile and mature 
cornified envelopes from three repeats of cornified envelope isolations from 3D 
culture (n=509) and mouse ear tip epidermis (n=622). Error bars show SEM. 
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Figure 4.7. Comparison of Cornified Envelopes from 2D and 3D Culture 
Cornified envelopes isolated from A) 2D low calcium; B) 2D high calcium; C) 3D 
scaffold 2 days submerged; D) 3D scaffold 7d air-liquid interface; E) 3D scaffold 
14d air-liquid interface; F) Mouse ear tip. All cornified envelopes stained with Nile 
Red for lipids and imaged at equal exposure for comparison. Scale bar 50µm for all 
images.   
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In Figure 4.6, samples of 14d 3D cultured CE and mouse ear tip CE were visualised 
by phase contrast microscopy for examination of their morphology.  
Published studies (Koch et al, 2000, Hirao et al, 2001 and Sevilla et al, 2007) have 
observed that cornified envelopes may be categorised into two main types: 
mature/rigid or immature/fragile. Mature cornified envelopes are of a relatively 
homogenous polygonal shape, with clearly defined rigid edges, larger size and 
stronger staining by Nile Red (Rawlings, 2003). Fragile or immature cornified 
envelopes taken on a more hetergenous morphology - usually being smaller, with 
irregular edges and a more rounded, less polygonal shape, sometimes with 
inclusions. 
A mixture of both mature and fragile cornified envelopes is visible in both samples. 
Cornified envelopes were counted from 10 fields of 3 samples each of 3D cultured 
cornified envelopes (n=509) and mouse ear tips (n=622) and categorised as mature or 
immature morphology. Results in Figure 4.6 show that the cornified envelopes 
isolated from the 3D scaffold are 64:36 mature:immature, whereas cornified 
envelopes from mouse ear tips are 75:25 mature:immature. This difference is 
statistically significant (P<0.05). This indicates that, on average, keratinocytes 
cultured within the 3D scaffold are displaying a more immature morphology than 
those from mouse epidermis. The 3D scaffold is much thicker than the epidermis of 
mouse ear tips, and the difference in the ratio shows that not all cells inside the 
scaffold are fully differentiated. In a comparison of size, the immature CE were 
found to be an average of 22% smaller than mature CE and the average diameter of 
mature CE was 38µm. 
4.2.2.1 Visualisation of Cornified Envelope Lipids  
Nile Red is a red fluorescent lipid probe first described by Greenspan et al, 1985 and 
characterised by Klinkner et al, 1997. It has been used previously (Hirao et al, 2001, 
Rawlings, 2003) to identify cornified envelopes with covalently attached lipids. 
Immature/fragile cornified envelopes stain inconsistently with Nile Red due to less 
covalent attachment of lipids (Hirao et al, 2001). Figure 4.7 shows cornified 
envelopes isolated from 2D and 3D cultured HaCaT cells as well as mouse ear tip 
epidermis. 
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Keratinocytes grown in 2D cultures (Figure 4.7) show very few cornified envelopes 
after 7 days in either low calcium (Panel A) or high calcium (Panel B) culture media. 
This is to be expected, as 2D culture generally does not produce matured cornified 
envelopes, even in the presence of high calcium concentrations. 
After 2 days submerged in the 3D scaffold (Figure 4.7C), the extraction shows 
similar results to 2D cultures, which is to be expected as cells do not differentiate 
when submerged (as desmonstrated in Figure 3.8). However, after 7 days at the air-
liquid interface (Figure 4.7D), there were more cornified envelopes extracted from 
the 3D scaffold cultures. These cornified envelopes also show more Nile Red 
staining than previous samples, indicating that they are more mature and have more 
covalently attached hydroxyceramides. 
After 14 days at the air-liquid interface (Figure 4.7E), there are many cornified 
envelopes extracted from the cultures. These cornified envelopes are more strongly 
stained with Nile Red than previous samples, however compared to those extracted 
from mouse ear tips (Figure 4.7F), the morphology of 3D cultured cornified 
envelopes is irregular and Nile Red staining is less intense, confirming the lower 
percentage of mature envelopes observed in Figure 4.7. 
In comparison to the cornified envelopes from mouse ear tips, the morphology of the 
3D scaffold-cultured cornified envelopes is quite variable. The morphology of the 
14d cultured CEs are generally larger, with less consistent Nile Red staining, mostly 
located around the periphery of each CE. By comparison, mouse ear tip CEs are 
smaller, more mature in polygonal shape and clearly stronger stained with Nile Red. 
Again, this probably reflects the constraints that the scaffold imposes on the cell 
morphology. 
 
4.2.3 Synthesis of Epidermal Lipids in the 3D Scaffold 
Cornified envelopes from 3D cultures were shown to have covalently attached lipids 
and ultrastructure of cells in 3D culture showed organelles such as lamellar bodies 
associated with lipid production and extrusion. As mentioned previously, the lipid 
profile is a useful measurement of the maturity of the epidermal barrier, and is also 
defective in many in vitro equivalents (Ponec et al, 2000). Most investigations into in 
vitro epidermal equivalents have focused on the quality of the dermal equivalent 
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such as the type, number and treatment of various fibroblast feeder cells. These 
experiments have been based on optimising the feedback between keratinocytes and 
fibroblasts in order to improve keratinocyte differentiation. However, when 
keratinocytes are cultured inside the 3D scaffold with no dermal equivalent or feeder 
cells, the main area for optimisation is the culture media itself. It has been shown that 
addition of compounds to the cell culture media can alter the differentiation of 
HaCaT cells (Breiden et al, 2007).  
Therefore, the 3D scaffold model was cultured in various conditions listed in Table 
4.1. The experiments were designed to separate factors influencing differentiation, 
such as the air-liquid interface, serum in the culture media, calcium concentration, 
and two additives shown to alter lipid metabolism. 
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Table 4.1. Culture Media Tested for Modifying 3D Keratinocyte Lipid Synthesis 
Culture 
Media 
Calcium 
(mM)* 
FBS 
(%) 
Ascorbic acid 
(µg/ml)** 
FFA*** 
SF low 0.06 - - - 
SF high 1.50 - - - 
High  0.06 10 - - 
Low 1.50 10 - - 
High AA 1.50 10 100 - 
High FFA 1.50 10 - Yes 
* 0.06mM or 1.5mM Calcium. Calcium concentration has been previously used to 
differentiate keratinocytes. Breiden et al, 2007, found that human keratinocytes 
grown under low calcium conditions synthesise only a simple profile of ceramides, 
including 50% more immature ceramide precursors. Under high calcium conditions, 
ceramide production increased and immature ceramide precursors reduced. 
** 100µg/mL Ascorbic Acid was initially shown to have a photoprotective effect 
against UV-b induced damage in keratinocytes (Miyai et al, 1996) and has since been 
widely used to improve the performance of 3D cultured epidermal equivalents. 
Ponec et al, 1997, showed improved lipid profile and barrier function in a DED-
based 3D model. Pasonen-Seppanen et al, 2001, cultured a rat epidermal keratinocyte 
(REK) model with 40µg/ml ascorbic acid and reported improved morphology of the 
stratum corneum, increase quantity and organisation of lipids in the stratum corneum, 
and improved barrier function (50% reduction of TEWL) in their model.  Uchida et 
al, 2001 demonstrated that ascorbic acid stimulated sphingolipid production, 
increased lamellar body formation and increased omega-hydroxylated ceramides. 
Boyce et al, 2002 showed that cultured epidermal substitutes with ascorbic acid 
showed improved viability and barrier function. 
*** FFA is a mixture of free fatty acids with bovine serum albumin as a carrier for 
fatty acids. This mixture comprises 10µM Linoleic Acid, 25µm palmitic acid, 7µm 
arachidonic acid and 2.4mM BSA, following the protocol of Ponec et al, 2003, who 
demonstrated that supplementation with these lipids increased the lipid synthesis of 
in vitro epidermal cultures, as well as altered the ceramide profile. This cocktail was 
also utilised by El Ghalbzouri et al, 2004 who noted increased differentiation and a 
lipid profile more similar to in vivo epidermis. 
Serum was also considered as a factor, as it is the main source for precursors. 
Therefore low and high calcium serum free cultures were set up as controls. 
4.2.3.1 Viability of 2D Cultured Keratinocytes in Modified Culture Media 
In order to determine the effect of these culture conditions on keratinocytes, a series 
of analyses were performed.  Firstly, cell viability in 2D was assessed using the MTS 
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assay to highlight any culture conditions which lead to detrimental effects on 
viability of the culture such as cell toxicity and death. HaCaT cells were cultured in 
24-well plates for 24 hours, then switched into different culture media as shown in 
Table 4.1. An MTS assay was performed after 6 hours, 2, 4 and 7 days in the culture 
media. The experiment was repeated three times, averaged and the SEM was 
calculated. The results shown in Figure 4.8 indicate that after 6 hours, all treatment 
groups are similarly viable. ANOVA analysis showed that there is no significant 
difference in viability of any treatment group, for instance from cell toxicity. This 
shows that no groups are having an immediate toxic effect on HaCaT cells. 
After 2 days, some small differences in cell viability were noted, with serum free 
conditions displaying lower viability than those containing serum. After 4 days, all 
cultures are more proliferative than after 2 days, as expected and HaCaT cells grown 
in both serum-containing and serum-free low calcium media are utilising 
significantly more MTS reagent than those grown in high calcium. High calcium 
culture media with serum leads to higher viability than serum-free high calcium 
media. However, these differences were slight. Culture media with ascorbic acid was 
not significantly different to other serum containing culture conditions, aside from 
the FFA group which had slightly higher viability. However, variability in viability 
with all treatments is low, with no evidence of toxicity. 
After 7 days, all cultures are more metabolically active than after 4 days, but the 
increase in activity is reduced compared to the increase from 2 to 4 days as the 
cultures have become more confluent. After 7 days, there is no significant difference 
in MTS viability after 7 days between any of the treatment groups. These results 
show that all culture conditions are capable of maintaining cultures of cells, without 
causing toxicity. Some small differences in viability appear between groups after 2-4 
days, but they do not result in any significant differences to the overall cell number 
in the culture after 7 days of culture.  
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Figure 4.8. MTS Assays of HaCaTs Cultured in Various 2D Conditions 
MTS assay of HaCaT cells grown in 2D for 6 hours, 2, 4 and 7 days under various 
culture conditions. Note several changes in y-axis. Error bars show SEM. * = p<0.05, 
** = p<0.01, n/s = not significant. No significant differences observed between 
different culture conditions at 6 hours or 7 days.  
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4.2.3.2 Effect of Culture Media on Keratinocyte Lipid Synthesis in 2D 
In order to examine the effect of each culture condition of the lipid production of 
HaCaT cells, T25 flasks of HaCaT cells were grown for 5 days to approximately 
80% confluence in each media type. Cell number was approximated by counting and 
lipids were then extracted, analysed and quantitated as detailed in Chapter Two. 
Results from three replicate experiments are experiments are expressed as the total 
amount of lipids normalised against cell number and standardised against the low 
calcium, serum free treatment as 100%. 
The results in Figure 4.9 show that calcium concentration is a key determinant in the 
lipid production of HaCaT cells. Under serum free and serum-containing conditions, 
the addition of calcium significantly increases lipid production (p<0.01). This is in 
line with published literature (Breiden et al, 2007). Addition of serum also increases 
the amount of lipid that could be extracted from HaCaT cells under high and low 
calcium conditions (p<0.01). This is to be expected, as the serum itself contains 
lipoproteins, cholesterol, FFA, triglycerides and phospholipids which can act as 
substrates for conversion into cellular lipids. Serum also contains proteins such as 
bovine serum albumin (BSA) which may aid in the transport and uptake of serum 
lipids into the cells (Price & Gregory 1982). 
The addition of ascorbic acid or bovine serum albumin did not increase lipid 
production compared to high calcium and serum alone. This is contrary to published 
data (Pasonen-Seppanen et al, 2001, Breiden et al, 2007), which suggests that lipid 
production should have increased. However, this may be because HaCaT cells are 
limited in their lipid production capability in the 2D environment.   
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Figure 4.9. Lipids Extracted from 2D Cultured HaCaT Cells 
Total lipid amount extracted from HaCaT cells grown in 2D for 5 days compared 
against serum free low calcium conditions and standardised against cell number. 
Error bars show SEM. * = P<0.05, ** = P<0.01, n/s = not significant. SF = serum 
free. High/low Ca
2+
 = 1.15mM/0.06mM, AA = 100µg/ml ascorbic acid, FFA = 
added cocktail of  free fatty acids.  
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4.2.3.3 Identification of Epidermal Lipids by ASAP-MS and TLC 
Quantitation of total lipid production does not reveal the types of lipids produced (i.e. 
FFA, ceramides, cholesterol etc). Therefore the proportion of each lipid was 
measured by separating whole cell lipid extracts on a thin layer chromatography 
(TLC) plate. Lipid extracts from the previous analysis were used and a three phase 
separation was carried out with three different combinations of solvents (as in 
Suhonen et al, 2007), and bands in the lanes of the TLC plate were identified by 
known standards, ASAP-MS and relevant literature. 
Figure 4.10 shows annotated lanes from a TLC plate showing two known standards 
(cholesterol and cholesterol oleate) which were separated on the plate. The RF values 
for these standards were calculated and lined up next to a lane of a whole cell lipid 
extract. Data on RF values from literature (Suhonen et al, 2007) was used to identify 
other lipids. To further verify the identification of lipids, Atmospheric Solids 
Analysis Probe - Mass Spectrometry (ASAP-MS) was used to confirm the identity of 
some bands on the TLC plate.  
Figure 4.11A shows an ASAP-MS scan of a 99.9% pure cholesterol standard which 
was analysed by ASAP-MS in powder form. There is a strong peak at m/z 369.3. A 
structural diagram of the cholesterol molecule is included as a reference. According 
to an ASAP-MS database at the Department of Chemistry, Durham University, this 
value corresponds to cholesterol (personal communication, Dr J. Mosely). When 
identifying the compounds corresponding to the m/z values, predictable changes to 
the molecule, such as loss of an OH group from cholesterol, were taken into account. 
This identification is also supported by m/z values in published literature (Astarita et 
al, 2011 and Piehowski et al, 2008). Figure 4.11 B shows an ASAP-MS scan from a 
sample scraped from the TLC plate at RF 0.65, corresponding to cholesterol. The 
cholesterol molecule is still detected in this scan, albeit with more background peaks 
from the solvents and silica gel coating on the TLC plate. This confirms that the band 
located at RF 0.65 is cholesterol. 
Ceramide NS (Figure 4.12A and B), cholesterol sulphate (Figure 4.12C) and 
cholesterol ester (Figure 4.13) were also subjected to ASAP-MS analysis in order to 
confirm their identifications from the TLC plate. 
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Figure 4.10. Identification of Epidermal Lipids by TLC 
Figure showing thin layer chromatography (TLC) separation of lipids from 3D 
Cultured HaCaT cells, along with cholesterol and cholesterol oleate (a cholesterol 
ester) standards. Other lipids identified by ASAP-MS and published literature 
(Suhonen et al, 2007). Lipid types and RF values are indicated.   
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Figure 4.11. ASAP-MS Analysis of Cholesterol Sample and Standard 
A) ASAP-MS scan of 99.9% pure cholesterol standard. The sample shows a high 
purity with low amounts of background. The strong peak at 369.3 corresponds with  
Durham University internal library data for cholesterol. The cholesterol molecule is 
presented, with the OH group indicated as the likely cleavage site (source: 
manufacturer data sheet for standard molecule); B) 3D cultured HaCaT cell lipid 
extract separated on the TLC plate and a band at RF = 0.65 (corresponding to 
cholesterol) scraped from  the TLC plate and subjected to ASAP-MS analysis. There 
is more “background”, likely from the solvents used in TLC separation, as well as 
the silica gel coating of the TLC plate. However, a peak at 369.3 is still observed. 
Note that the peak at 411.4 present in both samples is the contaminant plasticiser 
Diiooctyl phthalate, found in rubber/plastic tubing of the analyser (source: Durham 
University internal standards).  
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Figure 4.12. ASAP-MS Analysis of Sodium Cholesterol Sulphate and Ceramide 
A) Mass spectra of nonhydroxyceramide (Ceramide NS) band scraped from TLC 
plate. The largest two bands are m/z = 548.5 and 630.3. Both correspond to ceramide 
NS. B) Structure of ceramide NS molecule with molecular mass 649.637; C) Mass 
spectra of sodium cholesterol sulphate (SCS) scraped from TLC plate. The largest 
peak is at 355.1. The structure of SCS molecule is shown with the likely breakage 
point indicated by a dotted line (source: manufacturer data sheet for standard 
molecule).  
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Figure 4.13. ASAP-MS Analysis of Cholesterol Ester (Cholesterol Oleate) 
A) Mass spectra of cholesterol ester band identified by Rf value and scraped from 
TLC plate. The largest band is m/z = 374.1; B) Diagram of the cholesterol oleate 
molecule for reference (source: manufacturer data sheet for standard molecule).  
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Figure 4.12A shows the mass spectra for ceramide NS which was extracted from 
HaCaT cells, separated by TLC, scraped from the TLC plate and analysed by ASAP-
MS. Evenly spaced peaks 16 Da apart (364.4-348.3),(324.3-308.3),(536.5-520.5) are 
from cleavage of the long carbon chains in the molecule. Literature confirms the 
band at m/z = 630.3 (Astarita et al, 2011) and 548.5 (Duh et al, 1992) to both be 
ceramide ions. A small band is visible at 648.6, corresponding to exactly the mW of 
the intact ceramide molecule, minus one hydrogen. This confirms that bands 
identified as ceramide on the TLC plate are indeed ceramides. 
Figure 4.12C shows the ASAP-MS results for sodium cholesterol sulphate. This 
molecule has a mW of 488.7 but is based on a cholesterol molecule of mW 386.6. 
The most likely breakage point for the molecule is the loss of the SO4 group (mW 
96.0) as well as the Na
+
 molecule (23.0), annotated in Figure 4.12C. This leaves 
369.7 - i.e. the m/z for cholesterol, which is detected in a small amount in the shown 
mass spectra. Furthermore Wu-Nan Wu, 2006 confirms that m/z 355.1 corresponds 
to cholesterol sulphate. 
Figure 4.13 shows the mass spectra for cholesterol oleate, a cholesterol ester 
representing 45% of cholesterol esters in adult epidermis (Masahiro and Masao, 
2007, Tachi et al, 2008). The dominant peak is 355.1, which corresponds to 
cholesterol esters (Onorato et al, 2012). The cholesterol ester band on the TLC was 
already confirmed by the RF value for a standard as shown in Figure 4.10. 
In summary, these ASAP-MS results show that the main epidermal lipids cholesterol, 
cholesterol sulphate, cholesterol ester and ceramides have all been identified 
correctly on the TLC plate and verified by a second technique. Using the RF values 
of these known compounds, it is possible to use published literature to identify other 
bands on the TLC plate which fall between the known bands. 
4.2.3.4 Lipid Profile of 2D Cultured Keratinocytes 
Cell lipid extracts from HaCaTs grown in 2D conditions were separated on a TLC 
plate, bands identified by Rf value and each band quantitated by densitometry in 
ImageJ. Results are summarised in Figure 4.14. 
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Figure 4.14. Lipid Profile of HaCaT Cells Cultured in 2D 
Lipid extracts from HaCaTs grown in 2D for 7 days under various conditions. SF = 
serum free. High/low Ca
2+
 = 1.5mM/0.06mM calcium, AA = 100µg/ml ascorbic 
acid, FFA = added mixture of  free fatty acids. CER = ceramides, CHOL = 
cholesterol, FFA = free fatty acids, TG = triglycerides, CE = cholesterol esters, CS = 
cholesterol sulphate, GluCer = glucosylceramides. Error bars show SEM. 
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Lipids isolated from 2D HaCaT cells display an immature lipid profile, as expected. 
Findings are summarised in Table 4.2: 
Table 4.2. Lipid Composition of 2D Cultured Keratinocytes 
Lipid % in 2D cultures 
(lowest-highest) 
% in human epidermis or 
stratum corneum* 
Cholesterol esters 12-22 6-10% 
Cholesterol 16-18 20-25% (30% of SC) 
Triglyceride 16-21 6-12%  
Ceramides 13-18 30-50% (30-50% of SC) 
Free Fatty Acids 10-15 8-20% 
Cholesterol sulphate 3-5 5% (1% of SC) 
Glucosylceramides 10-13 2-3% 
*Data combined from Moghimi et al, 1996, Netzlaff et al, 2005, Pappinen et al, 
2008, Elias et al, 2012. 
Although cholesterol esters are some of the most hydrophobic lipids found in the 
epidermis (Masahiro and Mirao, 2007), 2D cultures produced an increased 
proportion of cholesterol esters which, conversely, is indicative of immature 
epidermis (Netzlaff et al, 2005). Cholesterol content was similar, albeit slightly lower 
than human epidermis in all samples. There was also no significant difference in 
cholesterol proportion between any of the culture groups in 2D, even though high 
calcium and supplemented ascorbic acid and FFA would have all been expected to 
increase cholesterol production. 
Triglyceride production was much higher than human epidermis, which may be 
associated with an immature epidermal barrier or a defect in lipid conversion 
pathways (Demerjian et al, 2006). Cholesterol sulphate (CSO4) levels are similar in 
2D cultures and human epidermis, but both are greater than in human stratum 
corneum. In human epidermis, cholesterol sulphate is mostly located in the granular 
layer, and is only present at low concentrations in the stratum corneum (Lampe et al, 
1983, Masahiro and Masao et al, 2008). This again suggests an immature profile of 
lipids.  
Ceramide is mostly synthesised during later stages of differentiation (Baroni et al, 
2012) and in all 2D cultures, ceramide content was significantly lower than human 
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epidermis or stratum corneum. In the FFA culture condition with added linoleic acid, 
ceramide content was a significantly greater percentage than found in other culture 
conditions, which is in line with findings by Breiden et al, 2007. Glucosylceramides 
were also found in higher concentrations in 2D culture conditions compared to 
human epidermis.  
In summary, cells cultured in 2D display a lipid profile of immature epidermis, 
including a higher proportion of lipid precursors such as glucosylceramides, and 
lower proportion of mature end-products such as ceramides or cholesterol. The 
addition of supplements to the culture media did alter some properties of the lipid 
profile (as well as increasing the total amount of lipid produced (Figure 4.9)), but 
none were able to produce a lipid profile corresponding to mature epidermis. This 
corresponds to data shown previously (Figure 4.7) where HaCaTs are unable to fully 
differentiate in 2D culture. However, they can terminally differentiate and produce 
cornified envelopes when grown in the 3D scaffold.  
4.2.3.5 Effect of Culture Media on Keratinocyte Differentiation in 3D  
The previous experiment was repeated using HaCaT cells cultured in the 3D scaffold 
using methodology described earlier. The 3D environment provides a more 
favourable environment for the differentiation of HaCaT cells by providing a longer 
culture period, a greater number of cells, increased cell-cell communication as well 
as an air-liquid interface which was shown (Figure 3.8) to induce differentiation and 
cornified envelope formation (Figure 4.7).  
The 3D scaffold model is serving two main purposes: firstly for testing compounds 
on the 3D model described so far to better understand their effects, and secondly for 
optimising the current model for lipid synthesis and barrier function. By testing in 
2D and 3D, the effect of the environment on how HaCaT cell differentiation and 
lipid production is altered by culture conditions can be determined. 
Lipids were extracted from 3D cultures by an adaptation of the previous protocol, 
described in the materials and methods chapter. A bar chart showing the total amount 
of lipids isolated after 14 days at the air-liquid interface in Figure 4.15. Separate 
scaffolds from the same treatment groups were also fixed and processed for H&E 
staining (Figure 4.16) and involucrin staining (Figure 4.17) to examine the effect of 
each treatment on cell morphology and differentiation.   
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Figure 4.15. Total Lipids Isolated from 3D Cultures 
Lipids isolated from 3D cultures grown for 14 days at the air-liquid interface. 
Normalised against protein concentration and the total lipid extracted from serum 
free low calcium culture conditions. SF = serum free, High/low Ca2+ = 
1.5mM/0.06mM, AA = 100µg/ml ascorbic acid, FFA = added cocktail of  free fatty 
acids. Error bars show SEM. * = P<0.05, ** = P<0.01, n/s = not significant.  
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Figure 4.16. H&E Images of 3D Cultures in Modified Culture Conditions 
H&E images from HaCaTs grown in 3D scaffold for 14 days at air-liquid interface 
under A) low calcium, serum free; B) high calcium, serum free; C) high calcium 
10% FBS; D) low calcium, 10% FBS; E) As C with 100µg/ml ascorbic acid; F) as C 
with FFA. All cultures appear intact although comparatively few nuclei are observed 
in A and B. Scale bar 100µm for all images.   
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Figure 4.17. Involucrin Immunofluorescence of 3D Cultures in Modified 
Culture Conditions 
Involucrin stained sections from HaCaTs grown in 3D scaffold for 14 days at air-
liquid interface under A) low calcium, serum free; B) high calcium, serum free; C) 
high calcium 10% FBS; D) low calcium, 10% FBS; E) As C with 100µg/ml ascorbic 
acid; F) as C with FFA. Scale bar 100µm for all images.   
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It was found that the pattern of lipid production is similar in 3D compared to 2D, 
although the differences between groups are more pronounced in the 3D environment 
(Figure 4.15).  For example, in 2D the addition of 1.5mM Ca2+ increased lipid 
production by 14%, but in 3D this difference was 28%. In 2D, the addition of serum 
increased lipid content by 22% for low calcium and 21% for high calcium, but in 3D 
the increase was 42% and 46% respectively.  
The addition of serum or high calcium concentration significantly increased the 
amount of lipid produced by HaCaT cells in the 3D cultures. Interestingly, where the 
addition of ascorbic acid or FFA slightly reduced the lipid production of HaCaT cells 
in 2D (compared to high calcium with serum), it increased the lipid production 
significantly in 3D. Compared to high calcium and FBS alone, the addition of 
100µg/ml increased lipid synthesis in the 3D culture by 63% and FFA 
supplementation increased lipid synthesis by 73%. These increases are in line with 
published literature (Uchida et al, 2001, Breiden et al, 2007). 
H&E images (shown in Figure 4.16) from HaCaTs grown in the 3D scaffold under 
these conditions show that all cultures were able to proliferate and fill the scaffold, 
although there are visible differences in the morphology of some culture conditions. 
Due to serum free growth conditions, panels A and B show less visible nuclei and 
more "debris" than images C, D, E or F. Cells in grown in high calcium but serum 
free condition (Figure 4.16B) show sparse flattened nuclei among large amounts of 
non-specific cytoplasmic staining. All scaffold cultures grown with 10% FBS (Figure 
4.16C, D, E and F) show a healthy morphology with no distinctly visible differences 
in appearance. 
In order to quickly approximate the level of differentiation of these cultures, sections 
were stained for the differentiation marker involucrin. Images were taken at the same 
exposure, so that a comparison of expression can be made. These images (Figure 
4.17) show a definite increase in involucrin expression when serum is added to the 
culture conditions. Panels A and B show very little involucrin staining whereas 
images C, D, E and F all show strong staining. Panel C (high calcium with 10% 
serum) staining clearly visible in cell cytoplasm throughout the full thickness of the 
scaffold with generally more staining towards the upper surface of the scaffold. 
Image D shows an interesting pattern of involucrin expression, where comparatively 
less staining is observed throughout the scaffold, and the majority is found on the 
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flattened, air-exposed surface. This is more in line with Involucrin distribution in 
native human epidermis. Image E (100µg/ml ascorbic acid with high calcium) shows 
a involucrin staining throughout the scaffold, although slightly less than in image C 
whereas image F (high calcium, with serum and FFA) shows an largely increased 
amount of involucrin. It is clear from these images that differentiation is occurring, 
and is increased by the presence of 10% FBS, high calcium concentration and free 
fatty acids in the culture media. Due to the lack of stratified layers and nucleated 
corneocytes observed in TEM analysis, the focus of these experiments was on 
increasing keratinocyte differentiation, which conditions C and F in particular have 
appeared to accomplish. However, in hindsight it is probable that this differentiation 
is too accelerated and that culturing the cells for a longer duration at the air-liquid 
interface in low calcium media (condition D) may have been optimal. This is due to 
reduction in the barrier function associated with premature differentiation observed 
in Chapter Five. 
4.2.3.6 Keratinocyte Lipid Synthesis in 3D  
The lipid extracts from 3D cultures were then subjected to separation on TLC plates. 
A sample of mouse back epidermis was also subjected to lipid extraction and 
quantification. Examples of these separations are shown in Figure 4.18. Visual 
comparison of the TLC lanes from HaCaT cells cultured at the air-liquid interface 
(Figure 4.18A) and mouse epidermis (Figure 4.18B) show a strong overall similarity. 
Hexane washing of mouse epidermis was found to reduce the amount of 
contamination from subdermal lipids (primarily triglycerides) as well as sebum and 
wax and allowed clearer separation of epidermal lipids into distinct bands. All major 
lipid classes were observed after hexane washing. 
Lipid profiles for both submerged and air-liquid interface 3D cultures at several time 
points were quantified and expressed as a bar chart, shown in Figure 4.19B. The lipid 
composition of mouse epidermis was also quantified and is shown for comparison.   
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Figure 4.18. TLC Lanes from 3D HaCaT Culture and Mouse Epidermis 
Images showing sample TLC separation of lipids extracted from A) 3D cultured 
HaCaT cells; B) mouse epidermis; C) non hexane-washed mouse epidermis. 
Similarities in the lipid content of 3D cultures and mouse epidermis are evident, 
although the distribution of individual ceramides appears different. 
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Figure 4.19. TLC Analysis of 3D Cultured HaCaT Cells 
Table showing % lipid composition of 3D cultured HaCaT cells after 2, 7 or 14 days 
submerged or 14 days at the air-liquid interface compared to mouse epidermis. It is 
apparent that submerged cultures display a different lipid profile than those cultured 
at the air-liquid interface. 
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After 2 days submerged in the 3D scaffold, (Figure 4.19), the most predominant 
lipids found in HaCaT cells are free fatty acids. In comparison to mouse epidermis 
and HaCaTs grown at the air-liquid interface, the lipid profile of the submerged 
keratinocytes is profoundly different. Submerged cultures show a higher proportion 
of FFA and less cholesterol and ceramides. This is a similar profile to the lipid 
profiles observed in 2D culture shown in Figure 4.14. Interestingly, highly 
hydrophobic cholesterol esters were found in lower proportions in submerged 3D 
cultures than in standard 2D cultures. 
After 7 and 14 days in submerged cultures, the most predominant lipid produced is 
cholesterol (28% and 38% respectively) which is markedly higher than the 
cholesterol content of mouse epidermis. Ceramides in submerged cultures (14% and 
11% after 7 and 14 days respectively) are significantly lower than the proportion in 
mouse epidermis. As mentioned previously, low ceramide content indicates an 
immature epidermal barrier. Earlier data (not shown) showed that between 7 to 14 
days submerged, the total amount of lipid produced by submerged HaCaT cells does 
not change. However, the lipid profile after 7 and 14 days in submerged cultures are 
slightly different overall. Through 2 to 14 days of submerged culture, the proportion 
of FFA in the culture decreases while the proportion of cholesterol increases. 
However, ceramides remain in very low proportions (11-14%) in all submerged 
cultures. 
In contrast, after 14 days of culture at the air-liquid interface, the overall profile is 
significantly different submerged cultures and is much more similar to mouse 
epidermis. In 3D cultures at the air-liquid interface ceramides make up the majority 
(43%) of the epidermal lipids, similar to mouse epidermis (47%) and published data 
for human epidermis (30-50%, Pappinen et al, 2008). This shows that the air-liquid 
interface has a profound effect on the lipid composition of HaCaT cells. Previous 
experiments have shown that HaCaT cells inside the 3D scaffold undergo a small 
amount differentiation when submerged (as determined by involucrin and K1 
staining), but these data show that the air-liquid interface is an important factor in 
lipid production. Even though there are still differences between the 3D cultured 
HaCaT cells and mouse epidermis, the 3D air-liquid interface cultured sample is 
clearly the closest of all the conditions examined. Therefore, both samples were 
expressed side by side in a comparative bar chart, shown in Figure 4.20.  
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Figure 4.20. Lipids of 3D Scaffold Cultures Compared to Mouse Epidermis 
Graph showing % lipid composition of 3D HaCaT culture (14 days air-liquid 
interface) compared to mouse epidermis. Error bars show SEM. * = P<0.05,  n/s = 
not significant.  
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Analysis by t-test in Figure 4.20 shows that significant differences (P<0.05) are 
observed in the proportion of free fatty acids, triglycerides, cholesterol esters and 
cholesterol sulphate. However, cholesterol and ceramides show a statistically similar 
proportion. This shows that HaCaT cells cultured at the air-liquid interface for 14 
days in the 3D scaffold display a mature lipid profile, similar to native epidermis in 
many aspects, aside from the proportion of FFA in the cultured epidermis samples 
are significantly lower than human epidermis (usually 10-15%, Pappinen et al, 
2008). 
4.2.3.7 Effect of Culture Media on Lipid Synthesis in Keratinocytes Cultured 
at the Air-liquid Interface 
3D cultures were then grown in the 6 different culture medias outlined previously in 
Table 4.1. Cultures were grown submerged for two days in standard culture 
conditions, then raised to the air-liquid interface and changed into the above media 
where they were kept for 7 or 14 days. Lipids were extracted, separated by TLC and 
quantitated as previously shown. Results for cells cultured for 7 and 14 days were 
expressed in a series of bar charts shown in Figure 4.21. 
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Figure 4.21. Lipid Composition of 3D Culture HaCaT Cells After 7 and 14 days 
Graphs showing lipid composition of HaCaT cells after A) 7 days at the air-liquid 
interface and B) 14 days at the air-liquid interface in various culture conditions. 
Culture conditions as follows; SF = serum free, Low/Hight Ca
2+
 = 0.06mM/1.5mM 
Ca2+, AA = 100µg/ml ascorbic acid, FFA = free fatty acids. Error bars show SEM.  
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A summary of the results in Figure 4.21 are shown below: 
Table 4.3. Summary of 3D Cultured Keratinocyte Lipid Profiles 
 
Figure 4.21 shows the lipid composition of 3D cultured HaCaT cells after 7 days and 
14 days at the air-liquid interface. The increasing maturity of the epidermal barrier 
with time is apparent - for instance, the lipid composition of the culture comprises 
18-33% ceramide after 7 days, whereas this has increased to 28-40% after 14 days. 
Cholesterol ester content decreases from high levels to physiologically normal levels 
between 7 and 14 days and cholesterol sulphate also decreases in most culture 
conditions. However, the proportion of FFA does not increase with time at the air-
liquid interface, which would have been expected. 
  
Lipid % in 7d ALI 
(lowest-highest) 
% in 14d ALI 
(lowest-highest) 
% in human 
epidermis or 
stratum corneum* 
Cholesterol esters 9-15% 6-11% 6-10% 
Cholesterol 5-15% 12-19% 20-25%  
(30% of SC) 
Triglyceride 10-17% 8-10% 6-12%  
Ceramides 19-33% 28-40% 30-50%  
(30-50% of SC) 
Free Fatty Acids 6-14% 6-8% 8-20% 
Cholesterol sulphate 16-27% 13-30% 5% (1% of SC) 
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Figure 4.22. Lipid Composition of 3D Cultured HaCaT Cells After 7 Days 
Graphs showing percentage lipid composition of HaCaT cells after 7 days at the air-
liquid interface in various culture conditions. The percentage of each lipid is then 
compared separately for each culture condition. Culture conditions as follows; SF – 
serum free, L/H = 0.06mM/1.5mM Ca
2+
, AA = 100µg/ml ascorbic acid, FFA = free 
fatty acids. Note changing y-axis throughout. Error bars show SEM.  
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Figure 4.23. Lipid Composition of 3D Cultured HaCaT Cells After 14 Days 
Graphs showing lipid composition of HaCaT cells after 14 days at the air-liquid 
interface in various culture conditions. The percentage of each lipid is then compared 
separately for each culture condition. Culture conditions as follows; SF = serum free, 
L/H = 0.06mM/1.5mM Ca
2+
, AA = 100µg/ml ascorbic acid, FFA = free fatty acids. 
Note changing y-axis throughout. Error bars show SEM. 
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Lipid extracts from 7 days and 14 days at the air liquid interface are shown in Figure 
4.22 and 4.23 respectively. After 7 days at the air-liquid interface, the addition of 
10% serum to the culture media significantly increases FFA, as expected. Ascorbic 
acid and supplementation with FFA do not have any further effect on the total 
proportion of FFA produced by the cells. Calcium concentration does not appear to 
cause an increase in FFA, as neither the differences between SF-L and SF-H or H 
and L are significantly different to each other after 7 or 14 days at the air-liquid 
interface. 
For cholesterol, no significant differences were observed between treatment groups 
after 7 days apart from the FFA-supplemented culture condition which has 
significantly lower cholesterol content. The reason for this is unknown. After 14 days 
there are no significant differences between treatment groups, including the FFA-
treated cultures. Compared to 7 days, the cholesterol content of the 3D cultures has 
increased as a whole (12-19% at 14 days compared to 5-15% at 7 days). 
For ceramide content, all cultures display a relatively high proportion of ceramide 
after 7 days (19-33%) which is close to native epidermis (30-50%). Again, the 
addition of serum and calcium are key factors in the proportion of ceramide in the 
lipid profile. Both low calcium culture conditions show the lowest percentage of 
ceramide content (19 and 22%) while high calcium culture conditions contain 30-
33% ceramide. After 7 days, the addition of 100µg/ml or FFA to the culture media 
does not further increase the total ceramide content of the 3D culture compared to the 
high calcium only condition. After 14 days, ceramides have increased as a proportion 
of the lipid profile from 7 days (19-33%) to 14 days (28-40%), which is more 
physiologically accurate. The addition of serum makes the largest difference to the 
proportion of ceramides, although supplementation with 100µg/ml ascorbic acid also 
significantly increased ceramides, as predicted (Uchida et al, 2001). 
After 7 days, triglyceride content varies between 10-17% with no significant 
difference between culture conditions, aside from 100µg/ml ascorbic acid which 
increased triglyceride content. After 14 days, no significant differences were 
observed between groups. Compared to 7 days, triglycerides fell slightly, ranging 
from 7.5-10.4% 
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Cholesterol sulphate content is quite high in all cultures after 7 days at the air-liquid 
interface, ranging from 13% to 27%, compared to around 5% in native human 
epidermis. This is interesting, as the addition of serum and/or high calcium makes no 
significant difference to the high proportion of cholesterol sulphate after 7 days at the 
air-liquid interface. However, ascrobic acid and FFA-supplemented culture 
conditions display the lowest cholesterol sulphate proportion. After 14 days, some of 
the treatment groups (high and low calcium with serum) show significantly lower 
cholesterol sulphate proportions than after 7 days, demonstrating increased maturity. 
Ascorbic acid and FFA-treated cultures display a significantly lower level of 
cholesterol sulphate compared to other treatment groups, reduced by almost 50%. 
This may indicate that these cultures are more differentiated, or alternatively the 
conversion of cholesterol sulphate into other derivatives is accelerated.  
Cholesterol esters are also found in a high proportion in some cultures after 7 days at 
the air-liquid interface, ranging from 9-15% (native human epidermis 6-10%). After 
14 days at the air-liquid interface, cholesterol ester content is lower than after 7 days. 
However, in the case of ascorbic acid and FFA-treated cultures, cholesterol ester 
content has slightly increased.  
Overall, all cultures show a lipid profile broadly comparable to mouse epidermis or 
native human tissue. All cultures display a more mature lipid profile after 14 days at 
the air-liquid interface compared to 7 days and differences lipid profile were 
observed in accordance with the culture media composition. Serum and ascorbic acid 
or FFA being the biggest determinants of lipid composition. On the other hand, 
calcium concentration did not appear to be a large determinant of lipid composition 
after 14 days. However, Figure 4.15 showed that high calcium culture conditions 
induce keratinocytes to synthesise more lipids in total, therefore showing that 
calcium is still a factor in keratinocyte lipid production. 
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4.3 Discussion 
4.3.1 Summary of Results 
Results have shown that keratinocytes can be cultured and induced to differentiate at 
the air-liquid interface in the 3D scaffold. Thin Toluidine Blue sections showed 
flattened cells throughout most of the thickness of the scaffold and SEM and TEM 
both confirmed that flattened keratinocytes were present in the 3D cultures. These 
methods also gave insight into the organisation of cells inside the 3D scaffold, 
showing that the keratinocytes are not organised into layers such as in native 
epidermis. Nevertheless, TEM imaging confirmed that most cells contain organelles 
associated with differentiation such as lamellar bodies and keratohyalin granules, and 
desmosomes were also observed throughout the culture, including attaching the 
flattened corneocytes. TEM imaging showed possible cornified envelope formation 
under the cell membranes of flattened, anucleate keratinocytes, and this was 
confirmed by cornified envelope extraction. Nile Red staining demonstrated that 
these cornified envelopes contained covalently attached lipids and that a mixture of 
mature and fragile cornified envelopes were present. An experiment demonstrated 
the importance of the 3D air-liquid interface in cornified envelope formation, as cells 
cultured in 2D did not produce cornified envelopes, even when induced to 
differentiate. 
An investigation was performed to desmonstrate the effect of culture conditions on 
keratinocyte lipid synthesis. Results in 2D showed that keratinocytes cultured in 
serum-containing media or in high (1.5mM) calcium produced more lipids. These 
results were quantified by thin layer chromatography and the identities of lipid bands 
on the plate were confirmed by a mass spectrometry technique. As expected, cells 
cultured in 2D did not produce a physiologically accurate lipid profile in comparison 
to native epidermis, although supplementation of culture media with ascorbic acid 
and FFAs did improve this slightly. 
When cultured in 3D, cells produced a markedly different lipid profile. Cultures 
which were left submerged for 14 days displayed an immature lipid profile, similar 
to 2D cultures, but those cultured at the air-liquid interface displayed a different, and 
more mature, lipid profile. When the culture media was altered, some morphological 
differences in the cultures were apparent and the amount of lipid extracted from cells 
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was dramatically increased, with cells in optimised conditions synthesising almost 
three times as much lipid than those in control conditions. 
In terms of the lipid profile, a general improvement in the physiological accuracy of 
the profile was noted as the culture period extended from 7 to 14 days. In retrospect, 
a longer time period such as 21 or 28 days may have been beneficial. The addition of 
ascorbic acid and FFA to the culture media altered the lipid profile, increasing 
ceramides and reducing cholesterol sulphate. 
4.3.1.1 Ultrastructure and Cornified Envelope Formation 
These results demonstrated that HaCaT cells are capable of reaching terminal 
differentiation inside the 3D scaffold. The flattened corneocytes observed by SEM in 
Figure 4.2 are similar to those observed by SEM in published literature (Mihara, 
1988, Kunii, 2003) although the corneocytes in the 3D cultures appear more variable 
in size and have less smooth surfaces compared to those from human epidermis. 
They also appear less tightly connected, with more visible "stitching" around the 
edges of each corneocyte compared to human skin which shows a more "cobble 
stone" appearance (Naoe et al, 2008). This may be due to processing, such as the 
dehydration and critical point drying procedures carried out before SEM imaging. 
The polystyrene material of the scaffold can become charged (as visible by SEM 
image banding in Figure 4.2B) and so during preparation for SEM, a thicker layer of 
gold is applied during sputter coating which may have altered the surface of the 
sample. 
SEM and TEM imaging also showed the possible presence of occasional nucleated, 
immature corneocytes on some of the air-exposed surface of the 3D cultures. These 
were sporadic but indicate that terminal differentiation is not uniformly complete 
across the whole surface of the culture. These immature, still-nucleated corneocytes 
have been linked by Kunii et al, 2003 to barrier dysfunction, measured by elevated 
transepidermal water loss (TEWL). Kunii et al, 2003 also found that when the 
epidermal barrier is defective from immature corneocytes, the ratio of cholesterol to 
ceramide content of the stratum corneum increases. Interestingly, this pattern of high 
cholesterol and low ceramide is found in a number of in vitro models (Ponec et al, 
2000) although not in the 3D scaffold model as shown in Figure 4.20. 
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Lamellar bodies are characteristic of the stratum granulosum region of the epidermis 
and contribute towards the differentiation process and barrier formation by secretion 
of enzymes, proteins and barrier lipids (Ishida-Yamamoto et al, 2011). Lamellar 
bodies were noted in cells located throughout the 3D scaffold after fourteen days at 
the air-liquid interface, potentially indicating that many cells are in this stage of 
differentiation.  
Some cells contained large number of vacuoles (Figure 4.4). These are a normal 
feature of differentiating epidermis, but excessive lipid vacuoles inside cells, 
particularly inside flattened cells or the stratum corneum, are indicative of a disorder 
of excess triglyceride retention (Ujihara et al, 2010). The overall triglyceride content 
of the 3D cultures was shown in Figure 4.21 to be marginally higher than native 
epidermis, although likely not high enough to indicate a pathogenic-type defect in 
lipid metabolism. TEM imaging only showed vacuoles inside nucleated cells and did 
not show any lipid vacuoles inside flattened corneocytes. 
TEM imaging has been used by researchers to examine the lamellar bilayer 
organisation of the stratum corneum. In organised layers of the stratum corneum 
Warner et al, 2003 showed TEM images of stratum corneum with organised banding 
of lamellar lipids filling intercellular spaces between corneocytes. In TEM images, 
this is observed as alternating bands of electron dense and electron lucid layers. 
However, in the 3D scaffold model, this pattern of organisation was not observed 
because cells differentiate inside the polystyrene structure and do not form these 
layered structures. This is an interesting property of the epidermal equivalent formed 
by the 3D scaffold  - showing that terminal differentiation (evidenced by cornified 
envelope production) can occur even without this layered organisation. It is likely 
that the absence of these organised lipid bilayers may have impact on the epidermal 
barrier function possible with the 3D scaffold. The barrier permeability of these 
cultures will be measured in the following chapter. 
Numerous desmosomes were observed throughout the 3D cultured keratinocytes. 
Desmosomes in native epidermis normally degrade so that desquamation of the 
upper layers of stratum corneum can occur. These degrading desmosomes have been 
observed by Warner et al, 2003 as electron dense "mushy" desmosomes, as opposed 
to those shown in Figure 4.5. Neither desquamation or any desmosome degradation 
was observed in any 3D cultures subjected to TEM analysis. As an observation, more 
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desmosomes were observed in cultures maintained at the air-liquid interface 
compared to those which were submerged (data not shown).  
Hydration of the epidermis is an important factor in barrier function. In particular, 
over-hydration of the stratum corneum causes structural changes in corneocytes, 
accelerated corneodesmosome degradation (Rawlings et al, 1995) and delaminated 
intercellular lamellae (Warner et al, 2003), which is an issue for certain occupations 
and for infants wearing nappies as it may lead to dermatitis. The data shown so far in 
this thesis again highlights the importance in the air-exposed surface and the drying 
of the upper layers of the 3D culture. Submerged cultures are morphologically 
different, show less evidence of differentiation, and produce a completely different 
profile of lipids (Figure 4.19). 
Figure 4.6 and Figure 4.7 showed that cornified envelopes can be extracted from the 
3D cultures to assess barrier maturity (as performed in Nolte et al, 1993, Sevilla et al, 
2007). When compared to those from mouse ear tip epidermis, cornified envelopes 
from the in vitro 3D scaffold model displayed a more immature, fragile morphology 
and less lipid content. Michel et al, 1990 performed tape stripping experiments where 
the cornified layers of the epidermis are removed layer by layer. They found that 
fragile immature cornified envelopes are more prevalent in the deeper layers of the 
stratum corneum, whereas rigid, mature cornified envelopes are found in the outer 
layers of the stratum corneum. This varies by body site with fragile cornified 
envelopes observed more frequently in areas of epidermis with reduced barrier 
function such as the face or lip, compared to areas such as the upper arm which 
contained more mature cornified envelopes. 
By comparing the images from Michel et al, 1990 and Hirao et al, 2001 with those in 
Figure 4.6 and Figure 4.7, an estimate about the maturity of the cornified envelopes 
can be made. Cornified envelopes extracted from 2D cultures (shown in panels A 
and B) appear most similar to those extracted from the 25th stripping (i.e. deep layers 
of the stratum corneum) whereas those from 3D cultures appear most similar to those 
extracted from between the 5th and 15th tape strippings. A similar tape stripping 
experiment with the 3D culture would be interesting but this technique is not possible 
with the 3D scaffold as the cells differentiate inside the rigid scaffold. Therefore the 
cornified envelopes collected from 3D scaffolds represent an average sample from 
the whole 200µm thickness of the scaffold and cannot be attributed to certain layers. 
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It is not clear whether there is any ordered distribution of mature and immature 
cornified envelopes inside the 3D scaffold or whether they are located throughout the 
full thickness of the scaffold.  
The ratio and location of mature and immature cornified envelopes has implications 
in skin conditions. In  psoriasis and keratoderma, immature corneocytes are more 
often found in the outer layers of the stratum corneum and these patients often 
display poor epidermal barrier function in those affected areas (Ishida-Yamamoto A 
et al, 1995). With hindsight, a longer culture time at the air-liquid interface would 
have been interesting to observe further changes in morphology and to determine if 
cornified envelopes became more mature with longer exposure to the air-liquid 
interface. An alternate method of electron microscopy, such as cryo-SEM 
preparation may also have been beneficial to observe any intracellular lipids which 
would likely be removed during the alcohol and solvent-based preparation 
techniques used for standard SEM. 
4.3.1.2 Lipid Synthesis in 2D Cultures 
Overall, 2D cultures produced a lipid profile which is not representative of native 
epidermis. The addition of serum, high calcium, ascorbic acid or FFA made some 
differences to the total amount of lipid produced, as well as the overall profile. 
However, these changes were minimal and no 2D cultures showed a mature lipid 
profile comparable to 3D-cultured keratinocytes, mouse epidermis or published data 
concerning human epidermis. This shows that the 3D environment is critical for 
keratinocyte production of epidermal barrier lipids. 
Low cholesterol content in 2D culture may be because cells in 2D are limited in their 
production of cholesterol such as the activity of the HMG-CoA reductase enzyme 
(Harris et al, 2000). HMG-CoA reductase is also inhibited by high CSO4 levels, 
which were found in all of the 2D culture conditions. Alternatively, cells in 2D may 
simply be producing very little cholesterol in the form of a barrier lipid, with the 
cholesterol in this analysis being mainly from cell membranes. As shown in Figure 
4.7, keratinocytes cultured in 2D do not terminally differentiate to produce mature 
cornified envelopes and so a mature lipid profile with a high percentage of ceramides 
would be unexpected. 
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Glucosylceramides are polar lipids found inside lamellar bodies, but after extrusion 
they are converted into ceramides by cleavage of the polar head (Pappinen et al, 
2003, Masahiro and Masao, 2007). The glucosylceramide to ceramide ratio is an 
indicator of barrier function (Chan et al, 2011) with high glucosylceramide content 
indicating immature epidermal barrier function. All 2D cultures showed higher than 
normal glucosylceramide levels, again indicating immaturity of lipid synthesis. 
 
4.3.1.3 Lipid Synthesis in 3D Cultures 
Table 4.4. Summary of 3D Culture and Mouse Epidermis Lipid Composition 
Lipid  3D 2d sub  3D 7d sub  3D 14d sub  3D  14d 
ALI** 
Mouse 
Epidermis  
FFA  29  18  11  6  9  
CHOL  15  28  38  17  19  
CER  13  14  11  43  47  
TRIG  13  10  12  10  9  
CS  11  6  4  4  7  
CE  6  13  14  12  9  
Others*  13  11  7  8  -  
* Including glucosylceramides, lanosterol and phospholipids 
** ALI = air-liquid interface 
 
Overall, the lipids extracted from 3D cultures are more physiologically accurate than 
those extracted from 2D-cultured keratinocytes. Table 4.4 also shows that the air-
liquid interface is was key factor in differentiation as submerged 3D cultures were 
shown to produce significantly more cholesterol but less ceramide than those at the 
air liquid interface. 
The results in this chapter showed that supplementing the culture media with serum, 
high calcium, ascorbic acid or FFA can alter the lipid profile produced by 
keratinocytes. This is immediately obvious in the total amount of lipid extracted from 
cultures (Figure 4.15) but also in the proportions of each synthesised lipid. While 
keratinocytes can independently synthesise some barrier lipids, they are still 
dependent on precursors from the diet, supplied by serum, particularly essential fatty 
acids. After 14 days of culture at the air-liquid interface, serum free cultures (Figure 
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4.21) showed a less mature profile than their serum containing counterparts. 
Noticeably, the addition of high calcium concentration to serum free culture 
conditions did not significantly alter the overall lipid composition. This shows that 
even when cells are actively induced to differentiate by high extracellular calcium 
concentration, they are unable to form a mature lipid profile. Particularly noticeable 
are the lower levels of ceramides in comparison other cultures, as well as 
significantly elevated cholesterol sulphate content, highly indicative of an under-
developed epidermal barrier (Elias et al, 2012). 
With regard to calcium concentration, results shown in Figure 4.15 showed that the 
total amount of lipid produced by high calcium conditions was significantly larger 
than by low calcium conditions after 14 days. Results in Figure 4.21 show that after 7 
days, high calcium concentration alters the lipid profile by increasing ceramide 
production. However, after 14 days the differences in lipid composition between high 
and low calcium conditions were only slight, with high calcium conditions showing a 
marginally more mature profile. This indicates that the air-liquid interface alone is 
sufficient to induce keratinocytes to produce barrier lipids. However, under high 
calcium conditions, the cells produced more lipids in total. Analysis of ceramide 
production by keratinocytes (Breiden et al, 2007) showed that in low calcium 
concentrations, keratinocytes can only synthesise some of the normal epidermal 
ceramides. However, the data shown previously in this chapter only addresses the 
total proportion of ceramides, and not the presence or absence of each individual 
ceramide found in human epidermis (12 in total, according to van Smeden et al, 
2011). 
These results showed that ascorbic acid and FFAs altered the lipid profile of 3D 
cultured keratinocytes in line with a more mature epidermal lipid profile. For 
instance, 3D cultures supplemented with ascorbic acid displayed the highest 
ceramide and cholesterol content, which were also the most physiologically accurate. 
This is in line with findings by Uchida et al, 2001. The 3D scaffold cultures treated 
with ascorbic acid also displayed the most physiologically accurate cholesterol 
sulphate content. However, ascorbic acid treated cultures displayed a significantly 
higher proportion of cholesterol esters than native epidermis.  
All 3D scaffold cultures still displayed a relatively low proportion of free fatty acids 
in comparison to published data for human epidermis (Pappinen et al, 2008). There 
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were also no significant differences in FFA proportion between treatment groups 
after 14 days. This suggests that there may be a limitation of HaCaT cells' ability to 
produce FFA (for instance if cells are utilising glucose in the culture media for ATP 
production rather than FFA synthesis). Alternatively, despite FFA supplementation 
(linoleic acid, arachadonic acid and palmitic acid) and fetal bovine serum in the 
culture media, the culture media may not contain all precursors for adequate FFA 
synthesis. 
In human epidermis, cholesterol sulphate is found in very low concentrations in 
stratum corneum in comparison to the rest of the epidermis. This indicates that the 
cultures with lower cholesterol sulphate content can be classified as more mature 
than those with higher cholesterol sulphate content. As mentioned previously, a high 
proportion of cholesterol sulphate in native epidermis is indicative of an immature 
epidermal barrier (Elias et al, 1984). Cholesterol sulphate is found predominantly in 
the granular layers of human epidermis (Higashi et al, 2004), and so the high 
proportion observed in these 3D cultures may indicate that many cells are in 
approximately this phase of differentiation. All 3D cultures showed higher than 
physiological levels of cholesterol sulphate, although the ascorbic acid and FFA-
supplemented culture conditions showed much lower levels which were closer to 
physiologically accurate. 
Linking these lipid profiles to involucrin staining (shown in Figure 4.17) shows that 
there is some link between a 3D culture with stronger involucrin staining and a more 
mature lipid profile, but this is not absolute. For example, under low calcium, serum 
free conditions the culture shows very little involucrin staining and has a 
correspondingly immature lipid profile with a high percentage of cholesterol sulphate 
as well as low cholesterol and low ceramide percentages. However, the "high Ca
2+ 
FFA cultures showed very strong involucrin staining present throughout the entire 
scaffold but a lipid profile which was no more mature than other, lesser staining, 
cultures such as "high Ca
2+
" or "high Ca
2+
 AA" which contained ascorbic acid.  
With hindsight, it is possible that the cultures utilising ascorbic acid and the FFA 
cocktail may be over-differentiated, i.e. differentiated too quickly in an uncontrolled 
manner. The focus for most of the experiments in this thesis were based on 
increasing the amount of differentiation, as well as the rate, with the assumption that 
the barrier properties of the 3D cultures would be improved by more differentiation. 
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This was because previous results have shown that cornified envelopes were less 
mature than those from native epidermis, some flattened cells still contained nuclei 
and that there were only 2-3 layers of flattened cells on the surface of the culture - all 
indicating incomplete differentiation. Therefore experimentation focused on 
increasing the differentiation of the cultures. However, the results shown in Chapter 
Five support the idea that differentiating keratinocytes too quickly may result in 
reducing barrier function, even though markers such as involucrin and the amount of 
epidermal barrier lipids produced rise. 
4.3.2 Factors Affecting Lipid Synthesis in the 3D Scaffold 
Lipid synthesis and metabolism is clearly essential for proper epidermal barrier 
formation and this complex process of epidermal barrier assembly is overviewed in 
the Introduction Chapter of this thesis. Experiments in this chapter have shown that 
the profile of lipids produced by keratinocytes is dependent on many factors such as 
the availability of precursors (i.e. culture media with serum), calcium concentration 
and the drying caused by the air-exposed upper surface. These conclusions are in line 
with information gained in animal models or human studies - for instance, dietary 
sphingolipid intake (and thus provision of raw materials for lipid synthesis) affects 
skin barrier function (Duan et al, 2012), and exposure of the skin water causes 
increased epidermal barrier permeability (Warner et al, 2003). 
Investigations in this chapter showed that 3D cultures produce an overall profile of 
barrier lipids which are approximately physiologically accurate to native human 
epidermis. It is worth noting that the relatively wide-ranging reference figures used 
for "native epidermis" (i.e. ceramide content of 30-50% or FFA of 8-20%) is due to 
large variation in human samples. These are due to several factors which may 
include age, gender, race, geographical location, body sampling site and more - 
although many of these factors are still not fully understood (Darlenski et al, 2012). 
Even the time of day may affect the composition of epidermis, as evidenced by Le 
Fur et al, 2001. 
Optimised 3D cultures showed a lipid composition comprising almost 50% ceramide 
in total. This high proportion of ceramide is associated with the final stages of 
epidermal differentiation, as the ceramide content in the basal, spinous and granular 
layers of human epidermis is very low (Baroni et al, 2012). However, the results in 
this chapter do not show the proportion of each type of ceramide present in the 3D 
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culture. Native human epidermis contains 12 major classes of ceramide in the 
stratum corneum, varying by sphingoid base and attached fatty acid chains (van 
Smeden et al, 2011). Some types of ceramide are more important to barrier function 
than others - for example, in mice the depletion of ELOVL4, which elongates fatty 
acids, results in a lack ω-hydroxy very long chain fatty acid ceramides. Mice with 
this knockout show a delayed epidermal maturity, an abnormally structured stratum 
corneum and die within 24 hours from dehydration caused by epidermal barrier 
failure (Li et al, 2007).  
It is clear that the ratio of different epidermal ceramides is critical for barrier 
function. Therefore, in artificial epidermal equivalents, much effort has been devoted 
towards analysing the subtypes of ceramide present in the epidermis and stratum 
corneum. A study by Ponec et al, 2000 examined 8 epidermal ceramides in three 
commercial in vitro epidermal equivalents and found their percentage distribution to 
be inaccurate when compared to native epidermis (i.e. ceramide 2 comprised 42-55% 
of all ceramides in epidermal equivalents but only 25% of native epidermis, and 
ceramide 5 comprised 3-9% of equivalents but 21% of human epidermis).  
Over time, improvements have been made to the ceramide profile of in vitro 
equivalents. In 2003, Ponec et al demonstrated that supplementation with linoleic 
acid, palmitic acid, arachadonic acid increased keratinocyte lipid production, and the 
physiological accuracy, of the proportions of each ceramide subtype produced by an 
in vitro equivalent. Therefore, this methodology was adopted for the "FFA" group 
shown in this chapter. Furthermore, Breiden et al, 2007 found that addition of 10µM 
linoleic acid to culture media, in combination with high calcium, resulted in a 
twofold increase in ceramide concentration, but also an increase in covalently bound 
ceramides and  ω-hydroxylated fatty acids. Linoleic acid has dual functions as an 
agonist and transcription factor for PPAR-alpha and also as a substrate for ceramide 
biosynthesis in keratinocytes. PPAR-alpha regulates the synthesis of lipids including 
ceramides, FFAs, cholesterol and cholesterol esters, all of which play important roles 
in epidermal barrier function (Elias et al, 2012). 
Pappinen et al, 2008 performed an in-depth comparison of ceramide subtypes from 
an in vitro model based on rat keratinocytes and compared them to human epidermis. 
They found that some ceramides were different or entirely absent from the in vitro 
cultures, in particular the important ω-linked acyl chains in hydroxyceramides 
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(acylCer) were altered. They showed that 10-20% of acylCer were in the linoleate 
form in the in-vitro model, compared to 80% in human epidermis. They hypothesised 
that this is likely due to the nature of in vitro models utilising serum as a nutrition 
source to supply essential fatty acids. For instance, calf serum contains only low 
levels of linoleic acid, hence part of the rationale behind supplementation of the 
culture media with free fatty acids, including 10µm linoleic acid. 
All 3D cultures presented in this chapter showed a lower proportion of free fatty acid 
content (8% on average) compared to native epidermis (15-20%). Even those 
cultures with supplemented ascorbic acid or free fatty acids, which included linoleic 
acid, contained only 8% FFA. Interestingly, this pattern of low FFA content is found 
across many in vitro epidermis equivalents (Pappinen et al, 2012).  
4.3.3 Future/potential Work into Lipid Analysis 
As the 3D scaffold model does not form clear separation into distinctive epidermal 
layers, it would be interesting to assess the locations of various lipids throughout the 
3D scaffold. For instance, precursor glucosylceramides are normally located inside 
lamellar bodies of the granular layer and are not found in the stratum corneum, 
whereas the end-product ceramides are located in extracellular spaces of the stratum 
corneum (Vielhaber et al, 2001). Similar analysis of the 3D scaffold cultures using 
immunogold labelled TEM would be interesting - namely to determine whether 
intercellular spaces are filled with ceramide and whether lamellar body packaging 
and secretion is fully functional in the 3D model. 
As mentioned previously, the ceramide subtypes were not analysed in the previous 
experiments. As the data showed a high proportion of ceramide content (up to 43%) 
in the 3D cultures, it would be worth investigating the exact composition of these 
ceramides. This can be done by liquid chromatography combined with ESI-MS, as 
detailed in Pappinen et al, 2008. 
The TLC protocol utilised in the previous chapter was chosen for clear separation of 
the essential barrier components of the epidermis - namely ceramides, FFA and 
cholesterol. However, not every epidermal lipid can be separated by the same solvent 
separation. For instance, lanosterol is a cholesterol precursor which is not detected by 
the TLC method used in this chapter. Lanosterol is present in low amounts in native 
human epidermis, and also in 3D cultures (Ponec et al, 2000) and high lanosterol 
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content can an immature barrier function due to anomalies in cholesterol processing. 
In the 3D cultures presented in this chapter, most showed a relatively normal 
proportion of cholesterol, suggesting that lanosterol is unlikely to be found in 
significant concentrations. However, if needed, different TLC development protocols 
could be used to determine the lanosterol to cholesterol ratio as a measure of lipid 
profile maturity. 
There are a number of other cell culture additives and pharmaceutical agents which 
have been shown to affect epidermal lipid composition. In this project, most 
experiments were based on optimising the culture conditions for physiologically 
accurate results. However, purposefully disrupting keratinocyte differentiation or 
interfering with lipid production would be viable avenues for research. Researching 
the effects of exposure to irritants is a common use for in vitro epidermal 
equivalents. Surfactants such as SLS (found in most soaps and shampoos) have long 
been recognised as damaging to epidermal barrier function (Wilhelm et al, 1993) in 
terms of removing lipids, neutralising pH and changing stratum corneum hydration. 
Surfactants have been more recently found to induce changes to ceramide and FFA 
biosynthesis, as well as causing rearrangement of stratum corneum lipid lamellae 
(Torma and Berne, 2007). After damage by surfactants, the epidermal barrier 
undergoes repair (de Koning et al, 2012), and this response can be measured. These 
experiments could be carried out on 3D cultures and cultures analysed at various 
time points to assess barrier repair. Following on from this, cultures could be formed 
from cells with ablated proteins related to barrier repair such as transglutaminase, 
and the ability of cultures to re-form normal cornified envelopes after barrier 
disruption could be measured. 
It is possible to measure the effect of a compound on lipid biosynthesis by provision 
of radiolabelled essential fatty acids or precursors, then measuring the radioisotope 
incorporation into each lipid fraction after a given amount of time (Uchida et al, 
2010). This could be used to highlight the source of precursors involved in 
keratinocyte lipid synthesis. 
Epidermal models have typically not been assessed for natural moisturising factor 
(NMF) production or the pH gradient found in native epidermis. This is due to the 
difficulties of creating and maintaining such a gradient under culture conditions - for 
instance, most culture media contains buffers so that cellular metabolism and CO2 
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production will not create an acidic pH. The epidermis has a pH gradient which is 
contributed towards by many factors which are not replicable in vitro, such as sweat 
and the secretions of native microorganisms such as Staphlococcus epidermidis 
(Baroni et al, 2012). However, the acidity of the stratum corneum is a key factor in 
barrier permeability and is worth investigating.  
4.3.4 Implications of Culture Media Supplementation 
Shapiro et al, 1978 first understood X-linked Ichythosis caused by steroid sulphatase 
deficiency, showing that disorders in epidermal lipid metabolism are responsible for 
skin disorders and Elias, 1983 noted a disproportionate number of skin conditions 
associated with cholesterol metabolites. Culture experiments have shown that 
changing the conditions in which epidermal-equivalents are grown can alter their 
barrier properties. This has clear routes into potential therapeutic uses, particularly in 
disorders associated with a lack of certain lipid classes in the epidermis.  
Therefore, researchers in the field have proposed lipids or pharmacological agents 
targeting lipid biosynthesis as a therapy for skin disorders - both in terms of dietary 
input (Belury et al, 2007, Duan et al, 2012) and the direct application of  such agents 
to the skin surface. For instance, sphingolipids or their derivatives have also been 
shown experimentally to promote keratinocyte differentiation and may be used 
therapeutically to correct skin barrier defects in conditions such as psoriasis or atopic 
dermatitis (Paragh et al, 2008). Linoleic acid precursors have been applied to the 
epidermis in a cream to increase lipid metabolism and content of the epidermis 
(Raufast et al, 2010), and application of cholesterol directly to the skin surface has 
been used to restore barrier function in ichthyoses due to defects in lipid metabolism 
(Paller et al, 2011). 
By better understanding the pathways of epidermal lipid metabolism, as well as 
feedback mechanisms, disorders can be targeted by providing raw materials for 
enzymatic conversion, using enzyme inhibitors to block degradation of target lipids, 
and to direct the lipid profile in the intended direction. Again, 3D models can aid in 
the understanding of the factors affecting lipid production and barrier formation, and 
may also be used as a substrate for testing the effect topical compounds. Ironically, 
one of the issues with topical treatment of skin disorders is the epidermal barrier 
itself which blocks many potentially therapeutic agents. 3D models can also aid in 
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this area by carrying out preliminary assessment of the permeability of 
pharmacological agents before moving onto animal or human studies. 
4.3.5 Findings from 2D and 3D Culture Conditions 
Results from 2D and 3D analysis did not always correlate. Figure 4.7 shows that 
HaCaT keratinocytes could not synthesise cornified envelopes under 2D culture 
conditions, even when differentiated with high calcium. In a comparison of lipid 
production, the differences between culture conditions were greater when cells were 
cultured in 3D vs 2D, for example, high calcium increased lipid production by 13% 
in 2D but by 28% in 3D. Conversely, the addition of 100µg/ml ascorbic acid 
increased lipid production by 63% in 3D but resulted in a slight decrease in 2D. In 
terms of lipid composition, 2D cultured and 3D cultured cells were completely 
different, likely because 2D cultured cells are always cultured submerged, rather than 
subjected to drying at the air-interface. However, even submerged 3D cultures 
produced a lipid profile which was different to 2D cultures (although different to 
those at the 3D air-liquid interface), suggesting that the 3D environment itself is a 
factor. It is known that cells cultured in 3D are more metabolically active and also 
more functional than their 2D-cultured counterparts. For instance, liver HepG2 cells 
produce more albumin (Bokhari et al, 2008) and more cP450 activity (Schutte et al, 
2011) when cultured in 3D than in 2D. It is likely that keratinocytes follow a similar 
behaviour and modify their protein and lipid production in accordance with the 3D 
environment, particularly when combined with an air-liquid interface which induces 
differentiation. These results highlight the importance of the culture conditions and 
show that results achieved using 2D cell culture may benefit from further 
investigation in 3D. 
4.3.6 The 3D Scaffold for Barrier Function Testing  
Keratinocytes cultured in the 3D scaffold differentiated and produced barrier proteins 
and barrier lipids. Therefore the next step for investigation is to assess the barrier 
function of the 3D scaffold cultures. The results in this chapter have also shown that 
the 3D model could be used to test the effects of pharmaceutical agents. Therefore 
the following chapter will address these issues.  
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Functional Testing of the 3D Epidermal Model 
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5.1 Introduction 
5.1.1.1 Aims, Objectives and Overview 
Results from the previous chapters have shown that keratinocytes form flattened 
cornified envelopes with covalently attached lipids, and synthesised lipids in a 
profile similar to native epidermis. Optimisation of the culture conditions by addition 
of ascorbic acid and a cocktail of free fatty acids was able to further modify the lipid 
profile to a more physiologically accurate composition. 
This chapter will focus on assessing the permeability of the 3D scaffold epidermal 
model to a known permeant compound. Secondly, Inhibition of JNK signalling 
pathways by SP600125, a compound known to affect keratinocyte differentiation, 
will be tested in 3D conditions and compared against 2D findings. The 3D model 
will then be used to assess the permeability of cultures which have been treated with 
SP600125 and the lipid analysis will be correlated with these findings. 
5.1.2 Barrier Permeability Assays 
The next step for the development of this model is to test the permeability of the 
culture to relevant compounds. This is an important measurement in several 
industries - namely the medical, pharmaceutical and cosmetic fields. Researchers can 
use permeability measurements to understand how disorders (such as psoriasis and 
dermatitis) or disruption (by chemicals, burns or pathogens) affect barrier 
permeability. Transdermal medicines are a popular method of drug delivery, as they 
are non-invasive, can deliver a dosage of drug continuously and bypass first pass 
liver metabolism (Godin et al, 2007, Trovatti et al, 2012). For example, smoking 
replacement patches deliver nicotine continuously to stave off cravings over 
extended periods of time, and Fentanyl patches deliver continuous pain relief (BNF 
vol 63). Data concerning the permeability of these active agents through the 
epidermis is essential in order to calculate the formulation of the medicine, the 
concentration of active ingredients and patient dosage instructions. Some drugs or 
cosmetics such as moisturisers are designed to act directly on the epidermis itself, 
and so passage through into the dermis and systemic circulation is to be avoided. 
Whereas, other compounds are designed for systemic release and need to pass 
through the epidermal barrier and into the circulatory system in order to take effect. 
There are also factors affecting barrier function such as hydration and moisturisation, 
which have implications for therapeutics. For instance, application of a Fentanyl skin 
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patch is contraindicated following bathing, due to increased skin absorption (BNF, 
Vol 63). Therefore, understanding the permeability of compounds through the 
epidermis and mechanisms of barrier function which affect absorption are essential. 
Commercial skin models and in vitro epidermal equivalents typically have barrier 
function which is inferior to in vivo epidermis. For instance, Suhonen et al, 2003 
carried out extensive analysis of their rat epidermal keratinocyte (REK) model by 
analysing the permeation of 18 lipid soluble and water soluble compounds. Their 
model produced an artificial epidermis with morphological similarity to real human 
epidermis, including several layers of differentiated keratinocytes, expression of 
differentiation markers and a thick stratum corneum. However, in the analysis of 
permeability, their model was 0.3 - 5.2x more permeable than human cadaver 
epidermis. These results were actually favourable when compared to many other 
commercial models which displayed permeabilities of tens to hundreds of times 
higher than in vivo epidermis (Perkins et al, 1999, Schmook et al, 2001). This limits 
the usefulness of in vitro epidermal equivalents for permeability assessments.  
There are two established standard methods for assessing epidermal barrier 
permeability. These are transepidermal water loss (TEWL) (Grubauer et al, 1987, 
Barel et al, 1995) and diffusion cell analysis (Larese et al, 2009, Trovatti et al, 2012). 
5.1.2.1 Transepithelial Water Loss (TEWL) 
TEWL analysis is a non-invasive technique which measures the water retention 
capacity of the skin. Transepidermal evaporation occurs because a water 
concentration gradient exists from the deep layers of the epidermis, through the 
stratum corneum and into the air (Barel et al, 1995). Damaged or disrupted skin is 
less efficient in retaining water content than healthy skin, and so evaporation through 
the epidermis is increased (Grubauer et al, 1987). In contrast, skin treated with 
moisturisers displays decreased transepidermal evaporation (de Paépe et al 2001). 
TEWL is typically performed on the skin surface of live subjects, although it can be 
used with epidermal equivalents (Kuntsche et al, 2008). Evaporation is measured by 
placing an evaporimeter with a humidity sensor in a closed or ventilated capsule 
against the skin. In the closed system, vapour loss is collected into a capsule and 
continues until the humidity reaches 100% and evaporation ceases. A curve of 
evaporation is plotted and the epidermal permeability is calculated. In the ventilated 
system, the chamber against the skin is supplied with a gas of known humidity. The 
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gas is continuously ventilated as skin evaporation occurs to maintain a constant 
humidity. The rate of gas ventilation allows for continuous measurement of 
transepidermal evaporation over longer periods of time (Sotoodian et al, 2012).  
The TEWL technique may be affected by ambient temperature, humidity, airflow of 
the room, and even the light sources in the room (Sotoodian et al, 2012) and requires 
the use of specialist evaporimeters such as the Tewameter (GmBH, Germany) or 
DermaLab (Cortex Technology, Denmark) systems. 
5.1.2.2 Diffusion Assays 
Diffusion assays are used to directly measure the permeability of known compounds 
through a barrier. Samples of epidermis, stratum corneum, full thickness skin, 
epidermal-equivalents or any other form of barrier are tightly sandwiched between 
two glass or plastic chambers which are each filled with a solution. Permeability 
assays can be performed in a vertical Franz chamber (Gabbanini et al, 2009) or a 
side-by-side chamber with continuous stirring of both sides (Suhonen et al, 2003). 
The choice of chamber type does not make a difference to the final permeability 
curve generated (Schreiber et al, 2005). All reactions should be carried out at 34-
37°C to maintain the living cells in the culture. One chamber is "spiked" with a 
permeant that can be measured as it diffuses across the barrier in accordance with the 
concentration gradient and the resistance posed by the sample. Samples are taken 
from both sides of the apparatus to preserve the volume gradient and the increasing 
concentration of the permeant in the recipient chamber is measured. The rate of 
diffusion and the time taken for equilibrium to be reached relate to the barrier 
permeability of the sample to that particular molecule. The diffusion cell is also an 
approved mechanism for testing the permeation of compounds through in vitro 
models according to the OECD (Series On Testing And Assessment, Number 28, 
ENV/JM/Mono,(2004)2). 
Clearly, diffusion assays are invasive methods as the analysis requires the epidermis 
to be removed before it is placed into the chamber. Therefore permeability assays are 
usually performed on human cadaver skin, excised animal samples (commonly 
murine or porcine) or on in vitro equivalents. Diffusion assays have been used for 
testing the epidermal permeability of compounds such as cosmetic additives such as 
menthol, camphor etc (Gabbanini et al, 2009) or even solid nanoparticle penetration 
(Larese et al, 2009).  
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A diffusion assay reveals more about the properties of the sample epidermis because 
it directly tests particular compounds against the barrier. Increased TEWL may 
indicate a barrier defect in general, but a diffusion assay will show more information, 
such as whether the epidermis is more permeable to lipid-soluble or water-soluble 
compounds. With some permeants, for instance the silver nanoparticles mentioned 
previously (Larese et al, 2009), samples can then be fixed and stained or imaged by 
TEM to determine where the permeant was blocked by the barrier. 
In this thesis, a permeability assay was established using a side-by-side diffusion cell 
(PermeGear, USA) shown in Figure 2.7. This assay was used to assess the barrier 
permeability of the 3D epidermal model which was described in detail during 
Chapter Four. The permeability co-efficient of each variation in the 3D model was 
calculated and these were compared to each other. Calculated permeability co-
efficients were also compared to published literature for other epidermal models and 
measurements of human skin. 
5.1.2.3 Corticosterone Permeability Assay 
Typically, permeability studies have used radiolabelled molecules as permeants, and 
measure diffusion into the recipient chamber by scintillation counters. However, for 
work in this thesis, radioactive isotopes were avoided for cost, safety and simplicity 
reasons. The assays presented in this chapter utilised corticosterone as a permeant 
molecule. Corticosterone is a steroid hormone produced in the adrenal glands, 
synthesised in vivo by conversion from cholesterol. Therefore it is lipid-soluble and 
structurally similar to other steroid hormones such as testosterone, progesterone and 
estradiol, which have therapeutic uses as transdermal treatments (Kuntsche et al, 
2008). Corticosterone permeability has been used in several previous studies and is 
well established as a measurement of epidermal barrier function (Pasonen-Seppanen 
et al, 2001
2
,
  
Chantasart et al, 2007, Kuntsche et al, 2008, Ibrahim et al, 2009). 
 
5.1.3 The Role of JNK Signalling Pathway in Epidermal 
Differentiation 
One purpose for in vitro epidermal models is to carry out basic research on epidermal 
differentiation and to test the effect of novel compounds on epidermal cell biology 
and barrier function. One such compound is SP600125 (Calbiochem/Sigma, UK) a 
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selective Jun N-terminal Kinase (JNK) inhibitor compound (Bennett et al, 2001) 
which has been shown in 2D cultures (Gazel et al, 2006) to reduce proliferation and 
promote differentiation of keratinocytes.  
JNK is normally inactive in healthy epidermis but shows constant low-level activity 
in cultured keratinocytes, whereas keratinocytes in tissue culture conditions have 
signalling pathways which more resemble an "activated" psoriatic or wound-healing 
state, rather than the basal epidermal keratinocytes under normal conditions 
(Freedburg et al, 2001). When exposed to stress via UV irradiation, JNK activity in 
cultured keratinocytes is further activated (Adachi et al, 2004). In mice, JNK 
inhibition by SP600125 has been used to reduce epidermal hyperplasia (Zhang et al, 
2004) and JNK(-/-) mice showed a reduction in proliferative cells in the basal 
epidermis (Weston et al, 2004). It could be speculated that downregulation of stress-
signalling pathways by JNK inhibition could be therapeutically applied in cases of 
hyperproliferation. 
JNKs are responsible for serine phosphorylation of c-Jun and ATF-2, which 
participate in the AP-1 complex which subsequently induced expression of proteins 
such as involucrin, loricrin and transglutaminases (Bikle et al, 2004, Miodovnik et al, 
2012). JNKs may also play a role in preventing the degradation of c-Jun ATF-2 and 
p53 by phosphorylating them (Sabapathy and Wagner, 2004). Phosphorylation of c-
Jun is known to be important in inflammation and proliferation, as fibroblasts 
cultured from transgenic Jun(-/-) mice showed that c-Jun is essential for G1-S phase 
cell cycle transition (Behrens et al, 1999). There are three JNKs, with JNK1 and 2 
expressed ubiquitously with four different splice isoforms each, and JNK3 mainly 
isolated to the brain. JNK1 is mostly involved with phosphorylation of c-Jun whereas 
JNK2 is primarily concerned with preventing c-Jun degradation and displays 25 
times higher affinity for c-Jun, compared to JNK1 (Sabapathy and Wagner, 2004). 
In the epidermis, evidence suggests that JNK is involved in the balance between 
proliferation and differentiation. JNK1 or JNK2-deficient mice display delayed 
epidermal development and deficiencies in both proliferation and differentiation. 
Epidermis of JNK(-/-) mice showed a lack of keratohyalin granules and reduced 
loricrin expression, and a reduction in the proliferating cells of the basal epidermis 
(Weston et al, 2004). JNK signalling is also implicated in transformation of 
epidermal cells in squamous cell carcinoma (Hengning et al, 2010). 
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Importantly, inhibition of the JNK pathway induces keratinocyte differentiation 
independently of calcium-initiated differentiation (Schmidt et al, 2000).  High 
calcium concentration has been used throughout this thesis to induce keratinocyte 
differentiation and will be combined with SP600125 in this chapter. 
Gazel et al, 2006 found that SP600125 reduced proliferation of cultured 
keratinocytes, induced stratification, and caused the production of cornified 
envelopes in 2D culture. Microarray analysis found that enzymes involved in lipid 
and steroid metabolism were activated as well as proteins associated with 
desmosome and tight junction formation.  
Firstly, these effects will be verified in 2D and 3D with the current HaCaT and WTK 
cell lines. Various concentrations of SP600125 will be used and examined for their 
effect on cell viability and proliferation in accordance with the literature presented. 
Using an optimal concentration, 3D cultures will be grown with the SP600125 
compound and compared to controls on the basis of morphology, cornified envelope 
production, lipid production and barrier permeability to corticosterone. Both calcium 
and SP600125-induced differentiation will be compared and conclusions about the 
activity of both will be made. 
Previous results have shown that keratinocyte differentiation occurs within the 3D 
scaffold - evidenced by cornified envelope production, a mature lipid profile and 
expression of proteins such as involucrin. However, there were also some deficiences 
observed - cornified envelopes were more fragile and immature than native 
epidermis counterparts, involucrin expression was disorganised throughout the 
scaffold and no stratified layers were formed, likely due to the confines of the 3D 
scaffold polystyrene. Therefore SP600125, shown to increase differentiation and 
promote cornified envelope formation, was used with the goal of increasing the level 
of differentiation of keratinocytes inside the 3D scaffold. This was hypothesised to 
improve the barrier function of the 3D cultures through increased production of 
barrier lipids and cornified envelopes. These experiments also investigate the role of 
JNK pathway inhibition in 3D culture, which had not been examined previously. 
These results also demonstrate the 3D scaffold epidermal model as a tool for 
studying the activity of a compound and its effect on keratinocyte differentiation and 
barrier function.  
218 
 
5.2 Results 
5.2.1 Barrier Permeability of 3D Cultures to Corticosterone 
Firstly, the permeability of the 3D scaffold epidermal model to corticosterone was 
measured. An enzyme immunoassay (EIA) for corticosterone was used and a 
standard curve was generated from corticosterone diluted in DMEM culture media at 
37°C. The standard curve used corticosterone concentrations between 20,000 and 
32pg/ml and is shown in Figure 5.1. The plot from the standard curve was analysed 
and a starting concentration of 15,000pg/ml corticosterone was selected for the 
permeability assessments, based on the sensitivity of the assay. The assay allowed a 
minimum concentration of 32pg/ml to be detected, which represents 0.2% of 
corticosterone diffused from the donor to recipient side. The assay was tested against 
the permeant corticosterone by diluting various concentrations of corticosterone in 
DMEM and was found to be accurate. 
In order to establish a baseline control level of diffusion across the 3D scaffold, 3T3 
cells were grown submerged inside the 3D scaffold for 7 days. 3T3 cells proliferate 
and fill the 3D scaffold, providing passive resistance but not a specialised 
keratinocyte barrier formed by cornified envelopes, barrier lipids and junctional 
proteins. It was not possible to use an empty 3D scaffold as a baseline control, due to 
excessive leaking from the diffusion chamber. Cultures were placed in the side-by-
side diffusion cell for 3 hours at 37°C and 15,000pg/ml corticosterone in DMEM was 
used as the permeant. The experiment was run for four hours at 37°C and results 
were discarded if any leaking was detected from the diffusion chamber. A graph 
showing the accumulating percentage of corticosterone diffused into the recipient 
chamber against time is shown in Figure 5.2.  
HaCaT cells were grown for 14 days at the air-liquid interface following protocols 
from the previous two chapters. These cultures were then placed into the diffusion 
apparatus with the air-exposed surface facing the donor chamber and the experiment 
was run for 3 hours at 37°C. Results of the diffusion assay compared to 3T3 cells as 
a control are shown in Figure 5.3 as the % of corticosterone diffused (up to a 
maximum of 50%) versus time in minutes for clear representation of the data. For 
permeability co-efficient calculations, graphs of cumulative amount of corticosterone 
(µg) versus time in seconds were made.   
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Figure 5.1. Standard Curve for the Corticosterone Assay 
A) Graph showing standard curve of corticosterone concentration vs % bound in 
assay. This was used to calculate the concentration of corticosterone, and 
subsequently the percentage which had diffused across the 3D scaffold; B) Structure 
of corticosterone molecule. Corticosterone is a steroid hormone synthesis from 
dietary cholesterol and secreted from the adrenal glands and is structurally similar to 
testosterone or estradiol.  
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Figure 5.2. Corticosterone Diffusion Assay of 3D Cultured Fibroblasts 
A) Graph showing % of corticosterone diffused into the recipient chamber against 
time through 3T3-NIH mouse fibroblasts  grown submerged in the 3D scaffold for 7 
days. After 4 hours, an average of 49.56% of the corticosterone has diffused across 
the scaffold, indicating that equilibrium had been reached. Permeability coefficient 
was calculated as 12.2x10
-5
. The 3T3 cells display little barrier function, as expected; 
B) H&E stained image of 3T3 cells cultured in the 3D scaffold for 7 days. Scale bar 
100µm. 
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Figure 5.3. Corticosterone Assay of 3D Cultured HaCaT Cells 
Graph showing % of corticosterone diffused into the recipient chamber against time 
through HaCaT cells cultured for 2 days submerged, then 14 days at the air-liquid 
interface under standard conditions as previously described. Diffusion curve of the 
3T3 fibroblasts from Figure 5.2 is repeated here for comparison. After 180 minutes 
of diffusion through cultures containing fibroblasts or HaCaTs, 38.8% (P= 12.2x10
-5
) 
and 8.4% (P= 2.6x10
-5
) of corticosterone had diffused through each culture 
respectively. This shows that the differentiated HaCaT cells have formed an 
epidermal barrier which is 4.7x more resistant than fibroblasts. 
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The permeability coefficient was calculated, as described in the Materials and 
Methods Chapter. After 4 hours, an average of 49.56% of the corticosterone has 
diffused across the scaffold containing 3T3 cells (Figure 5.2), indicating that 
equilibrium (50%) has been reached. The permeability co-efficient was calculated as 
P=12.2x10
-5
, showing that 3T3 cells form a poor permeability barrier, as expected. 
This is in line with published literature (Oshizaka et al, 2012) which shows that the 
dermis contributes very little towards skin barrier properties. Figure 5.2B shows that 
3T3 cells proliferate throughout the full thickness 3D scaffold. However, they do not 
form a specialised epidermal barrier. 
A comparison of 3D-cultured HaCaT cells against 3T3 cells over three hours of 
corticosterone diffusion is shown in Figure 5.3. After 3 hours, 8.36% of 
corticosterone added to the donor chamber has diffused across the HaCaT culture, 
compared to 38.8% through the 3T3-filled scaffold. This shows that HaCaT cells 
have produced an epidermal barrier (P=2.6x10
-5
) which is 4.7x more resistant to 
corticosterone diffusion than fibroblast cultures (P=12.2x10
-2
).  
WTK mouse keratinocytes were tested for their permeability to corticosterone after 
culture in low (0.06mM) and high (1.5mM) calcium conditions and compared to 
HaCaT keratinocytes. Results are shown in Figure 5.4. 
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Figure 5.4. Permeability of WTK Cells Cultured in 3D Scaffold 
A) Diffusion analysis over 3 hours of WTK cells grown at the air-liquid interface for 
14 days showing that after 180 minutes, 5.6% (P= 1.89x10
-5
)
 
and 3.2% (P= 1.12x10
-
5
)
 
of corticosterone had diffused for low and high calcium cultures respectively. This 
difference was significantly different; B, C) Involucrin and H&E staining from low 
calcium cultures; D, E) Involucrin and H&E staining from high calcium cultures. 
High calcium cultures show slightly more intense involucrin staining and flattened 
nuclei visible in the H&E image. 
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The experimental results (Figure 5.4) show that WTK cells form a functional barrier 
in the 3D scaffold when cultured at the air-liquid interface for 14 days in either low 
or high calcium conditions. All cultures show growth through the full thickness of 
the scaffold. Panel B shows that the low calcium culture is differentiated, although 
the high calcium culture (D) shows more differentiation as expected. H&E staining 
of the high calcium culture (E) shows some flattened cell nuclei but overall these 
cultures are similar in appearance and would both be expected to show similar barrier 
function. 
The graph in Panel A shows that the cultures have good barrier function. After three 
hours of corticosterone diffusion, 3.2% and 5.6% of the donor corticosterone has 
diffused through the high and low calcium cultures respectively. The high calcium 
cultured WTK cells have a more resistant barrier than those cultured in low calcium. 
This is most likely because, as shown in the previous chapter, high calcium induces 
more differentiation including barrier proteins, increased lipid production and a more 
mature lipid profile. For low calcium cultures, P = 1.89x10
-5
 and for high calcium 
cultures P = 1.12x10
-5
. 
Table 5.1. Summary of Permeability Coefficients 
Culture Px10
-5
 180 min %diff n 
3T3 Cells 12.2 49.56 ± 3.03 3 
HaCaT 2.60 8.36 ± 3.58 7 
WTK low calcium 1.89 3.21 ± 0.81 4 
WTK high calcium 1.12 5.57 ± 0.94 5 
Human epidermis 0.87x10
-7 
to 
3.4± 0.9x10-7 
- Kuntsche et 
al, 2008. 
Chantasart et 
al, 2009 
Px10
-5
 = permeability coefficient (cm/s). A lower number indicates lower 
permeability to corticosterone; 180 min %diff = percentage of permeant diffused to 
recipient chamber after 180 minutes; n = number of individual samples analysed. 
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5.2.2 Investigation of the JNK Inhibitor Compound SP600125 on 
Keratinocyte Differentiation 
Published data (Zhang et al, 2003, Sabapathy et al, 2004, Gazel et al, 2006) suggests 
that the JNK pathway may be a suitable target for therapeutic intervention in cases of 
hyperproliferation. As described earlier, the JNK inhibitor compound SP600125 has 
been shown to increase the rate of keratinocyte differentiation (Gazel et al, 2006) and 
rapidly reduce epidermal proliferation (Sabapathy et al, 2004).  
Therefore, the scaffold-based 3D epidermal model was used as part of a series of 
investigations to test a compound for its effect on keratinocyte differentiation and 
epidermal permeability. The compound was first tested on cells cultured in 2D, 
before being tested in 3D cultures. This will show whether the epidermal model 
using the 3D scaffold can act as a suitable predictor of how a compound will affect 
epidermal barrier function. 
To assess the morphology of keratinocytes with SP600125 treatment, four culture 
conditions were used in this study. Based on results in the previous chapter, all 
culture media were supplemented with 100µg/ml ascorbic acid to optimise epidermal 
lipid synthesis. 
Table 5.2. Culture Media Containing SP600125 
Culture Media Calcium Ascorbic Acid SP600125 cFBS 
High  0.06mM 100µg/ml - 10% 
Low 1.50mM 100µg/ml - 10% 
High SP AA 1.50mM 100µg/ml 50µM 10% 
Low SP AA 0.06mM 100µg/ml 50µM 10% 
 
As WTK mouse keratinocytes showed greater sensitivity to calcium concentration, 
WTK cells were cultured under standard conditions for 48 hours, then switched into 
the four culture conditions in Table 5.2 for 72 hours. Light microscopy images 
showing changes in cell morphology are shown in Figure 5.5. 
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Figure 5.5. SP600125 Differentiates WTK Mouse Keratinocytes 
Samples were cultured for 48 hours in low (0.06mM) calcium before being switched 
into low (0.06mM) or high (1.5mM) calcium in the presence or absence of 50µM 
SP600125 for 72 hours. Floating cornified envelopes are indicated by white boxes 
and examples of flattened cells are indicated by white arrows. Scale bars = 50µm.   
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Cells grown in low calcium culture media showed a standard cobblestone appearance 
with sparse floating cells. This is typical of proliferative, non-differentiated 
keratinocytes. Cells grown in high calcium media show flattening, closer cell-cell 
contacts and some cells (indicated with white arrows) are flattened to occupy a larger 
surface area of the culture flask, forming a sheet-like layer of cells. Keratinocytes 
cultured in the presence of SP600125 and high calcium are visibly very different to 
previous conditions, showing flattened cells in a much more "loose" arrangement in 
the flask with a large number of floating flattened objects which appear to be 
cornified envelopes. Keratinocytes cultured with SP600125 and low calcium show 
some morphological changes and appear similar to those cultured in high calcium 
alone, forming a sheet of flattened cells on the surface of the flask. 
This experiment was then repeated with HaCaT cells grown on glass cover slips for 
immunofluorescence staining of differentiation markers, as the WTK cell line does 
not adhere or proliferate well on glass. Cells were cultured under standard conditions 
for 24 hours before being switched into experimental culture media for 48 hours. 
Representative images are shown in Figure 5.6. 
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Figure 5.6. 2D Immunofluorescence of SP600125-treated HaCaT Cells 
2D Immunofluorescence staining of HaCaT cells grown in the presence of low or 
high calcium concentration and treated with either 0µM or 50µM SP600125. Scale 
bars 10µm. 
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Immunofluorescence staining shows that SP600125 accelerates HaCaT cell 
differentiation and these effects appear to be enhanced by high calcium concentration 
(Figure 5.6). For example, E-cadherin staining is negative when cells are cultured in 
low calcium, as expected, but is also negative when cells are cultured in low calcium 
with SP600125, indicating that JNK pathway inhibition is not sufficient to induce E-
cadherin expression or relocation to the cell membrane. As the formation of adherens 
junctions is calcium dependent (Delva et al, 2009), this is predictable as JNK 
inhibition and high calcium concentration induce differentiation by different 
mechanisms (Schmidt et al, 2000). However when cells are cultured with both 
SP600125 and high calcium, E-cadherin appears to be expressed more strongly along 
more cell-cell boundaries than with high calcium alone. 
With both involucrin and filaggrin staining, it appears that SP600125 alone is able to 
induce expression and subcellular distribution similar to high calcium conditions. 
However, when high calcium and SP600125 are combined, involucrin and filaggrin 
expression is very strong. The exposure for all images was equal to show the relative 
intensity of staining, hence overexposure in involucrin staining for the high calcium 
and SP600125 treatment panel. ZO-1, a tight junction component, is only slightly 
increased by SP600125 or by high calcium alone, but is strongly expressed at cell-
cell borders when SP600125 and high calcium are used in combination. Tight 
junctions are an important aspect of epidermal barrier function (Furuse et al, 2001, 
Kuroda et al, 2010), and so 3D cultures with SP600125 might be expected to form a 
more impermeable epidermal barrier. 
The results clearly show that SP600125 treatment accelerates keratinocyte 
differentiation, but it is not known how quickly these effects take place or how much 
impact SP600125 has on proliferation. This is important, as when culturing 
keratinocytes for 14 days at the air-liquid interface, there needs to be a sufficient 
number of cells proliferating inside the scaffold before being induced to differentiate. 
It also means that it may be optimal to introduce the SP600125 into the culture at a 
later stage of the 3D culture. 
Therefore, HaCaT cells grown on 2D glass coverslips were also stained for the 
proliferation marker Ki67. Five fields of cells were counted for each coverslip and 
cells were categorised as either totally absent from staining, intermediate staining or 
strong staining of mitotic chromosomes. Several concentrations of SP600125 were 
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used and experiments were carried out at several time points. The resulting graphs 
are shown in Figure 5.7. In addition, ViaCount analysis was performed on HaCaT 
cells cultured in 12 well plates for 24 hours to measure proliferative and apoptotic 
cells. Results are presented in Figure 5.7. 
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Figure 5.7. Ki67 and ViaCount Analysis of SP600125-treated HaCaT Cells 
A) Percentage of mitotic cells over time with 0µM, 5µM, 25µM or 250µM 
SP600125; B) ViaCount analysis showing proliferative and apoptotic cells after 24 
hours in various concentrations of SP600125. L/H = 0.06mM/1.5mM Ca
2+
. 
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HaCaT cells treated with SP600125 quickly become less proliferative in accordance 
with the concentration used, as shown in Figure 5.7A. Even with the lowest 
concentration of SP600125 (5µM), there is a rapid reduction in the percentage of 
mitotic cells in the culture after 4 hours compared to un-supplemented culture media. 
This decrease in proliferation is correlated with dosage. However, after 72 hours all 
cultures are similarly proliferative. 
Cultured media was replaced after 24 hours and these data suggest that lower 
concentrations of SP600125 such as 5µM "wear off" in the culture media. The 
number of mitotic cells in untreated cells continues to decrease as the confluence of 
the culture increases, as expected. From these data, two things can be determined - 
SP600125 acts quickly and shows effects on cell proliferation within 24 hours of 
being added to the culture media, and the effect of SP600125 reduces over time. 
In order to assess cell viability with SP600125, ViaCount analysis (Figure 5.7B) was 
used. ViaCount analysis counts cells by flow cytometry and classifies them as viable, 
mid-apoptotic or dead depending on their ability to uptake two dyes. The results 
show that the majority of cells remain proliferative after 24 hours, which appears 
contrary to Ki67 results. However, ViaCount includes all viable cells, and not only 
mitotic cells, whereas only mitotic cells were included in Ki67 analysis. The addition 
of 1.5mM calcium to the culture media slightly decreased the percentage of viable 
cells compared to low calcium conditions, possibly due to differentiation or growth 
arrest. Interestingly, the addition of SP600125 alone did not reduce the percentage of 
viable cells in the culture but when SP600125 was added in conjunction with high 
calcium, the proportion of viable cells decreases in a concentration-dependent 
manner. No significant differences in the proportion of apoptotic cells were noted, 
showing that 50µM SP600125 does not induce apoptosis. The remaining 40% of 
cells in the culture were as classed as "dead", although the ViaCount assay is likely 
mislead by differentiated, anucleate cells.  
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5.2.3 Assessment of SP600125 JNK Inhibition in 3D Cultures 
5.2.3.1 Cell Proliferation and Morphology 
To assess the affect of SP600125 in 3D conditions, HaCaT cells were cultured in 3D 
scaffolds, following the protocols established earlier. As previous experiments have 
shown that SP600125 acts quickly, 50µM SP600125 was introduced after the 
cultures were raised to the air-liquid interface. After seven days at the air-liquid 
interface an MTS assay was carried out. ViaCount is not compatible with the 3D 
scaffold as the cells cannot be reliably trypsinised out of the scaffold for analysis. 
Results of the MTS assay, showing a large and significant reduction in the 
conversion of MTS reagent, are shown in Figure 5.8. Cultures grown to 14 days were 
fixed and stained with H&E and for involucrin and these images are shown in Figure 
5.9 to observe changes in morphology and differentiation. 
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Figure 5.8. MTS Assay of 3D Cultured HaCaT Cells with SP600125 
MTS assay showing HaCaT cell viability of 3D cultures grown for 7 days in the 
presence or absence of low/high (0.06/1.5mM) calcium and/or 50µM SP600125. 
Error bars show SEM. * = P<0.05, n/s = not significant. 
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Figure 5.9.  3D Cultured HaCaT Cells with SP600125 
H&E and Involucrin staining of HaCaT cells cultured at the air-liquid interface for 
14 days in culture media containing. All scale bars 100µm.  
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The MTS assay shown in Figure 5.8 shows a significant and large reduction in 
metabolic activity when 50µM SP600125 is present. This may be due to the 
increased terminal differentiation present within the culture. This corresponds with 
the findings in 2D cultures where the population of proliferating cells significantly 
decreased with SP600125 treatment (Figure 5.7), although the difference is more 
pronounced in the 3D environment. Interestingly, SP600125 alone was enough to 
significantly reduce the metabolic activity of the entire culture, even with low 
calcium concentration.  While high calcium induced a small decrease in MTS 
viability without SP600125, there was no significant difference in MTS viability 
observed between the low or high calcium SP600125 cultures. 
H&E and involucrin-stained sections from 3D cultures are shown in Figure 5.9. H&E 
stained sections show some slight differences between each culture condition, 
although all cultures have fully filled the depth of the 3D scaffold. Cells grown in 
high calcium show flatter nuclei than those grown in low calcium. Similar to 2D 
culture experiments, low calcium with 50µM SP600125 shows a morphology more 
differentiated than low calcium alone but less differentiated than high calcium alone. 
Cultures grown in 50µM SP600125 and high calcium show the most involucrin 
staining, in line with previous findings that SP600125 and raised calcium 
concentration increases differentiation. As shown in Chapter Three, the air-liquid 
interface influences differentiation of keratinocytes -  therefore there are three major 
contributing factors to the differentiation seen in the cultures - the air-liquid 
interface, calcium concentration and the presence or absence of SP600125. 
5.2.3.2 Cornified Envlope Formation in SP600125-treated 3D Cultures 
As SP600125 clearly accelerates keratinocyte differentiation, and structures 
appearing to be cornified envelopes were observed in 2D culture, cornified envelope 
extractions were performed on 3D cultures and stained with 0.5mg/ml Nile Red. 
Results of the extraction showing isolated cornified envelopes are presented in 
Figure 5.10. 
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Figure 5.10. Cornified Envelopes Isolated From SP6001250-treated 
Keratinocytes 
Nile Red-stained cornified envelopes extracted from HaCaT cells grown in the 3D 
scaffold for 2d submerged, then 14d at the air-liquid interface in A) 0.06mM Ca
2+
; 
B) 1.5mM Ca
2+ 
;C) 0.06mM Ca
2+
 and 50µM SP600125; D) 1.5mM Ca
2+
 and 50µM 
SP600125. Contamination by pieces of 3D scaffold marked with white arrow. Scale 
bar 50µm. 
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Cornified envelope extraction and Nile Red staining shows that cornified envelopes 
can be isolated from all culture conditions.  Similar to results presented in the 
previous chapter, a mixture of mature and immature cornified envelopes are 
observed in all culture conditions. There were more cornified envelopes isolated 
from SP600125-treated cultures, although interestingly they do not show more 
intense staining with Nile Red than those from standard high calcium conditions. 
This suggests that while SP600125 may increase cornified envelope formation, it 
does not necessarily increase their maturity in terms of structure and covalently 
attached lipids. To support this, there was no difference observed in cornified 
envelopes from low or high calcium with SP600125. Staining in Figure 5.9 showed 
more intense involucrin staining (panel D), which is a component of the cornified 
envelope (Ishida-Yamamoto et al, 1995) and there are more cornified envelope 
isolated from the same culture conditions (i.e. high calcium with 50µM SP600125). 
However, this does not necessarily mean that the attachment of ceramides onto the 
protein structure is also increased, hence no changes in Nile Red staining. In 
microarray analysis of keratinocytes treated with SP600125 Gazel et al, 2006 showed 
that transglutaminase 1 (TGase1) was upregulated two-fold. However, those analyses 
were performed in 2D where TGase1 activity is normally very low compared to work 
in this chapter where the air-liquid interface differentiates the cells and likely 
increases TGase activity. 
5.2.3.3 Effect of SP600125 on 3D Cultured Keratinocyte Lipid Profile 
In order to examine the effect of SP600125 on the lipid profile of 3D cultured 
keratinocytes, lipid extractions, separation on TLC plates and quantitation using 
ImageJ were performed. HaCaT cells were cultured in 3D and the total lipid 
extracted from 3D cultures, standardised against protein extracts, and a summary of 
the lipid profiles are shown in Figure 5.11.  
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Figure 5.11. Lipid Composition of 3D Cultures with SP600125 
A) Total lipids extracted from HaCaT cells grown in 3D culture in low/high calcium 
concentration and the presence or absence of 50µm SP600125. Lipid concentration 
expressed as a % against control; B) Spots of lipid extracts from each culture 
condition showing increased concentration from SP600125-treated cultures; C) 
Summary graph showing overall lipid composition of 3D cultured keratinocytes in 
low/high calcium in the presence/absence of SP600125. * = p<0.05, ** = P<0.01, n/s 
= not significant. Error bars show SEM.  
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Figure 5.12. Lipid Composition of 3D Cultures After 14 Days with SP600125 
Low Ca
2+
 = 0.06mM calcium, High Ca
2+ 
= 1.5mM calcium, SP = SP600125. Error 
bars show SEM. 
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Quantitation of the average lipid content from each culture condition (Figure 5.11) 
shows that SP600125 dramatically increases lipid production. The presence of high 
calcium in the culture media moderately increased lipid production, but SP600125 
was a far larger variable in increasing lipid production. 
The overview in Figure 5.11 and detailed analysis shown in Figure 5.12 shows that 
SP600125 is the largest determinant in the lipid composition of the cultures. Aside 
from triglyceride and FFA which were moderately reduced by high calcium, calcium 
concentration did not alter the lipid composition of the cultures whereas with 
SP600125 treatment, every lipid was significantly different to untreated counterparts. 
Again, the presence of both high calcium and SP600125 did not significantly change 
lipid composition compared to low calcium and SP600125. However, high calcium 
did increase the total amount of lipid isolated from 3D cultures (Figure 5.11). 
Ceramide production has significantly increased due to SP600125 treatment. Yet, the 
whole lipid content appears to show a more immature profile if compared to native 
human epidermis or to the samples cultured without SP600125. For instance, 
cholesterol ester content, which is highly hydrophobic and essential in barrier 
function (Masahiro and Masao, 2007), has significantly decreased in both SP600125 
treatment groups, as well as free fatty acids. In native human epidermis, cholesterol 
ester comprises 6-10% of epidermal lipids (Elias et al, 2012). All 3D cultures show 
FFA content which is significantly lower than native epidermis (~15%), but those 
treated with SP600125 contain almost no FFA. Cholesterol content has also fallen in 
cultures treated with SP600125, and correspondingly, the immature precursor 
cholesterol sulphate has increased in proportion. Overall, SP600125-treated cultures 
show a more immature lipid profile, even though lipid production as a whole is 
dramatically increased. 
5.2.3.4 Effect of SP600125 on Barrier Function of 3D Cultured Keratinocytes 
The results suggest that SP600125 inhibition of the JNK pathway increases ceramide 
synthesis as part of keratinocyte differentiation. To determine the effect of these 
changes in lipid composition on barrier function, samples were assessed for their 
permeability to corticosterone and are shown in Figure 5.13. 
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Figure 5.13. Corticosterone Permeability of SP600125-treated 3D Cultures 
Graph showing % of corticosterone diffused into the recipient chamber against time 
through HaCaT keratinocytes or 3T3-NIH fibroblast cells cultured in the 3D 
scaffold. HaCaT cells were cultured for 2d submerged in standard culture media, 
then lifted to the air-liquid interface for 14 days in the presence of absence of 
SP600125. Fibroblast cultures were grown submerged for 7 days and are shown for 
comparison. The results show that after 180 minutes, the addition of SP600125 made 
the barrier more permeable to corticosterone diffusion. Permeability coefficients as 
Px10
-5
 are noted in the legend. Error bars show SEM. 
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The permeability assays shown in Figure 5.13 show that the JNK pathway inhibition 
by SP600125 in combination with high calcium reduced the barrier function of 3D 
cultured HaCaT keratinocytes. A summary of the findings from all permeability 
experiments, including SP600125-treated cultures and comparitive data from 
published literature, is shown in Table 5.3 below. 
Table 5.3. Summary of All Permeability Coefficients 
Culture Px10
-5
 180 min %diff n 
3T3-NIH Fibroblasts 12.2 49.56 ± 3.03 3 
HaCaT  
DMEM 
2.60 8.36 ± 3.58 7 
WTK Low Calcium 1.89 3.21 ± 0.81 4 
WTK High Calcium 1.12 5.57 ± 0.94 5 
HaCaT 50µM 
SP600125 Low 
Calcium 
3.40 12.75 ± 2.65 6 
HaCaT  
50µM SP600125  
High Calcium 
7.50 20.21 ± 1.61 6 
Published Data 
Name Px10
-7
 Reference 
Human cadaver 
epidermal membrane 
2.1 Ibrahim et al, 2009 
Human cadaver 
epidermis 
1.62 ± 0.84 Suhonen et al, 2003 
Human epidermis 0.89 Buchwald et al, 2001 
Human epidermis 0.80 Kuntsche et al, 2008 
Human epidermis 3.4 ± 0.9 Chantasart et al, 2009 
ROC (Rat Organotypic 
Culture) 
1.75
a
 
2.72 ± 1.08
b
 
a
Kuntsche et al, 2008 
b
Suhonen et al, 2003 
All keratinocytes cultured for 14 days at the air-liquid interface. 3T3-NIH fibroblasts 
cultured subermerged for 7 days. Permeability coefficients from published literatire 
are based on corticosterone permeability in either side-by-side or Franz type 
diffusion chambers at 37°C. The solvent for corticosterone was PBS or culture 
media, and no permeation enhancers were present. The corticosterone concentration 
was determined by ELISA or radioactive scintillation and permeability coefficients 
calculated. 
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These findings are in line with previous data which showed that SP600125 caused 
abnormalities in the lipid profile and a reduction in many barrier-forming lipids such 
as cholesterol ester and free fatty acids. Interestingly, SP600125 in combination with 
high calcium showed a significantly greater barrier permeability than in combination 
with low calcium (P=7.5 x10
-5
 vs P= 3.5x10
-5
), even though the lipid profile, 
extracted cornified envelopes and involucrin expression of those cultures were very 
similar. There was also no difference in the viability of the cultures (Figure 5.8) 
which may have explained the increased permeability of the high calcium cultures. 
The results show that while SP600125 undoubtedly accelerates keratinocyte 
differentiation, the resulting phenotype does not display better barrier function than 
other samples. This is potentially due to the rapidly accelerated differentiation of 
keratinocytes not allowing a sufficient barrier to form within the 14 day time period. 
With hindsight it may have been beneficial to culture the epidermal equivalents for a 
longer time, then added SP600125 at a later timepoint. 
5.3 Discussion 
5.3.1 Summary of Results 
Results have shown that keratinocytes cultured in the 3D scaffold form an epidermal 
barrier with resistance to the diffusion of the lipid-soluble compound corticosterone. 
The level of permeability is correlated with characteristics of the cells in the 3D 
scaffold, including the profile of lipids produced by the cultured cells. However, the 
overall barrier permeability is considerably more permeable than human skin. 
The 3D scaffold model developed over the previous chapters was used to assess the 
action of a JNK pathway inhibitor. Previous results shown in Chapter Four showed 
that 3D cultures did not form several layers of flattened cells or a stratum corneum, 
and some corneocytes still appeared to contain nuclei, indicating a deficiency in 
differentiation. SP600126 has been shown to induce keratinocyte differentiation in 
2D conditions (Gazel et al, 2006) and was therefore chosen as a potential method to 
accelerate differentiation within the 3D scaffold cultures, with the aim of improving 
the barrier function of the cultures. SP600125 had also not been tested in 3D culture 
conditions, or tested for its impact on barrier permeability. 
Firstly, the compound was analysed in 2D and confirmed to rapidly reduce 
proliferation and increase differentiation of keratinocytes. When keratinocytes were 
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cultured with SP600125 in 2D conditions, cells showed differentiation as visualised 
by changes in cell morphology and increased involucrin, desmoplakin and filaggrin 
expression. SP600125 also induced tight junction formation, visualised by ZO-1 
staining. In 3D, SP600125 was found to increase the number of cornified envelopes 
isolated from the culture although these cornified envelopes were not necessarily 
more mature, as visualised by Nile Red staining for covalently attached lipids. These 
findings indicated that keratinocytes cultured in the presence of SP600125 would be 
expected to form a more hydrophobic and more resistant epidermal barrier. 
However, lipid extractions showed that SP600125 significantly increased the 
proportion of ceramides produced by 3D cultured keratinocytes. A high percentage 
(~35-50%) of ceramides is physiologically normal and associated with mature barrier 
function (Stahl et al, 2009) but SP600125-treated cultures contained almost 80% 
ceramides, which is abnormally high. Perhaps more significantly, the proportion of 
hydrophobic cholesterol esters, cholesterol and free fatty acids were significantly 
lower, and the precursor lipid cholesterol sulphate was also elevated with SP600125 
treatment. These lipid precursors have been shown to have their own effect on 
epidermal differentiation. For example, cholesterol sulphate has been recently found 
to induce differentiation markers such as filaggrin through the retinoic acid receptor-
related orphan receptor alpha (RORα) (Hanyu et al, 2012). Cholesterol and 
ceramides have also been found to have co-ordinated signalling roles in the 
epidermis, where their release from lamellar bodies and subsequent conversion into 
active molecules which regulate the development of the stratum corneum (Feingold 
and Jiang, 2011). Therefore it is possible that the disturbances in the 3D cultured 
epidermis caused by SP600125 not only affected the profile of lipids important in the 
barrier function, but also affected the signalling involved in maturation of the stratum 
corneum. These factors combined to cause a decreased barrier function in cultures 
supplemented with SP600125. 
Gazel et al, 2006 showed that several genes coding enzymes associated with lipid 
production and conversion were upregulated with SP600125 treatment, supporting 
this theory. These included ACAT2 (cytosolic acetoacetyl-CoA thiolase, responsible 
for cholesterol ester synthesis) and FABP2 (epidermal fatty acid binding protein 2, 
involved with fatty acid metabolism and upregulated in psoriasis). A number of 
lipodolytic enzymes were also regulated, although none of those mentioned in the 
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published data are associated with epidermal lipid lipodolysis. Lipid extraction from 
the 3D epidermal cultures in this chapter showed that cholesterol ester content 
decreased, which would be unexpected if ACAT2 is upregulated. However, Gazel 
and colleagues' microarray analysis was performed on 2D-cultured cells which are 
normally maintained in a basal, non-differentiated state, compared to the 3D scaffold 
where keratinocytes will differentiate at the air-liquid interface without the need for 
further external stimulus such as raised calcium or SP600125. The 3D environment 
has been shown to change cellular behaviour throughout this thesis, and so results 
from 2D and 3D cultures can not necessarily be compared like for like. It is probable 
that gene expression of keratinocytes cultured in the 3D scaffold would be different 
to keratinocytes cultured in 2D dishes and therefore the whole basis for comparing 
the action of SP600125 would be different. 
The SP600125-treated cultures with altered lipid composition showed increased 
permeability to corticosterone compared to other cultures, highlighting the 
importance of lipids in the barrier permeability of epidermal cultures. However, 
cultures grown in high/low calcium with SP600125 showed differing permeabilities, 
even though their lipid profiles, extracted cornified envelopes and viabilities were 
similar, showing that there may be other factors affecting permeability that remain 
unaccounted for. In this case, it is likely that SP600125 accelerated differentiation to 
the point where the cells differentiated prematurely before being able to form a 
mature barrier. This highlights the importance of ordered differentiation, and with 
hindsight, a lower concentration of SP600125 introduced at a later stage of the 
culture period may have been beneficial. 
These results showed that the 3D scaffold model developed in the previous two 
chapters could be used to measure the effect of a compound on keratinocyte 
behaviour and barrier function. These results also highlight the importance of 
functional testing such as direct barrier assessment and show that findings in 2D and 
3D environments can differ substantially. Zhang et al, 2003 demonstrated that 
inhibition of the JNK pathway by SP600125 was able to reverse epidermal 
hyperplasia in mice. However they did not assess the barrier function or lipid 
production of the resulting epidermis. The observations in this Chapter indicate that 
accelerating differentiation or reducing proliferation by inhibition of the JNK 
pathway may not be a suitable therapeutic approach for treatment of skin disorders 
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due to profound changes in the lipid profile and barrier permeability of the 
epidermis. However, this would need to be investigated further. One key difference 
is that the 3D scaffold model represents a somewhat "normal" epidermis which 
already forms a normal lipid profile and barrier function and so SP600125 disrupts 
that behaviour. However, disordered skin may still be corrected by SP600125.  
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5.3.2 Future Work 
Testing the 3D scaffold model permeability with more compounds would be 
beneficial as the corticosterone compound used in this chapter is a lipid-soluble 
steroid molecule and permeates through the barrier of corneocytes, extracellular 
lipids and viable cell membranes more readily than water-soluble substances. The 
OECD guidelines mentioned previously recommend use of both lipid and water 
soluble permeants in assessing an epidermal permeability model. Water soluble 
substances used for permeability testing include caffeine, mannitol or glucose 
(Buchwald and Bodor, 2001, Suhonen et al, 2003, Pappinen et al, 2012). Caffeine is 
also the OECD Guidance 28 (OECD, 2004) approved standard for permeability 
testing of in vitro equivalents designed for replacing in vivo testing. A low molecular 
weight tracer, colloidal lanthanum nitrate has been used previously (Gruber et al, 
2011) to visualise paracellular transport through the epidermis. Use of a tracer, as 
well as water-soluble compounds will give insight as to the diffusion pathway taken 
by molecules through the 3D cultures (i.e. transcellular or intercellular) and show 
possible areas of improvement for the model. 
One important factor for an in vitro model is not necessarily to match the 
permeability of human skin exactly, but rather to accurately predict the penetration of 
a compound through human skin. This so-called "permeability ratio" of Pmodel/Phuman 
can be used to predict the permeability of a compound through human skin based on 
the permeation through an epidermal model (Pappinen et al, 2012). In order to 
further assess the usefulness of the 3D scaffold model for predicting the effect of 
compounds on epidermis, animal epidermal samples could be used to formulate a 
more complete permeability ratio for multiple compounds.  
It is important to note that in vitro epidermal equivalents can vary considerably in 
their permeabilities to different compounds relative to human epidermis. For 
instance, Suhonen et al, 2003 compared a well-developed epidermal model to human 
epidermis. While their model was very accurate for some compounds such as 
Nadolol and Pindolol (Pmodel/Phuman 1.0 and 1.2 respectively), it was far less 
permeable to water soluble salicylic acid (0.3) but much more permeable to lipid 
soluble beta-estradiol (5.2). This is likely due to the preferred permeability pathways 
of each molecule and lack of hair follicles in in vitro models. In vitro epidermal 
equivalents can still be useful even with varying permeabilites compared to real 
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epidermis - as long as the permeability rating for a particular compound is consistent. 
Therefore, in order to fully characterise the 3D scaffold model, a greater number of 
permeants need to be tested and larger numbers of repeats performed. In addition, 
organotypic models typically overestimate the permeation enhancing effect of 
compounds such as ethanol or SDS, but if these results are predictable then they are 
still useful (Pappinen et al, 2007). 
For reference, published corticosterone permeability coefficients of human epidermis 
are Px10
-7
 = 1.62±0.84 (Suhonen et al, 2003) or 0.87 (Kuntsche et al, 2008), which 
are significantly lower than the coefficients derived for the 3D scaffold model in this 
chapter. However, it is difficult to directly compare these figures as the calculated 
permeability coefficient will depend on which part of the slope of increasing 
permeant concentration is used for the calculation. Clearly, the most rapid diffusion 
into the recipient chamber is at the start of the experiment where the concentration 
gradient between the two chambers is largest. Over time, the rate of diffusion will 
fall and would provide a much smaller permeability coefficient. Alternatively, some 
permeants display a lag time before any of the substance diffuses through. Therefore, 
the figures provided above are for reference and not direct comparison as it is not 
known which area of the graph was used for calculation in the published literature.  
As mentioned previously, low and high calcium SP600125-treated cultures in 3D 
showed increased involucrin staining and increased cornified envelope formation and 
very similar lipid profiles. However, low and high calcium SP600125 cultures 
significantly differed in terms of barrier permeability. One reason may be that cells 
are being differentiated too quickly, rather than undergoing the controlled and 
ordered process which normally occurs. For instance, Ishida-Yamamoto et al, 1995 
found that cornified envelope formation occurs too early within the differentiation 
process of psoriatic skin, resulting in reduced epidermal barrier function. The 
cornified envelopes isolated from these patients were also determined to be more 
fragile than those from normal skin. Staining shown in Figure 5.10D shows that 
while SP600125 induced more cornified envelope production, they were not 
necessarily more mature in terms of covalently attached lipids. Adding earlier time 
points to the work in this chapter would show whether this is the case for SP600125 
treatment. Future work could also alter the timing of SP600125 addition so that it 
could potentially be used to enhance terminal differentiation after keratinocytes have 
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already begun to differentiate at the air-liquid interface. Future work could also 
assess the structural stability of cornified envelopes by use of sonication as a measure 
of their maturity (as in Sevilla et al, 2007). Analysing the ceramides produced by 
SP600125-treated cultures would also be worthy of investigation, as the bands on the 
TLC plate suggested that two particular ceramides are increased in comparison to the 
other cultures (data not shown). 
Mouse keratinocytes formed a more effective barrier to corticosterone penetration 
than HaCaT cells and ideally future work would be carried out utilising this cell line, 
although their much slower proliferation makes this significantly more time 
consuming. 
5.3.2.1 Evaluation of SP600125 and JNK Pathway Function  
To date, the effect of SP600125 on epidermal barrier function had not been tested. 
Data presented in this chapter suggests that SP600125 induces premature 
differentiation of keratinocytes and reduces overall barrier function under in vitro 
conditions where the cells differentiate normally. This hypothesis could be tested 
using animal studies and cornified envelope extractions, lipid extractions and barrier 
permeability analysis could be compared between the 3D scaffold model and 
samples of the animal epidermis. 
The results in this chapter show that SP600125 induced differentiation in 
keratinocytes and dramatically increased ceramide content, but these changes did not 
translate to improved barrier resistance to corticosterone. However, the 3D scaffold 
model is based on healthy epidermis with a physiologically accurate lipid profile and 
mature cornified envelope production. Inhibition of the JNK pathway with SP600125 
and corresponding changes in keratinocyte behaviour may have potential therapeutic 
uses in cases where the target skin is not physiologically normal. For instance, 
hyperproliferation and incomplete terminal differentiation (lack of cornified 
envelopes, or immature envelopes) are both features of psoriasis (Kawashima et al, 
2004). Psoriatic skin also shows larger intercellular spaces (Kawashima et al, 2004), 
reduced barrier function (Wolf et al, 2012) and reduced ceramide synthesis 
correlated with clinical severity (Cho et al, 2004). 
In data presented in this chapter, SP600125 increased cell-cell tight junctions and 
increased ceramide content, as well as reduced the rate of keratinocyte proliferation, 
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all of which may be beneficial when applied to psoriatic skin. Although SP600125 
has not been directly tested against psoriatic skin, published data and the data shown 
in this chapter suggest that compounds altering keratinocyte proliferation and  
differentiation may have therapeutic uses in some cases of psoriasis. Zhang et al, 
2004 applied topical SP600125 to mice with hyperproliferative epidermis and found 
that keratinocyte proliferation was reduced to normal levels. Clearly, psoriasis is a 
complex disorder which may caused by several deficiencies in keratinocyte 
behaviour (such as genetic transglutaminase deficiency, pathogenic T-cells and drug 
side effects (Cho et al, 2004, Wolf et al, 2012)), but based on findings utilising the 
3D scaffold model, application of SP600125 to a psoriatic mouse model (such as 
Zenz et al, 2004) or psoriatic in vitro model (such as Barker et al, 2004) would be an 
interesting line of investigation.  
Findings from the 3D culture model could be confirmed by further experiments using 
siRNAs. Keratinocyte JNK expression (both isoforms of JNK, either separately or 
together) could be ablated with a lentiviral vector (for stability, due to the long 
growth period required in the 3D scaffold) and those cells could be cultured in the 
3D scaffold. If there was an effect on differentiation and barrier permeability, this 
would show that the normal activity of the JNK pathway is important for suppressing 
differentiation. Carrying on from this, target proteins such as c-Jun and ATF-2 could 
be independently knocked down which would give insight as to which activator is 
most important in suppressing keratinocyte differentiation. Analysing the 
keratinocytes at multiple time points would also give insight as to the process of how 
JNK regulates differentiation. 
In Chapter Three, MET4 squamous carcinoma cells were successfully cultured in the 
3D scaffold. These cells are known to show cell cycle disorders and the inability to 
differentiate (Proby et al, 2000). Studies have shown overactive JNK in over 75% of 
squamous cell carcinoma patients, and JNK inhibitor drugs and compounds are under 
investigation as potential therapeutics (Hengning et al, 2010). MET cell lines could 
be cultured in the 3D scaffold with and without SP600125, and assessed for JNK 
activity as well as proliferation and viability. 
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5.3.2.2 Other Types of Epidermal Permeability Assessment 
Diffusion analysis is an effective method for measuring barrier function, although it 
has several negative aspects. Firstly, cultures which have been subjected to diffusion 
cell analysis lose integrity over time and will absorb some of the permeant molecule 
(or radioactivity if radiolabelled compounds are used), meaning that they cannot be 
re-tested in the future. Also, to reach equilibrium on both sides of the diffusion 
apparatus may take several days, during which time the integrity of the cultured 
epidermis reduces. The upper surface of in vitro cultures or real epidermis is 
normally air-exposed and dry, but during diffusion analysis the sample is fully 
submerged. As discussed in the previous chapter, over-hydration of the epidermis has 
a profound effect on barrier permeability (Warner et al, 2003). During investigations 
in this chapter, some cultures were subjected to corticosterone diffusion for up to 48 
hours, during which results became more variable as the integrity of the culture 
lessened. Therefore, samples were measured over the first three hours to measure 
barrier permeability without adverse effect on the cultures themselves and a 
permeability curve was generated. Schreiber et al, 2005, showed that in vitro 
substitutes are more susceptible to the effect of the experimental environment than 
human epidermis samples during diffusion-based permeability assessment. For 
instance, when Igepal was used as a solubiliser in the permeant solution, it increased 
permeability of the in vitro epidermis models SkinEthic and EpiDerm by five to 
seven-fold but did not affect human or porcine epidermal samples. Therefore, long-
term diffusion assays of in vitro equivalents are not ideal. 
Other techniques have been used to act as a proxy for epidermal barrier function. For 
instance, the water content of the stratum corneum is a key indicator of barrier 
function which can be measured directly by NMR (Sotoodian et al, 2012). Transient 
thermal transfer (TTT) uses a heated probe (Hydrascan by Dermascan labs, France) 
applied to the surface of the skin. A thermometer measures the temperature increase 
at a distal site, and the rate of temperature increase with relation to distance is 
correlated with barrier function (Girard et al, 2000). As TTT is a non-destructive 
technique, cultures differentiating at the air-liquid interface could be measured 
repeatedly over time as a quick assessment of barrier function until an optimal barrier 
function is reached. Diffusion analysis could then be carried out on optimised 
cultures which reached a pre-determined TTT score, thus improving reliability of 
data. Transepithelial electrical resistance (TEER) is a similar non-destructive method 
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which passes a small electrical current across the culture without affecting viability. 
Higher electrical resistance is caused by drying and high lipid content and is 
therefore correlated with barrier function (Girard et al, 2000). Either of these 
methods could be used to assess barrier permeability in the 3D scaffold model 
before, during or after diffusion testing as a means of quality control. This would 
improve the reliability of the gathered data by standardising the cultures selected for 
permeability testing i.e. cultures could be selected for permeability testing once a 
certain TEER score has been achieved. The TEER of the cultures could be measured 
continuously during permeability testing, showing if any degradation in the barrier 
occurs. TEER could also be used to determine the optimal time for addition of 
compounds such as SP600125 by monitoring the formation of the barrier and adding 
the compound when "normal" barrier maturity is reached. 
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6 General Discussion 
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6.1 Summary of Results 
The results presented in this thesis have shown that a porous polystyrene 3D scaffold 
can be used to culture keratinocytes without a dermal equivalent. When raised to the 
air-liquid interface, these cultures of keratinocytes are induced to terminally 
differentiate, expressing proteins such as keratin 1, involucrin and filaggrin. Further 
examination showed that keratinocytes displayed features such as lamellar bodies, 
keratin bundling, desmosomes and keratohyalin granules, all of which are essential 
for epidermal barrier function. However, cells appeared to be disordered and only 2-
3 layers of flattened cells were observed. Nevertheless, cornified envelopes were 
isolated from the cultures, indicating that keratinocytes had reached terminal 
differentiation. 
These cultures were found to synthesise lipids associated with barrier function 
(ceramide, free fatty acids and cholesterol), and modifying the culture conditions 
with supplements such as ascorbic acid increased the level of keratinocyte 
differentiatin and optimised the lipid synthesis with a resulting lipid profile similar to 
native epidermis. However, these cultures still did not display a normal organisation 
of differentiation markers or the formation of several stratified layers of flattened 
corneocytes. The 3D scaffold epidermal model was subsequently characterised in 
terms of barrier resistance to corticosterone diffusion and was used to investigate the 
effect of a compound, SP600125, which had been shown to induce differentiation 
under 2D conditions but had not been previously studied in a 3D environment. 
Inhibition of the JNK pathway by SP600125 appeared to rapidly induce 
differentiation in 2D and 3D culture conditions and altered the lipid synthesis of the 
cells. The effect of this compound on 3D cultured cells was different in comparison 
to cells cultured in 2D, highlighting the importance of the 3D culture environment on 
behaviour of cells. In spite of increased cell differentiation, the barrier formed by 
SP600125-treated keratinocytes was more permeable, likely due to the disturbance in 
normal lipid synthesis and accelerated differentiation. This was counter to the 
original hypothesis stated in Chapter One (1.5). This demonstrates that 2D culture 
does not necessarily give predictable results and emphasises the importance of 
functional testing in addition to analysing barrier components. 
 
256 
 
Overall, the results showed that complete terminal differentiation was able to take 
place even when keratinocytes were constrained within the porous 3D material. This 
shows that horizontal, flat stratification observed in vivo is not a requirement for 
keratinocyte terminal differentiation and cornified envelope formation, nor is it 
required for epidermal lipid synthesis. This was observed with both HaCaT cells and 
mouse keratinocytes and could be further validated by cell culture in alternative 3D 
materials with altered physical properties and use of human primary cells. 
6.1.1 Potential Uses of the 3D Scaffold and Future Work 
As well as culturing keratinocytes at the air-liquid interface directly, there are many 
other uses for the 3D scaffold. Preliminary investigation in this chapter showed that 
fibroblasts can be cultured in the 3D scaffold. Therefore a multi-layered co-culture 
may be possible, where fibroblasts are cultured to confluence inside the scaffold and 
keratinocytes seeded onto the surface, then raised to the air-liquid interface. Initially, 
attempts were made to create this model (data not shown) but the fibroblast cultures 
were not confluent enough to prevent keratinocytes from falling inside the scaffold. 
When cultures were stained for markers of fibroblasts or keratinocytes, only 
keratinocytes were detected, located throughout the 3D material. This shows that the 
keratinocytes had most likely fallen into the 3D scaffold and outcompeted the 
fibroblasts. Separating the fibroblasts culture with a thin layer of Matrigel or collagen 
and then seeding a keratinocyte culture on the surface may produce the desired 
results. 
Other co-cultures would also be possible with the 3D scaffold, utilising the well-
inserts to bind multiple scaffolds containing different cell types. This may be used 
for culture of dependent cell types such as keratinocytes and feeder fibroblasts, or 
astrocytes and neuronal cells. This system would allow two cell types to be cultured 
in 3D while sharing the same culture media. 
6.1.1.1 Cell Motility and Invasion Studies 
The 3D scaffold may be used for cancer cell invasion studies. Collagen gels or 
collagen-coated matrices have been used previously (McInroy et al, 2007, 2011) to 
monitor carcinoma cell invasion behaviour. Typically this is achieved by seeding 
carcinoma cells onto the surface of a gel which represents healthy tissue, and 
encouraging carcinoma cells to invade. The 3D scaffold could be used to culture an 
in vitro "tissue" that can then be subjected to cell invasion. For instance, the 
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epidermal model developed in this chapter could be subjected to invasion by 
carcinoma cell line such as MET4 cells, or the HBL human melanoma cell line (Eves 
et al, 2003). 
6.1.1.2 Perfusion Chamber System 
Experiments in Chapter One showed that a larger amount of cell culture media 
available to cells growing in 3D improved their viability. This could be taken a step 
further by use of a perfusion chamber system, where 3D scaffolds are subject to 
constant culture media turnover and infusion of oxygen, allowing for optimal cell 
nutrition, waste clearance and buffering of the culture media. This system could be 
utilised for submerged cell culture of other cell types. This method was recently used 
with a biodegradable poly(lactic acid)-based scaffold to culture liver cells and 
measure their cytochrome P450 activity in response to cytotoxic anticancer drugs 
(Ma et al, 2012). Such systems have been used previously (Sun et al, 2005) to culture 
keratinocytes at an air-liquid interface with constant media turnover, resulting in 
improved cell viability. The 3D scaffold used in this study could be similarly used 
and may be advantageous due to its inherent stability for long culture periods. 
6.1.1.3 Routine Cell Culture 
The 3D scaffold could be for routine 3D cell culture. Increasingly, cell biologists are 
becoming aware of limitations in 2D cell culture (Schmeichel, 2003, Baker et al, 
2012). 2D cell culture has many deficiencies, and even alters long-term cell 
behaviour of cell lines after prolonged culture, further removing cells from their in 
vivo behaviour. This is outlined in greater detail during Chapter One. As the 3D 
scaffold is stable and non-biodegradable it should be possible to remove cultured, 
semi-confluent cells from the scaffold for sub-culture into new scaffolds. It would 
therefore be possible to routinely maintain cultured cells in 3D rather than 2D, 
potentially improving their usefulness for studying cell biology and modelling 
disease by reducing the adaptations cells undergo in prolonged 2D culture. 
Preliminary investigations showed that it was difficult to trypsinise cultured HaCaT 
cells out of the 3D scaffold used in this thesis, however HaCaT cells which strongly 
adhere to surfaces are also not an ideal cell line for this type of routine 3D culture. 
HaCaT cultures subjected to 40+ minutes of trypsinisation at 37°C still showed 
considerable numbers of keratinocytes inside the 3D scaffold after fixation and H&E 
staining. However, work undertaken by a project student in our lab showed that a 
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SW480 colon cancer cell line could be successfully grown in the 3D scaffold, 
separated from the material and then re-seeded into a new 3D scaffold, allowing for 
full long-term 3D culture cell maintenance. A new version of the 3D scaffold and 
improved protocols using non-enzymatic cell detachment methods are also under 
development in our lab with this routine cell culture purpose in mind. Keratinocytes 
could then be cultured long-term in low calcium, submerged conditions which have 
been shown in Chapter Three to prevent differentiation. Cultures can then be raised 
to the air liquid interface for experimentation purposes. 
6.1.1.4 Isolation of Primary Cells 
Current methods of primary keratinocytes isolation rely on separating the epidermis 
from the dermis, and then isolating keratinocytes by trypsinisation, centrifugation, 
physical agitation or heat. The isolated cells are then seeded directly onto 2D Petri 
dishes or glass plates (Turksen et al, 2006). This forces selective pressure onto cells, 
where only those capable of quickly adhering to the surface and adapting to the 
submerged 2D cultured conditions are able to survive and proliferate. As a result, 
these primary cells do not necessarily represent their in vivo counterparts closely. 
Assuming that current issues around cell trypsinisation are resolved, a stable, 
relatively rigid material such as the 3D scaffold could potentially be used for 
isolation and initial culture of primary keratinocytes from epidermal samples. This 
allows for more cell-cell contact and communication and long-term, this may 
preserve more of the cells' in vivo proliferative characteristics, allowing for more 
representative results in vitro. The use of the 3D scaffold for tissue explants is 
currently under investigation in our lab. 
6.1.1.5 Further Development of the 3D Scaffold Material 
The scaffold itself is under further development in our lab. Steps have been taken 
towards functionalisation of the polymer surface, such as covalent attachment of 
ligands, including collagen coating discussed in this chapter. Incorporation of soluble 
signalling molecules and growth factors into the 3D scaffold is also under 
investigation, for the production of "smart materials" which direct cell fate (Zeyfert 
et al, 2009). Other labs have shown that multiple growth factors can be released from 
materials over time due to differing release kinetics, and staggered to create optimal 
culture conditions with multi-stage proliferation or differentiation signals 
(Richardson et al, 2001). 
259 
 
Improvements to lab techniques and adjustments to standard protocols are being 
developed so that more techniques such as live cell imaging, cell transfections and 
protein extractions can be used in combination with cells cultured in the 3D scaffold. 
 
6.1.2 Further Investigation into the 3D Scaffold Epidermal Model 
Clearly no in vitro epidermal equivalent can yet replace native epidermis for final 
stage testing before a novel compound is approved for human use. This is for several 
reasons, but primarily because these models, including the 3D scaffold model, are 
still simple cultures utilising only keratinocytes or keratinocytes with a simple 
dermal equivalent. Although most models show several stratified layers of epidermal 
cells, differentiation markers and representative lipid profiles, these epidermal 
models have lack of vascularisation (and therefore only viable for short-term 
experiments), absence of Langerhans cells or melanocytes, lack of hair follicles, 
sebaceous glands or native floral microorganisms (Baroni et al, 2012). Several 
factors such as the presence/absence of hair follicles, lipid composition and 
morphology have been shown to be important in barrier permeability (Lademann et 
al, 2001) and therefore the current generation of epidermal models can not 
completely represent in vivo epidermis. 
Therefore all in vitro equivalents using current technology are limited and generally 
have permeabilities exceeding those of native epidermis (Schmook et al, 2001, 
Suhonen et al, 2003, Pappinen et al, 2012). However, 3D models are useful for 
preliminary testing the permeability of novel compounds and also for assessing the 
effect of compounds on epidermal differentiation, as SP600125 was assessed during 
the previous chapter. Understanding the actions of such compounds will uncover 
more understanding of signalling pathways involved in proliferation, differentiation 
and barrier function and how they may be manipulated for therapeutic benefit. For 
instance, some epidermal disorders may be treated by topical application of 
compounds affecting lipid metabolism (Elias et al, 2012).  
As mentioned in Chapter One, the epidermal barrier, in particular the stratum 
corneum, is the principle site of resistance to topical drug treatments. Therefore 
considerable research effort has been focused on increasing the permeability of 
molecules through the epidermis in order to improve drug delivery and the 
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effectiveness of topical treaments including delivery of hormones (testosterone 
replacement, hormonal contraception), nicotine replacement and painkillers in the 
form of creams or patches. These topical treatments are attractive therapeutically as 
they are painless, non-invasive and can be administered at home by the patient, 
making them preferable to injections. They also bypass first pass liver metabolism 
which represents an advantage over oral medications in terms of ease of drug design 
and avoiding complications due to metabolic byproducts. As described in Chapter 
One, these techniques for improving epidermal permeability have included using 
lipophilic permeation enhancers (Ochalek et al, 2012), microneedles (Wu et al, 2006) 
or encasing drugs inside lipid nanoparticles (Kuntsche et al, 2008), as well as mixing 
target compounds with oils, alcohols and other lipid soluble diluents to aid their 
passage through the epidermis. Testing of these compounds is one potential use for 
in vitro epidermal models, as they are reproducible and can cultured in large numbers 
for high volume testing. The 3D epidermal model established in this thesis could be 
treated with a chemical permeation enhancer and the effect on permeant diffusion 
measured. This is a common area of research where models generally exaggerate the 
permeation enhancing effect of compounds (Pappinen et al, 2007). 
The 3D scaffold model was generally reliable and reproducible, with only a few 
cultures being discarded because of leaking during diffusion experiments. In terms of 
morphology and lipid composition, 3D scaffold cultures were repeatable and 
reproducible because the 3D scaffold material itself is synthetic and stable, and the 
use of a stable cell line further increased reproducibility. As mentioned previously, 
native human epidermis shows considerable variation depending on the age, gender, 
race and genetics of individual donors, as well as body site, skin moisturisation and 
many other factors (Darlenski and Fluhr, 2012). This variation has also been found in 
commercial in vitro models using human NEK cells (Ponec et al, 2000, Schreiber et 
al, 2005) and variation in human epidermis permeability can be observed in data 
presented in Table 5.3. This makes preliminary testing of compounds more difficult 
and time-consuming due to increased variability in human samples. 
Interestingly, the direction of diffusion (i.e. dermis to epidermis or epidermis to 
dermis) shows equal resistance in human full thickness skin for most permeants, but 
is observed to be different for some large molecular weight compounds using in vitro 
skin equivalents (Oshizaka et al, 2012). The reason for this is likely due to the lack of 
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hair follicles in the in vitro model, which provide a route of passage for some 
hydrophilic compounds, whereas these compounds diffuse very slowly through 
paracellular pathways of the mature stratum corneum. Similar to findings in this 
chapter modelled by a 3D culture of 3T3 fibroblasts, Oshizaka and colleagues noted 
that the dermis alone provides very little barrier function (supported by further 
evidence in Schreiber et al, 2005) and proposed a "conical pore" model for the 
passage of hydrophilic and lipophilic in both directions of diffusion. Although the 
epidermal to dermal permeation of compounds is the most frequently studied, clearly 
dermal to epidermal diffusion is also important to maintain the homeostasis of the 
body. This could be tested using the 3D scaffold epidermal model by reversing the 
orientation of the culture in the diffusion apparatus. 
 
6.1.3 Future Work for 3D Materials 
Although promising, three dimensional cell culture is still a developing technique 
used by a minority of laboratories, even though the benefits are relatively well 
described. In order to achieve more widespread use, 3D cell culture needs to become 
more standardised, with routine protocols for cell seeding, analysis and 
experimentation widely available and economically viable. It is likely that in the 
intermediate future 3D cell culture may be used for validating discoveries made in 
2D, rather than replacing 2D culture outright for initial experimentation. 
Commercially, there is a growing demand for alternatives to animal models. 
Epidermal equivalents are one such area, which will be discussed in the following 
subsection. Liver biology is also an emerging 3D culture niche (Xu et al, 2003), as 
most pharmaceutical drugs are metabolised by the liver and many drugs display a 
level of hepatotoxicity (Bokhari et al, 2008, Skardal et al, 2012). An in vitro model 
of liver which can accurately predict drug toxicity and/or metabolism will be 
commercially successful, and so considerable efforts are being directed towards 3D 
hepatocyte culture.  
Regulatory steps also need to be taken by lawmakers in order to recognise future in 
vitro models as suitably verified alternatives to animal testing, which is often itself 
required by law before a drug, pharmaceutical or cosmetic can be used on humans. 
The European Centre for Validation of Alternate Methods (ECVAM) and the US 
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Food and Drug Administration (FDA) have approved some in vitro models for skin 
irritancy, corneal irritancy and epidermal permeability testing, but these review and 
approval processes are very slow and often lag far behind scientific developments 
(Wagner et al, 2012).  
In terms of the 3D culture materials themselves, there are currently no clear 
"winners", as different cell types each benefit from different materials and different 
culture conditions. However, there are interesting developments such integrating 
more extracellular matrix features, customising material surfaces to release growth 
factors, or altering micro-scale surface features and patterns to influence cell 
alignment and behaviour (Lee et al, 2008). Carbon nanotubes are an emerging 
material which can be precisely manufactured into highly specialised nanoscale 
surfaces. These surfaces are multi-purpose and can be used to control cell behaviour, 
track cells through embedded electrochemical resistance sensors or to provide 
structural support for synthetic polymer matrices (Harrison et al, 2007).  
Future developments in cell culture materials, culture techniques and analytical 
technology will help to make in vitro analyses more relevant and representative of in 
vivo behaviour, reducing animal testing as well as improving the safety of 
commercial products and acclerating research in the area.  
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